{
  "nbformat": 4,
  "nbformat_minor": 0,
  "metadata": {
    "colab": {
      "provenance": [],
      "gpuType": "T4"
    },
    "kernelspec": {
      "name": "python3",
      "display_name": "Python 3"
    },
    "language_info": {
      "name": "python"
    },
    "accelerator": "GPU",
    "widgets": {
      "application/vnd.jupyter.widget-state+json": {
        "53dc0e65be0b47af93ff04908c3c1f69": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HBoxModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HBoxModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HBoxView",
            "box_style": "",
            "children": [
              "IPY_MODEL_f1354b54455f46b39b956231ec38a639",
              "IPY_MODEL_0df1d57039d641849cc85352b2dcf962",
              "IPY_MODEL_e027623ed29c4f2396385f5ca7514e7b"
            ],
            "layout": "IPY_MODEL_1fc0ebf03d704c21aa7f0773ac43c606"
          }
        },
        "f1354b54455f46b39b956231ec38a639": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HTMLModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HTMLModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HTMLView",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_359cd67521234752bd27b0166a329522",
            "placeholder": "​",
            "style": "IPY_MODEL_8a46f755a0934603a766dc3e61b34626",
            "value": "Downloading builder script: "
          }
        },
        "0df1d57039d641849cc85352b2dcf962": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "FloatProgressModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "FloatProgressModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "ProgressView",
            "bar_style": "success",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_3d82a7da6b1346a5a72e515825c7fbf6",
            "max": 1,
            "min": 0,
            "orientation": "horizontal",
            "style": "IPY_MODEL_7128fd6e541b4708aab7d937255a1948",
            "value": 1
          }
        },
        "e027623ed29c4f2396385f5ca7514e7b": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HTMLModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HTMLModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HTMLView",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_3e94fc8c1f844f5f92b5908fab8917be",
            "placeholder": "​",
            "style": "IPY_MODEL_42b523d9112f4e00b7ef003e1f448b3c",
            "value": " 6.14k/? [00:00&lt;00:00, 379kB/s]"
          }
        },
        "1fc0ebf03d704c21aa7f0773ac43c606": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "359cd67521234752bd27b0166a329522": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "8a46f755a0934603a766dc3e61b34626": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "DescriptionStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "DescriptionStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "description_width": ""
          }
        },
        "3d82a7da6b1346a5a72e515825c7fbf6": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": "20px"
          }
        },
        "7128fd6e541b4708aab7d937255a1948": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "ProgressStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "ProgressStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "bar_color": null,
            "description_width": ""
          }
        },
        "3e94fc8c1f844f5f92b5908fab8917be": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "42b523d9112f4e00b7ef003e1f448b3c": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "DescriptionStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "DescriptionStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "description_width": ""
          }
        },
        "4fb99c701cae442bad9c6ef83bfdc270": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HBoxModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HBoxModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HBoxView",
            "box_style": "",
            "children": [
              "IPY_MODEL_af6dc6ef700249f988d5a2a831c9c476",
              "IPY_MODEL_1cf1402270ff4285a14694d704be3484",
              "IPY_MODEL_c5fee0c6fff4457cbed716b0f595dcfd"
            ],
            "layout": "IPY_MODEL_25ac0b56376a45fd9f9e4f1c05b91240"
          }
        },
        "af6dc6ef700249f988d5a2a831c9c476": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HTMLModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HTMLModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HTMLView",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_ba142f8814dc40ac898a9e6a0d9a92d4",
            "placeholder": "​",
            "style": "IPY_MODEL_7bdf5838c4ce44f68958fe7329892793",
            "value": "Downloading builder script: "
          }
        },
        "1cf1402270ff4285a14694d704be3484": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "FloatProgressModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "FloatProgressModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "ProgressView",
            "bar_style": "success",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_6ee273f9f5bb4fda82d0d07b2b461bd8",
            "max": 1,
            "min": 0,
            "orientation": "horizontal",
            "style": "IPY_MODEL_98acfbcf257d41afa18468cd2b6f7346",
            "value": 1
          }
        },
        "c5fee0c6fff4457cbed716b0f595dcfd": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HTMLModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HTMLModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HTMLView",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_122a97c8f18f43b9aea83f140988aadc",
            "placeholder": "​",
            "style": "IPY_MODEL_7dcfd470ecf24a279d6e29e5903ffde7",
            "value": " 5.94k/? [00:00&lt;00:00, 187kB/s]"
          }
        },
        "25ac0b56376a45fd9f9e4f1c05b91240": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "ba142f8814dc40ac898a9e6a0d9a92d4": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "7bdf5838c4ce44f68958fe7329892793": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "DescriptionStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "DescriptionStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "description_width": ""
          }
        },
        "6ee273f9f5bb4fda82d0d07b2b461bd8": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": "20px"
          }
        },
        "98acfbcf257d41afa18468cd2b6f7346": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "ProgressStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "ProgressStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "bar_color": null,
            "description_width": ""
          }
        },
        "122a97c8f18f43b9aea83f140988aadc": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "7dcfd470ecf24a279d6e29e5903ffde7": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "DescriptionStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "DescriptionStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "description_width": ""
          }
        },
        "e3ccc246046a4da083ba2ca9bf0d5eea": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HBoxModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HBoxModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HBoxView",
            "box_style": "",
            "children": [
              "IPY_MODEL_d6a0eb40b964473b8319cc2ff55da527",
              "IPY_MODEL_30b89adb718c4f8c8a6a09e9a1f33f1e",
              "IPY_MODEL_28071be0ea9e4bf382ff970e75a0a203"
            ],
            "layout": "IPY_MODEL_19f40f7d184a4c7e8096fe7431cfdb3f"
          }
        },
        "d6a0eb40b964473b8319cc2ff55da527": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HTMLModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HTMLModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HTMLView",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_07fda43f79d14c2f9aa219e70b3adb7c",
            "placeholder": "​",
            "style": "IPY_MODEL_4af5743537c64b4598b4fed149c10c9a",
            "value": "Downloading extra modules: "
          }
        },
        "30b89adb718c4f8c8a6a09e9a1f33f1e": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "FloatProgressModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "FloatProgressModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "ProgressView",
            "bar_style": "success",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_856eb9842163499097b35c670972d3fc",
            "max": 1554,
            "min": 0,
            "orientation": "horizontal",
            "style": "IPY_MODEL_c4531ace52094d518ae6185c25008715",
            "value": 1554
          }
        },
        "28071be0ea9e4bf382ff970e75a0a203": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HTMLModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HTMLModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HTMLView",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_43dc7946b0294937afe1fc6fe9e7cfa7",
            "placeholder": "​",
            "style": "IPY_MODEL_c5719fa413a94be2a742c21c5c0b2061",
            "value": " 4.07k/? [00:00&lt;00:00, 360kB/s]"
          }
        },
        "19f40f7d184a4c7e8096fe7431cfdb3f": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "07fda43f79d14c2f9aa219e70b3adb7c": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "4af5743537c64b4598b4fed149c10c9a": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "DescriptionStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "DescriptionStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "description_width": ""
          }
        },
        "856eb9842163499097b35c670972d3fc": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "c4531ace52094d518ae6185c25008715": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "ProgressStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "ProgressStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "bar_color": null,
            "description_width": ""
          }
        },
        "43dc7946b0294937afe1fc6fe9e7cfa7": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "c5719fa413a94be2a742c21c5c0b2061": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "DescriptionStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "DescriptionStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "description_width": ""
          }
        },
        "6cab491972c14b399b4eae9ee2bd3639": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HBoxModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HBoxModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HBoxView",
            "box_style": "",
            "children": [
              "IPY_MODEL_1959634c96364955af45cea54a958c33",
              "IPY_MODEL_d5ceef6748014b2ca5cfd0811c8a4f70",
              "IPY_MODEL_13943c4345db4075bbc608d7ccafa0af"
            ],
            "layout": "IPY_MODEL_79629c8356754c7283a33a73dfbc453d"
          }
        },
        "1959634c96364955af45cea54a958c33": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HTMLModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HTMLModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HTMLView",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_9bca380c558d436c8b329a3615e4af65",
            "placeholder": "​",
            "style": "IPY_MODEL_3acf3ffba1d642c598c0ba4d60e5b31b",
            "value": "Downloading extra modules: "
          }
        },
        "d5ceef6748014b2ca5cfd0811c8a4f70": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "FloatProgressModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "FloatProgressModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "ProgressView",
            "bar_style": "success",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_d297a4a9bd3d4b58bc3a18343ce95934",
            "max": 1,
            "min": 0,
            "orientation": "horizontal",
            "style": "IPY_MODEL_90059f8edb8a4595addc637ae6e4d3c8",
            "value": 1
          }
        },
        "13943c4345db4075bbc608d7ccafa0af": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HTMLModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HTMLModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HTMLView",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_bf895907ac7549969d752b8f59ac95a6",
            "placeholder": "​",
            "style": "IPY_MODEL_98d67b71d9f44958b142ba1f668b8d4c",
            "value": " 3.34k/? [00:00&lt;00:00, 98.8kB/s]"
          }
        },
        "79629c8356754c7283a33a73dfbc453d": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "9bca380c558d436c8b329a3615e4af65": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "3acf3ffba1d642c598c0ba4d60e5b31b": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "DescriptionStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "DescriptionStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "description_width": ""
          }
        },
        "d297a4a9bd3d4b58bc3a18343ce95934": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": "20px"
          }
        },
        "90059f8edb8a4595addc637ae6e4d3c8": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "ProgressStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "ProgressStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "bar_color": null,
            "description_width": ""
          }
        },
        "bf895907ac7549969d752b8f59ac95a6": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "98d67b71d9f44958b142ba1f668b8d4c": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "DescriptionStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "DescriptionStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "description_width": ""
          }
        },
        "77571eed282a45acb60290b4450b4849": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HBoxModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HBoxModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HBoxView",
            "box_style": "",
            "children": [
              "IPY_MODEL_8a4309981bde49f1b40b59ea63965f53",
              "IPY_MODEL_55561f7c1b8944ca91313fe423066cf6",
              "IPY_MODEL_c6f86846052d488289bb25321ef05be7"
            ],
            "layout": "IPY_MODEL_01e20475790e484f8606f66ce1c32803"
          }
        },
        "8a4309981bde49f1b40b59ea63965f53": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HTMLModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HTMLModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HTMLView",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_2c4bf337a67a412282cbbba724e2aad1",
            "placeholder": "​",
            "style": "IPY_MODEL_8ffafe055dd9486dac101c71a9a7a3dd",
            "value": "tokenizer_config.json: "
          }
        },
        "55561f7c1b8944ca91313fe423066cf6": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "FloatProgressModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "FloatProgressModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "ProgressView",
            "bar_style": "success",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_0d073957cc954bb1abc475872b7bc028",
            "max": 1,
            "min": 0,
            "orientation": "horizontal",
            "style": "IPY_MODEL_9939c49f926147a4be8fd4434d5f3fa5",
            "value": 1
          }
        },
        "c6f86846052d488289bb25321ef05be7": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HTMLModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HTMLModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HTMLView",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_37aa1a40b3844834be16380fa39932b0",
            "placeholder": "​",
            "style": "IPY_MODEL_7b8b7117cefe4097bd639c8ec68ef672",
            "value": " 7.30k/? [00:00&lt;00:00, 685kB/s]"
          }
        },
        "01e20475790e484f8606f66ce1c32803": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "2c4bf337a67a412282cbbba724e2aad1": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "8ffafe055dd9486dac101c71a9a7a3dd": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "DescriptionStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "DescriptionStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "description_width": ""
          }
        },
        "0d073957cc954bb1abc475872b7bc028": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": "20px"
          }
        },
        "9939c49f926147a4be8fd4434d5f3fa5": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "ProgressStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "ProgressStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "bar_color": null,
            "description_width": ""
          }
        },
        "37aa1a40b3844834be16380fa39932b0": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "7b8b7117cefe4097bd639c8ec68ef672": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "DescriptionStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "DescriptionStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "description_width": ""
          }
        },
        "790fb99c0eb1473783be787fae775fee": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HBoxModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HBoxModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HBoxView",
            "box_style": "",
            "children": [
              "IPY_MODEL_3be558e034fb495a92264e37d2237eb2",
              "IPY_MODEL_2e75a4660add48e895af3b3c1a51eb70",
              "IPY_MODEL_5b1af550aa1542d9bade9e7ee70c2ce2"
            ],
            "layout": "IPY_MODEL_94a517405b1d4cc79c10562b74026dd3"
          }
        },
        "3be558e034fb495a92264e37d2237eb2": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HTMLModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HTMLModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HTMLView",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_0f952b9c44e14f119580e406de55f009",
            "placeholder": "​",
            "style": "IPY_MODEL_10d682df61ee469e93ac2320e422c099",
            "value": "vocab.json: "
          }
        },
        "2e75a4660add48e895af3b3c1a51eb70": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "FloatProgressModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "FloatProgressModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "ProgressView",
            "bar_style": "success",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_dee5298ad82f4bd58bcca8f04168d479",
            "max": 1,
            "min": 0,
            "orientation": "horizontal",
            "style": "IPY_MODEL_69791fdf03c9498cb23e3c76784d4b07",
            "value": 1
          }
        },
        "5b1af550aa1542d9bade9e7ee70c2ce2": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HTMLModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HTMLModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HTMLView",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_8774b5cd04034789b96d6b2debd0ad01",
            "placeholder": "​",
            "style": "IPY_MODEL_204238bf2d51486094bcc1fd7e702604",
            "value": " 2.78M/? [00:00&lt;00:00, 52.9MB/s]"
          }
        },
        "94a517405b1d4cc79c10562b74026dd3": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "0f952b9c44e14f119580e406de55f009": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "10d682df61ee469e93ac2320e422c099": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "DescriptionStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "DescriptionStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "description_width": ""
          }
        },
        "dee5298ad82f4bd58bcca8f04168d479": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": "20px"
          }
        },
        "69791fdf03c9498cb23e3c76784d4b07": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "ProgressStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "ProgressStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "bar_color": null,
            "description_width": ""
          }
        },
        "8774b5cd04034789b96d6b2debd0ad01": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "204238bf2d51486094bcc1fd7e702604": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "DescriptionStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "DescriptionStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "description_width": ""
          }
        },
        "3e816a3761e845cc8b91504a4dc52eab": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HBoxModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HBoxModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HBoxView",
            "box_style": "",
            "children": [
              "IPY_MODEL_84aa00d6029c452c81d4e1f3530d6808",
              "IPY_MODEL_ef11d3bdde204116bdb01040aa19bb0f",
              "IPY_MODEL_e9fa4c0b9ffa456596d920ecda0cf725"
            ],
            "layout": "IPY_MODEL_87a8b129d1814cfbaab1ec600225ee98"
          }
        },
        "84aa00d6029c452c81d4e1f3530d6808": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HTMLModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HTMLModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HTMLView",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_8eafadd650834a538da36e0d5accc103",
            "placeholder": "​",
            "style": "IPY_MODEL_d72e32cd364645768e12324284c68c8f",
            "value": "merges.txt: "
          }
        },
        "ef11d3bdde204116bdb01040aa19bb0f": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "FloatProgressModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "FloatProgressModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "ProgressView",
            "bar_style": "success",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_00442c5fa8d546b593b37a553bffd1e7",
            "max": 1,
            "min": 0,
            "orientation": "horizontal",
            "style": "IPY_MODEL_3dbb95a695b642bebc97b416c4b9113b",
            "value": 1
          }
        },
        "e9fa4c0b9ffa456596d920ecda0cf725": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HTMLModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HTMLModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HTMLView",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_ea87e257833f4f81a5896da3cc36938a",
            "placeholder": "​",
            "style": "IPY_MODEL_bf4b564377674f69a29ee49c5a43cf93",
            "value": " 1.67M/? [00:00&lt;00:00, 47.1MB/s]"
          }
        },
        "87a8b129d1814cfbaab1ec600225ee98": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "8eafadd650834a538da36e0d5accc103": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "d72e32cd364645768e12324284c68c8f": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "DescriptionStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "DescriptionStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "description_width": ""
          }
        },
        "00442c5fa8d546b593b37a553bffd1e7": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": "20px"
          }
        },
        "3dbb95a695b642bebc97b416c4b9113b": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "ProgressStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "ProgressStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "bar_color": null,
            "description_width": ""
          }
        },
        "ea87e257833f4f81a5896da3cc36938a": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "bf4b564377674f69a29ee49c5a43cf93": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "DescriptionStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "DescriptionStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "description_width": ""
          }
        },
        "f14c88e3f5144513ad823dd4c24d24a0": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HBoxModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HBoxModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HBoxView",
            "box_style": "",
            "children": [
              "IPY_MODEL_a9a6975063fb4e9182a3ba43741c087c",
              "IPY_MODEL_1861b5bb0c0741f89e512220779ec9d4",
              "IPY_MODEL_cdc4f92b911e44e1b26d8a7290c2811a"
            ],
            "layout": "IPY_MODEL_6d1d93570b914387ae054fed62207c1a"
          }
        },
        "a9a6975063fb4e9182a3ba43741c087c": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HTMLModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HTMLModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HTMLView",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_dc8ba01475f54170b962566f11336885",
            "placeholder": "​",
            "style": "IPY_MODEL_1e52c2f55d5c48e6ae7ce25e1657b74e",
            "value": "tokenizer.json: "
          }
        },
        "1861b5bb0c0741f89e512220779ec9d4": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "FloatProgressModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "FloatProgressModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "ProgressView",
            "bar_style": "success",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_230e4cbc920e4581be8d90b7de63dc8a",
            "max": 1,
            "min": 0,
            "orientation": "horizontal",
            "style": "IPY_MODEL_3d8d731d48df486787519d88d77ea5ff",
            "value": 1
          }
        },
        "cdc4f92b911e44e1b26d8a7290c2811a": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HTMLModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HTMLModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HTMLView",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_677014d898e2489ca779386a67139f7f",
            "placeholder": "​",
            "style": "IPY_MODEL_42cc915ffaab492d8d2476974c7564a8",
            "value": " 7.03M/? [00:00&lt;00:00, 136MB/s]"
          }
        },
        "6d1d93570b914387ae054fed62207c1a": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "dc8ba01475f54170b962566f11336885": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "1e52c2f55d5c48e6ae7ce25e1657b74e": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "DescriptionStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "DescriptionStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "description_width": ""
          }
        },
        "230e4cbc920e4581be8d90b7de63dc8a": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": "20px"
          }
        },
        "3d8d731d48df486787519d88d77ea5ff": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "ProgressStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "ProgressStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "bar_color": null,
            "description_width": ""
          }
        },
        "677014d898e2489ca779386a67139f7f": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "42cc915ffaab492d8d2476974c7564a8": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "DescriptionStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "DescriptionStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "description_width": ""
          }
        },
        "7eb5a5c4a1e94bc6b23ed6042d9ddedc": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HBoxModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HBoxModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HBoxView",
            "box_style": "",
            "children": [
              "IPY_MODEL_192e75a70dff466da2ac80ea0530372f",
              "IPY_MODEL_70f2595845054d67b3f39d933d6a9dac",
              "IPY_MODEL_534b972d5f0841f0aa48514ff349b163"
            ],
            "layout": "IPY_MODEL_c90d167c97724028b2aa8ef70ea730f5"
          }
        },
        "192e75a70dff466da2ac80ea0530372f": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HTMLModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HTMLModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HTMLView",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_f12f221689d64f6593eb9b7dadfdf3b5",
            "placeholder": "​",
            "style": "IPY_MODEL_61cd49ff8988467da76437f60eed4ca0",
            "value": "config.json: 100%"
          }
        },
        "70f2595845054d67b3f39d933d6a9dac": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "FloatProgressModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "FloatProgressModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "ProgressView",
            "bar_style": "success",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_1a7e943fd5ec41e3a0292104f3a13138",
            "max": 660,
            "min": 0,
            "orientation": "horizontal",
            "style": "IPY_MODEL_90618aba610744f9bf6462f86a9959de",
            "value": 660
          }
        },
        "534b972d5f0841f0aa48514ff349b163": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HTMLModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HTMLModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HTMLView",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_1ac98add40da40c7a06d210c0e477a66",
            "placeholder": "​",
            "style": "IPY_MODEL_17999f177b8c4954ba27d66186472717",
            "value": " 660/660 [00:00&lt;00:00, 58.5kB/s]"
          }
        },
        "c90d167c97724028b2aa8ef70ea730f5": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "f12f221689d64f6593eb9b7dadfdf3b5": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "61cd49ff8988467da76437f60eed4ca0": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "DescriptionStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "DescriptionStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "description_width": ""
          }
        },
        "1a7e943fd5ec41e3a0292104f3a13138": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "90618aba610744f9bf6462f86a9959de": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "ProgressStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "ProgressStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "bar_color": null,
            "description_width": ""
          }
        },
        "1ac98add40da40c7a06d210c0e477a66": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "17999f177b8c4954ba27d66186472717": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "DescriptionStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "DescriptionStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "description_width": ""
          }
        },
        "0c6c873e96d14b00b2b3171ffa616c6b": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HBoxModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HBoxModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HBoxView",
            "box_style": "",
            "children": [
              "IPY_MODEL_7efdd61f159f42f3a3fd1beb3402e345",
              "IPY_MODEL_48ae62e20cb94ffd88cb3ff15414049b",
              "IPY_MODEL_70fc87d8975b4c6a97a630f395ef2882"
            ],
            "layout": "IPY_MODEL_9981922ab236454a9a92060e0a66a380"
          }
        },
        "7efdd61f159f42f3a3fd1beb3402e345": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HTMLModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HTMLModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HTMLView",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_1bed3e8d2a494eadac6afa06ec739eb3",
            "placeholder": "​",
            "style": "IPY_MODEL_84f72b92be304246a514e32ab6a6c8cd",
            "value": "model.safetensors: 100%"
          }
        },
        "48ae62e20cb94ffd88cb3ff15414049b": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "FloatProgressModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "FloatProgressModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "ProgressView",
            "bar_style": "success",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_3f8b01d6d4184e6ba0eeec5a4d33b248",
            "max": 3087467144,
            "min": 0,
            "orientation": "horizontal",
            "style": "IPY_MODEL_fb467c05d94740f09959976253b123d0",
            "value": 3087467144
          }
        },
        "70fc87d8975b4c6a97a630f395ef2882": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HTMLModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HTMLModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HTMLView",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_8f8d3f71faed4aab8b42c957d5529636",
            "placeholder": "​",
            "style": "IPY_MODEL_a65e3f89868d4e30bbe098a14bbd5851",
            "value": " 3.09G/3.09G [00:24&lt;00:00, 275MB/s]"
          }
        },
        "9981922ab236454a9a92060e0a66a380": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "1bed3e8d2a494eadac6afa06ec739eb3": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "84f72b92be304246a514e32ab6a6c8cd": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "DescriptionStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "DescriptionStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "description_width": ""
          }
        },
        "3f8b01d6d4184e6ba0eeec5a4d33b248": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "fb467c05d94740f09959976253b123d0": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "ProgressStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "ProgressStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "bar_color": null,
            "description_width": ""
          }
        },
        "8f8d3f71faed4aab8b42c957d5529636": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "a65e3f89868d4e30bbe098a14bbd5851": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "DescriptionStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "DescriptionStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "description_width": ""
          }
        },
        "b72120e99603471b8960fa74fc0f5666": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HBoxModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HBoxModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HBoxView",
            "box_style": "",
            "children": [
              "IPY_MODEL_119f03c47c82442a9cac73d14001c684",
              "IPY_MODEL_36f98f3bdd924e03a44695c0648d0a67",
              "IPY_MODEL_59d6d92496fc4cc7a93fcf2015e413e9"
            ],
            "layout": "IPY_MODEL_2c04d00dcdab4849a62bb66e49f29f9a"
          }
        },
        "119f03c47c82442a9cac73d14001c684": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HTMLModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HTMLModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HTMLView",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_c55f218cd2d4477f8ecc5dc73ecdc848",
            "placeholder": "​",
            "style": "IPY_MODEL_2416eb44e24f4de38f4943f7af05c6b0",
            "value": "generation_config.json: 100%"
          }
        },
        "36f98f3bdd924e03a44695c0648d0a67": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "FloatProgressModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "FloatProgressModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "ProgressView",
            "bar_style": "success",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_b9cc4ab085db4481acf2cdae02d0713b",
            "max": 242,
            "min": 0,
            "orientation": "horizontal",
            "style": "IPY_MODEL_ee80638e8fea4e1aa3cf595c2703fa71",
            "value": 242
          }
        },
        "59d6d92496fc4cc7a93fcf2015e413e9": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HTMLModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HTMLModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HTMLView",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_bee31cf7fd57416abaeda07707f850a6",
            "placeholder": "​",
            "style": "IPY_MODEL_2e803a3870544a91b0713d5f3792d3cc",
            "value": " 242/242 [00:00&lt;00:00, 5.32kB/s]"
          }
        },
        "2c04d00dcdab4849a62bb66e49f29f9a": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "c55f218cd2d4477f8ecc5dc73ecdc848": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "2416eb44e24f4de38f4943f7af05c6b0": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "DescriptionStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "DescriptionStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "description_width": ""
          }
        },
        "b9cc4ab085db4481acf2cdae02d0713b": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "ee80638e8fea4e1aa3cf595c2703fa71": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "ProgressStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "ProgressStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "bar_color": null,
            "description_width": ""
          }
        },
        "bee31cf7fd57416abaeda07707f850a6": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "2e803a3870544a91b0713d5f3792d3cc": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "DescriptionStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "DescriptionStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "description_width": ""
          }
        }
      }
    }
  },
  "cells": [
    {
      "cell_type": "markdown",
      "source": [
        "# **Project: COVID-19 Vaccine QA Fine-Tuning & Deployment Pipeline**\n",
        "\n",
        "**Overview**\n",
        "\n",
        "This notebook implements a modular, end-to-end pipeline to collect, process, and fine-tune a Small Language Model (SLM) on domain-specific medical data (COVID-19 Vaccine Safety).\n",
        "\n",
        "**Key Features**:\n",
        "\n",
        "1. **Automated Data Extraction**  \n",
        "   - Processes PDFs and extracts structured text.  \n",
        "   - Attaches metadata for source attribution and traceability.  \n",
        "\n",
        "2. **Synthetic QA Dataset Generation**  \n",
        "   - Generates high-quality question-answer pairs using LLMs.  \n",
        "   - Ensures each answer is strictly grounded in the source text.  \n",
        "   - Validates output against structured Pydantic schemas for consistency.\n",
        "\n",
        "3. **Model Fine-Tuning**  \n",
        "   - Adapts a base causal LLM to domain-specific knowledge using LoRA/PEFT.  \n",
        "   - Supports CPU/GPU setups and reproducible workflows.\n",
        "\n",
        "4. **Evaluation & Benchmarking**  \n",
        "   - Measures model performance using automated metrics (ROUGE, BLEU).  \n",
        "   - Tracks inference latency and throughput for production readiness.\n",
        "\n",
        "**Goal**:  \n",
        "Enable accurate, domain-specific question answering on COVID-19 vaccine safety literature with a reproducible and production-ready pipeline.\n",
        "\n",
        "\n",
        "# **1. Environment Setup & Configuration**\n",
        "\n",
        "This block prepares the notebook for the entire pipeline:\n",
        "\n",
        "- Mounts Google Drive for data access\n",
        "- Installs required libraries\n",
        "- Loads the project configuration (`config.yaml`)\n",
        "- Sets global variables (model ID, device, paths)\n",
        "- Prepares utility functions for the pipeline\n",
        "\n",
        "> This ensures the pipeline is modular, reproducible, and ready for any domain.\n",
        "## 1.1 Dependency Installation"
      ],
      "metadata": {
        "id": "ikjuwDzwZgoI"
      }
    },
    {
      "cell_type": "code",
      "source": [
        "# Run once\n",
        "!pip install -qU transformers==4.45.2 peft==0.12.0 accelerate==0.34.2\n",
        "!pip install -qU datasets==3.1.0 optimum==1.22.0\n",
        "!pip install -qU openai==1.61.0 wandb json-repair==0.30.0\n",
        "!pip install -qU pdfplumber PyYAML instructor\n",
        "!pip install -qU google-generativeai\n",
        "!pip install evaluate rouge_score absl-py"
      ],
      "metadata": {
        "id": "DrQGrAM6GpN4",
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "outputId": "c513e109-55ec-4333-c711-b1c833ce7399"
      },
      "execution_count": 6,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "\u001b[2K     \u001b[90m━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━\u001b[0m \u001b[32m44.4/44.4 kB\u001b[0m \u001b[31m2.9 MB/s\u001b[0m eta \u001b[36m0:00:00\u001b[0m\n",
            "\u001b[2K   \u001b[90m━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━\u001b[0m \u001b[32m9.9/9.9 MB\u001b[0m \u001b[31m84.7 MB/s\u001b[0m eta \u001b[36m0:00:00\u001b[0m\n",
            "\u001b[2K   \u001b[90m━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━\u001b[0m \u001b[32m296.4/296.4 kB\u001b[0m \u001b[31m28.1 MB/s\u001b[0m eta \u001b[36m0:00:00\u001b[0m\n",
            "\u001b[2K   \u001b[90m━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━\u001b[0m \u001b[32m324.4/324.4 kB\u001b[0m \u001b[31m30.1 MB/s\u001b[0m eta \u001b[36m0:00:00\u001b[0m\n",
            "\u001b[2K   \u001b[90m━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━\u001b[0m \u001b[32m3.0/3.0 MB\u001b[0m \u001b[31m97.9 MB/s\u001b[0m eta \u001b[36m0:00:00\u001b[0m\n",
            "\u001b[2K     \u001b[90m━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━\u001b[0m \u001b[32m43.7/43.7 kB\u001b[0m \u001b[31m3.3 MB/s\u001b[0m eta \u001b[36m0:00:00\u001b[0m\n",
            "\u001b[2K     \u001b[90m━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━\u001b[0m \u001b[32m61.0/61.0 kB\u001b[0m \u001b[31m5.5 MB/s\u001b[0m eta \u001b[36m0:00:00\u001b[0m\n",
            "\u001b[2K   \u001b[90m━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━\u001b[0m \u001b[32m480.6/480.6 kB\u001b[0m \u001b[31m19.8 MB/s\u001b[0m eta \u001b[36m0:00:00\u001b[0m\n",
            "\u001b[2K   \u001b[90m━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━\u001b[0m \u001b[32m453.7/453.7 kB\u001b[0m \u001b[31m43.9 MB/s\u001b[0m eta \u001b[36m0:00:00\u001b[0m\n",
            "\u001b[2K   \u001b[90m━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━\u001b[0m \u001b[32m18.0/18.0 MB\u001b[0m \u001b[31m80.5 MB/s\u001b[0m eta \u001b[36m0:00:00\u001b[0m\n",
            "\u001b[2K   \u001b[90m━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━\u001b[0m \u001b[32m9.5/9.5 MB\u001b[0m \u001b[31m9.6 MB/s\u001b[0m eta \u001b[36m0:00:00\u001b[0m\n",
            "\u001b[2K   \u001b[90m━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━\u001b[0m \u001b[32m46.0/46.0 kB\u001b[0m \u001b[31m2.9 MB/s\u001b[0m eta \u001b[36m0:00:00\u001b[0m\n",
            "\u001b[2K   \u001b[90m━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━\u001b[0m \u001b[32m86.8/86.8 kB\u001b[0m \u001b[31m4.6 MB/s\u001b[0m eta \u001b[36m0:00:00\u001b[0m\n",
            "\u001b[2K   \u001b[90m━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━\u001b[0m \u001b[32m3.6/3.6 MB\u001b[0m \u001b[31m46.7 MB/s\u001b[0m eta \u001b[36m0:00:00\u001b[0m\n",
            "\u001b[?25h\u001b[31mERROR: pip's dependency resolver does not currently take into account all the packages that are installed. This behaviour is the source of the following dependency conflicts.\n",
            "opencv-python 4.12.0.88 requires numpy<2.3.0,>=2; python_version >= \"3.9\", but you have numpy 1.26.4 which is incompatible.\n",
            "pytensor 2.36.3 requires numpy>=2.0, but you have numpy 1.26.4 which is incompatible.\n",
            "tobler 0.13.0 requires numpy>=2.0, but you have numpy 1.26.4 which is incompatible.\n",
            "shap 0.50.0 requires numpy>=2, but you have numpy 1.26.4 which is incompatible.\n",
            "jaxlib 0.7.2 requires numpy>=2.0, but you have numpy 1.26.4 which is incompatible.\n",
            "opencv-python-headless 4.12.0.88 requires numpy<2.3.0,>=2; python_version >= \"3.9\", but you have numpy 1.26.4 which is incompatible.\n",
            "jax 0.7.2 requires numpy>=2.0, but you have numpy 1.26.4 which is incompatible.\n",
            "rasterio 1.5.0 requires numpy>=2, but you have numpy 1.26.4 which is incompatible.\n",
            "opencv-contrib-python 4.12.0.88 requires numpy<2.3.0,>=2; python_version >= \"3.9\", but you have numpy 1.26.4 which is incompatible.\u001b[0m\u001b[31m\n",
            "\u001b[0m\u001b[31mERROR: pip's dependency resolver does not currently take into account all the packages that are installed. This behaviour is the source of the following dependency conflicts.\n",
            "instructor 1.14.4 requires openai<3.0.0,>=2.0.0, but you have openai 1.61.0 which is incompatible.\u001b[0m\u001b[31m\n",
            "\u001b[0mRequirement already satisfied: evaluate in /usr/local/lib/python3.12/dist-packages (0.4.6)\n",
            "Requirement already satisfied: rouge_score in /usr/local/lib/python3.12/dist-packages (0.1.2)\n",
            "Requirement already satisfied: absl-py in /usr/local/lib/python3.12/dist-packages (1.4.0)\n",
            "Requirement already satisfied: datasets>=2.0.0 in /usr/local/lib/python3.12/dist-packages (from evaluate) (3.1.0)\n",
            "Requirement already satisfied: numpy>=1.17 in /usr/local/lib/python3.12/dist-packages (from evaluate) (1.26.4)\n",
            "Requirement already satisfied: dill in /usr/local/lib/python3.12/dist-packages (from evaluate) (0.3.8)\n",
            "Requirement already satisfied: pandas in /usr/local/lib/python3.12/dist-packages (from evaluate) (2.2.2)\n",
            "Requirement already satisfied: requests>=2.19.0 in /usr/local/lib/python3.12/dist-packages (from evaluate) (2.32.4)\n",
            "Requirement already satisfied: tqdm>=4.62.1 in /usr/local/lib/python3.12/dist-packages (from evaluate) (4.67.1)\n",
            "Requirement already satisfied: xxhash in /usr/local/lib/python3.12/dist-packages (from evaluate) (3.6.0)\n",
            "Requirement already satisfied: multiprocess in /usr/local/lib/python3.12/dist-packages (from evaluate) (0.70.16)\n",
            "Requirement already satisfied: fsspec>=2021.05.0 in /usr/local/lib/python3.12/dist-packages (from fsspec[http]>=2021.05.0->evaluate) (2024.9.0)\n",
            "Requirement already satisfied: huggingface-hub>=0.7.0 in /usr/local/lib/python3.12/dist-packages (from evaluate) (0.36.0)\n",
            "Requirement already satisfied: packaging in /usr/local/lib/python3.12/dist-packages (from evaluate) (25.0)\n",
            "Requirement already satisfied: nltk in /usr/local/lib/python3.12/dist-packages (from rouge_score) (3.9.1)\n",
            "Requirement already satisfied: six>=1.14.0 in /usr/local/lib/python3.12/dist-packages (from rouge_score) (1.17.0)\n",
            "Requirement already satisfied: filelock in /usr/local/lib/python3.12/dist-packages (from datasets>=2.0.0->evaluate) (3.20.2)\n",
            "Requirement already satisfied: pyarrow>=15.0.0 in /usr/local/lib/python3.12/dist-packages (from datasets>=2.0.0->evaluate) (18.1.0)\n",
            "Requirement already satisfied: aiohttp in /usr/local/lib/python3.12/dist-packages (from datasets>=2.0.0->evaluate) (3.13.3)\n",
            "Requirement already satisfied: pyyaml>=5.1 in /usr/local/lib/python3.12/dist-packages (from datasets>=2.0.0->evaluate) (6.0.3)\n",
            "Requirement already satisfied: typing-extensions>=3.7.4.3 in /usr/local/lib/python3.12/dist-packages (from huggingface-hub>=0.7.0->evaluate) (4.15.0)\n",
            "Requirement already satisfied: hf-xet<2.0.0,>=1.1.3 in /usr/local/lib/python3.12/dist-packages (from huggingface-hub>=0.7.0->evaluate) (1.2.0)\n",
            "Requirement already satisfied: charset_normalizer<4,>=2 in /usr/local/lib/python3.12/dist-packages (from requests>=2.19.0->evaluate) (3.4.4)\n",
            "Requirement already satisfied: idna<4,>=2.5 in /usr/local/lib/python3.12/dist-packages (from requests>=2.19.0->evaluate) (3.11)\n",
            "Requirement already satisfied: urllib3<3,>=1.21.1 in /usr/local/lib/python3.12/dist-packages (from requests>=2.19.0->evaluate) (2.5.0)\n",
            "Requirement already satisfied: certifi>=2017.4.17 in /usr/local/lib/python3.12/dist-packages (from requests>=2.19.0->evaluate) (2026.1.4)\n",
            "Requirement already satisfied: click in /usr/local/lib/python3.12/dist-packages (from nltk->rouge_score) (8.3.1)\n",
            "Requirement already satisfied: joblib in /usr/local/lib/python3.12/dist-packages (from nltk->rouge_score) (1.5.3)\n",
            "Requirement already satisfied: regex>=2021.8.3 in /usr/local/lib/python3.12/dist-packages (from nltk->rouge_score) (2025.11.3)\n",
            "Requirement already satisfied: python-dateutil>=2.8.2 in /usr/local/lib/python3.12/dist-packages (from pandas->evaluate) (2.9.0.post0)\n",
            "Requirement already satisfied: pytz>=2020.1 in /usr/local/lib/python3.12/dist-packages (from pandas->evaluate) (2025.2)\n",
            "Requirement already satisfied: tzdata>=2022.7 in /usr/local/lib/python3.12/dist-packages (from pandas->evaluate) (2025.3)\n",
            "Requirement already satisfied: aiohappyeyeballs>=2.5.0 in /usr/local/lib/python3.12/dist-packages (from aiohttp->datasets>=2.0.0->evaluate) (2.6.1)\n",
            "Requirement already satisfied: aiosignal>=1.4.0 in /usr/local/lib/python3.12/dist-packages (from aiohttp->datasets>=2.0.0->evaluate) (1.4.0)\n",
            "Requirement already satisfied: attrs>=17.3.0 in /usr/local/lib/python3.12/dist-packages (from aiohttp->datasets>=2.0.0->evaluate) (25.4.0)\n",
            "Requirement already satisfied: frozenlist>=1.1.1 in /usr/local/lib/python3.12/dist-packages (from aiohttp->datasets>=2.0.0->evaluate) (1.8.0)\n",
            "Requirement already satisfied: multidict<7.0,>=4.5 in /usr/local/lib/python3.12/dist-packages (from aiohttp->datasets>=2.0.0->evaluate) (6.7.0)\n",
            "Requirement already satisfied: propcache>=0.2.0 in /usr/local/lib/python3.12/dist-packages (from aiohttp->datasets>=2.0.0->evaluate) (0.4.1)\n",
            "Requirement already satisfied: yarl<2.0,>=1.17.0 in /usr/local/lib/python3.12/dist-packages (from aiohttp->datasets>=2.0.0->evaluate) (1.22.0)\n"
          ]
        }
      ]
    },
    {
      "cell_type": "markdown",
      "source": [
        "## 1.2 import all libraries"
      ],
      "metadata": {
        "id": "ybsLYR2JagMt"
      }
    },
    {
      "cell_type": "code",
      "source": [
        "# Standard libraries\n",
        "import os\n",
        "import random\n",
        "from pathlib import Path\n",
        "from datetime import datetime\n",
        "import hashlib\n",
        "from pprint import pprint\n",
        "import json\n",
        "import csv\n",
        "import yaml\n",
        "import math\n",
        "from typing import List, Dict, Optional\n",
        "\n",
        "# PDF parsing\n",
        "import pdfplumber\n",
        "\n",
        "# Data manipulation\n",
        "import pandas as pd\n",
        "import numpy as np\n",
        "\n",
        "# QA / LLM processing\n",
        "import transformers\n",
        "from transformers import AutoTokenizer, AutoModelForCausalLM, pipeline\n",
        "\n",
        "# Dataset & evaluation utilities\n",
        "from datasets import Dataset, DatasetDict, load_dataset\n",
        "import evaluate\n",
        "\n",
        "# Schema validation\n",
        "from pydantic import BaseModel, Field\n",
        "\n",
        "# Model tracking / MLOps\n",
        "import wandb\n",
        "\n",
        "# Optional: for visualization\n",
        "import matplotlib.pyplot as plt\n",
        "import seaborn as sns\n",
        "\n",
        "# Optional: for saving Excel reports\n",
        "import openpyxl\n"
      ],
      "metadata": {
        "id": "ycCBBOT1aZ08"
      },
      "execution_count": 1,
      "outputs": []
    },
    {
      "cell_type": "markdown",
      "source": [
        "## 1.3 Drive Mounting and Working Directory & Dependency Installation"
      ],
      "metadata": {
        "id": "wbog3j_tXf7C"
      }
    },
    {
      "cell_type": "code",
      "source": [
        "# Google Drive Mount\n",
        "from google.colab import drive\n",
        "drive.mount('/content/drive')\n",
        "# Project Paths & Config\n",
        "import os\n",
        "PROJECT_PATH = \"/content/drive/MyDrive/COVID-19 Vaccine Side Effects and Safety/\"\n",
        "os.chdir(PROJECT_PATH)\n",
        "CONFIG_PATH = os.path.join(PROJECT_PATH, \"config.yaml\")\n",
        "# Load Configuration\n",
        "import yaml\n",
        "with open(CONFIG_PATH, \"r\") as f:\n",
        "    config = yaml.safe_load(f)\n",
        "\n",
        "print(f\"Target Domain: {config.get('domain')}\")\n",
        "print(f\"Data Directory: {config.get('data_directory')}\")\n",
        "print(f\"PDF Files: {config.get('pdfs')}\")\n",
        "\n",
        "import torch\n",
        "BASE_MODEL_ID = \"Qwen/Qwen2.5-1.5B-Instruct\"\n",
        "DEVICE = \"cuda\" if torch.cuda.is_available() else \"cpu\"\n",
        "print(f\"Device: {DEVICE}\")\n",
        "\n",
        "import json_repair\n",
        "\n",
        "def parse_json(text):\n",
        "    \"\"\"\n",
        "    Safely parse LLM output using json_repair.\n",
        "    Returns a dictionary or None if invalid JSON.\n",
        "    \"\"\"\n",
        "    try:\n",
        "        return json_repair.loads(text)\n",
        "    except:\n",
        "        return None"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "SHpqueAbZ4y2",
        "outputId": "62993bff-393c-4958-fd94-a6b2e109df4c"
      },
      "execution_count": 2,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "Drive already mounted at /content/drive; to attempt to forcibly remount, call drive.mount(\"/content/drive\", force_remount=True).\n",
            "Target Domain: COVID-19 vaccine side effects\n",
            "Data Directory: data/raw/\n",
            "PDF Files: ['Clinical Analysis of Long Post-COVID Vaccination Syndrome (LPCVS).pdf', 'covid_side_effects.pdf', 'COVID_Vaccine_Neuro_Effects.pdf', 'COVID_Vaccine_Safety_Facts.pdf', 'jj_vaccine_risks.pdf', 'Long_Term_Side_Effects_Medics.pdf', 'Pfizer_Platelet_LongTerm_Study.pdf', 'Rare_Vaccine_Side_Effects.pdf', 'Vaccine_Efficacy_Omicron_vs_Delta.pdf', 'WHO_XEC_Variant_Risk.pdf']\n",
            "Device: cuda\n"
          ]
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "PROJECT_PATH = \"/content/drive/MyDrive/COVID-19 Vaccine Side Effects and Safety/\"\n",
        "config_path=PROJECT_PATH+\"config.yaml\"\n",
        "config_path = os.path.join(PROJECT_PATH, \"config.yaml\")\n",
        "with open(config_path, \"r\") as f:\n",
        "    config = yaml.safe_load(f)\n",
        "\n",
        "print(f\"Target Domain: {config['domain']}\")"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "VmYzH5pRacKO",
        "outputId": "3c078a91-a398-428a-8096-32668bcbc834"
      },
      "execution_count": 3,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "Target Domain: COVID-19 vaccine side effects\n"
          ]
        }
      ]
    },
    {
      "cell_type": "markdown",
      "source": [
        "# **2. Data Extraction / Collection**\n",
        "This is responsible for turning raw PDFs into structured, machine-readable text.\n",
        "## 2.1 PDF Parsing & Metadata extraction and source attribution"
      ],
      "metadata": {
        "id": "NBbXakPnaRvS"
      }
    },
    {
      "cell_type": "code",
      "source": [
        "raw_dir = Path(PROJECT_PATH) / config[\"data_directory\"]\n",
        "pdf_files = [raw_dir / pdf for pdf in config[\"pdfs\"]]\n",
        "\n",
        "documents=[]\n",
        "for pdf_path in pdf_files:\n",
        "    with pdfplumber.open(pdf_path) as pdf:\n",
        "        for page_num, page in enumerate(pdf.pages, start=1):\n",
        "          text = page.extract_text()\n",
        "          if text and text.strip():\n",
        "              doc = {\n",
        "                  \"id\": f\"{pdf_path}_page_{page_num}\",\n",
        "                  \"text\": text.strip(),\n",
        "                  \"metadata\": {\n",
        "                      \"source\": pdf_path.name,\n",
        "                      \"page\": page_num,\n",
        "                      \"domain\": config[\"domain\"],\n",
        "                      \"created_at\": datetime.now().isoformat()\n",
        "                  }\n",
        "              }\n",
        "              documents.append(doc)\n",
        "\n",
        "\n"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "xthBKGf3wgeO",
        "outputId": "c47b2b28-632a-4585-eaca-4eb5cb71ab81"
      },
      "execution_count": 4,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "WARNING:pdfminer.pdffont:Could not get FontBBox from font descriptor because None cannot be parsed as 4 floats\n",
            "WARNING:pdfminer.pdffont:Could not get FontBBox from font descriptor because None cannot be parsed as 4 floats\n",
            "WARNING:pdfminer.pdffont:Could not get FontBBox from font descriptor because None cannot be parsed as 4 floats\n",
            "WARNING:pdfminer.pdffont:Could not get FontBBox from font descriptor because None cannot be parsed as 4 floats\n",
            "WARNING:pdfminer.pdffont:Could not get FontBBox from font descriptor because None cannot be parsed as 4 floats\n"
          ]
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "documents[0]"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "uKYDCNpebCeb",
        "outputId": "9d083597-93d3-4870-f2be-8a07b27bd682"
      },
      "execution_count": 5,
      "outputs": [
        {
          "output_type": "execute_result",
          "data": {
            "text/plain": [
              "{'id': '/content/drive/MyDrive/COVID-19 Vaccine Side Effects and Safety/data/raw/Clinical Analysis of Long Post-COVID Vaccination Syndrome (LPCVS).pdf_page_1',\n",
              " 'text': 'Journal of Clinical and Translational Research 2022; 8(6): 506-508\\nJournal of Clinical and Translational Research\\nJournal homepage: http://www.jctres.com/en/home\\nORIGINAL ARTICLE\\nA retrospective analysis of clinically confirmed long post-COVID vaccination\\nsyndrome\\nJosef Finterer1*, Fulvio A. Scorza2\\n1Neurology and Neurophysiology Center, Vienna, Austria, 2Department of Neurological, Federal University of Sao Paolo Rua Pedro de Toledo,\\nSão Paulo, Brasil\\nARTICLE INFO ABSTRACT\\nArticle history: Background and Aim: Long post-COVID vaccination syndrome (LPCVS) is an increasingly\\nReceived: August 17, 2022 recognized disease that occurs after SARS-CoV-2 vaccinations and lasts >4 weeks. However, little\\nRevised: September 13, 2022 is known about the clinical presentation, underlying pathophysiology, treatment, and outcome of\\nAccepted: October 24, 2022 LPCVS. This study aims to present a series of patients with LPCVS, their treatment, and outcomes.\\nPublished online: November 9, 2022 Methods: This was a retrospective analysis of three patients with LPCVS.\\nResults: In an observation period of 2 months (January and February 2022), three patients were\\nKeywords: collected in whom side effects after vaccination against COVID-19 lasted >4 weeks and in whom\\nSARS-CoV-2 instrumental examinations were largely unremarkable. All three patients received only symptomatic\\nCOVID-19 therapy and only partially recovered within 6–8 months after vaccination. LPCVS significantly\\nvaccination impaired the quality of life of the included patients.\\nside effects Conclusions: SARS-CoV-2 vaccinations may cause not only short-term but also long-term side\\nlong-term outcome effects that include not only known diseases but also non-specific symptoms with normal or slightly\\nabnormal clinical and instrumental findings. Although LPCVS leads to long-term disability, it is not\\n*Corresponding author: widely recognized and not always accepted by manufacturers, health authorities, and even scientists.\\nJosef Finterer LPCVS should not be dismissed as a functional disorder and patients with LPCVS should be taken\\nNeurology and Neurophysiology Center, seriously.\\nVienna, Austria. Relevance for Patients: The possible causal relation between some long side effects and SARS-CoV-2\\nEmail: fifigs1@yahoo.de vaccines cannot be ignored. The pathophysiology of LPCVS should be further studied to lay a\\nfoundation for further improvement of the vaccines.\\n© 2022 Author(s). This is an Open-Access\\narticle distributed under the terms of the\\nCreative Commons Attribution-Noncommercial\\nLicense, permitting all non-commercial use, 1. Introduction\\ndistribution, and reproduction in any medium,\\nprovided the original work is properly cited. It is well known that vaccinations against COVID-19 are not free from side effects in\\nsome patients [1]. Real world data have shown that these side effects can be mild or serious\\nand can be short-lived or last for weeks or even months. Post-SARS-CoV-2 vaccination\\ncomplications either include well defined diseases with abnormal findings on clinical\\nexamination and instrumental investigations (e.g., Guillain-Barre syndrome, venous sinus\\nthrombosis (VST), and immune encephalitis), or one or more symptoms with or without\\nabnormal findings on clinical examination or instrumental investigations. If side effects\\nto SARS-CoV-2 vaccinations persist for >4 weeks with no or minimal abnormal findings\\non clinical or instrumental investigations, the condition is classified as long post-COVID\\nvaccination syndrome (LPCVS) or long post-SARS-CoV-2 vaccination syndrome [2], in\\nanalogy to long-COVID-syndrome. We recently described a patient with LPCVS in whom\\nclinical examination and instrumental investigations were negative [2]. Since then, a\\nnumber of other patients with LPCVS and with or without abnormal instrumental findings\\nDOI: http://dx.doi.org/10.18053/jctres.08.202206.008',\n",
              " 'metadata': {'source': 'Clinical Analysis of Long Post-COVID Vaccination Syndrome (LPCVS).pdf',\n",
              "  'page': 1,\n",
              "  'domain': 'COVID-19 vaccine side effects',\n",
              "  'created_at': '2026-01-21T00:56:04.531444'}}"
            ]
          },
          "metadata": {},
          "execution_count": 5
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "# Shuffle the documents in-place\n",
        "random.seed(42)\n",
        "random.shuffle(documents)"
      ],
      "metadata": {
        "id": "_LoOmOQoBEm1"
      },
      "execution_count": 9,
      "outputs": []
    },
    {
      "cell_type": "markdown",
      "source": [
        "# **3. Structured Output Schema (Pydantic)**\n",
        "We enforce a strict JSON schema for the LLM responses using Pydantic.\n",
        "This guarantees:\n",
        "- Consistent output format\n",
        "- Easy parsing\n",
        "- Validation of model responses\n",
        "- Production-readiness"
      ],
      "metadata": {
        "id": "dE0dLOhdG5Xo"
      }
    },
    {
      "cell_type": "code",
      "source": [
        "class GenerateAnswer(BaseModel):\n",
        "    answer: str = Field(..., description=\"Final answer to the user question\")\n",
        "    # source: str = Field(..., description=\"Source document name\")\n",
        "    # page: int = Field(..., description=\"Page number in the document\")\n",
        "    confidence: float = Field(..., description=\"Model confidence between 0 and 1\")\n"
      ],
      "metadata": {
        "id": "5wr7lGhF7wNa"
      },
      "execution_count": 10,
      "outputs": []
    },
    {
      "cell_type": "code",
      "source": [
        "user_question =\"Based on the longitudinal retrospective analysis of platelet activity and the 2022 clinical analysis of LPCVS, what specific biomarker concentrations are suggested for evaluating long-term vaccine activity, and what was the recorded recovery timeline for the three patients who received only symptomatic therapy?\"\n",
        "\n",
        "qa_extraction_messages = [\n",
        "    {\n",
        "        \"role\": \"system\",\n",
        "        \"content\": \"\\n\".join([\n",
        "            \"You are a professional medical data analyst.\",\n",
        "            \"You will be provided with a user question.\",\n",
        "            \"Your goal is to answer the question accurately based ONLY on the provided text.\",\n",
        "            \"Follow the provided Pydantic Scheme to generate a valid JSON output.\",\n",
        "            \"If the answer is not in the text, state that you don't know and set confidence to 0.\",\n",
        "            \"Do not generate any introduction or conclusion.\"\n",
        "        ])\n",
        "    },\n",
        "    {\n",
        "        \"role\": \"user\",\n",
        "        \"content\": \"\\n\".join([\n",
        "            \"## User Question:\",\n",
        "            user_question,\n",
        "            \"\",\n",
        "            \"## Pydantic Details (Output Schema):\",\n",
        "            json.dumps(GenerateAnswer.model_json_schema(), ensure_ascii=False),\n",
        "            \"\",\n",
        "            \"## Structured Answer:\",\n",
        "            \"```json\"\n",
        "        ])\n",
        "    }\n",
        "]"
      ],
      "metadata": {
        "id": "omtMcu40Piar"
      },
      "execution_count": 11,
      "outputs": []
    },
    {
      "cell_type": "markdown",
      "source": [
        "# **4. Evaluation on Base Model**\n",
        "This block tests the pre-trained LLM on your structured pipeline, using the previously defined Pydantic schema to validate outputs.\n",
        "## 4.1 Load Base Model"
      ],
      "metadata": {
        "id": "JnnUvYExjRV5"
      }
    },
    {
      "cell_type": "code",
      "source": [
        "from transformers import AutoModelForCausalLM, AutoTokenizer\n",
        "import torch\n",
        "model_id = config[\"base_model\"]  # read from config\n",
        "device = torch.device(\"cuda\" if torch.cuda.is_available() else \"cpu\")\n",
        "tokenizer = AutoTokenizer.from_pretrained(model_id)\n",
        "model = AutoModelForCausalLM.from_pretrained(\n",
        "    model_id,\n",
        "    torch_dtype=\"auto\",\n",
        "    device_map=\"auto\" )\n",
        "tokenizer = AutoTokenizer.from_pretrained(model_id)"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 365,
          "referenced_widgets": [
            "77571eed282a45acb60290b4450b4849",
            "8a4309981bde49f1b40b59ea63965f53",
            "55561f7c1b8944ca91313fe423066cf6",
            "c6f86846052d488289bb25321ef05be7",
            "01e20475790e484f8606f66ce1c32803",
            "2c4bf337a67a412282cbbba724e2aad1",
            "8ffafe055dd9486dac101c71a9a7a3dd",
            "0d073957cc954bb1abc475872b7bc028",
            "9939c49f926147a4be8fd4434d5f3fa5",
            "37aa1a40b3844834be16380fa39932b0",
            "7b8b7117cefe4097bd639c8ec68ef672",
            "790fb99c0eb1473783be787fae775fee",
            "3be558e034fb495a92264e37d2237eb2",
            "2e75a4660add48e895af3b3c1a51eb70",
            "5b1af550aa1542d9bade9e7ee70c2ce2",
            "94a517405b1d4cc79c10562b74026dd3",
            "0f952b9c44e14f119580e406de55f009",
            "10d682df61ee469e93ac2320e422c099",
            "dee5298ad82f4bd58bcca8f04168d479",
            "69791fdf03c9498cb23e3c76784d4b07",
            "8774b5cd04034789b96d6b2debd0ad01",
            "204238bf2d51486094bcc1fd7e702604",
            "3e816a3761e845cc8b91504a4dc52eab",
            "84aa00d6029c452c81d4e1f3530d6808",
            "ef11d3bdde204116bdb01040aa19bb0f",
            "e9fa4c0b9ffa456596d920ecda0cf725",
            "87a8b129d1814cfbaab1ec600225ee98",
            "8eafadd650834a538da36e0d5accc103",
            "d72e32cd364645768e12324284c68c8f",
            "00442c5fa8d546b593b37a553bffd1e7",
            "3dbb95a695b642bebc97b416c4b9113b",
            "ea87e257833f4f81a5896da3cc36938a",
            "bf4b564377674f69a29ee49c5a43cf93",
            "f14c88e3f5144513ad823dd4c24d24a0",
            "a9a6975063fb4e9182a3ba43741c087c",
            "1861b5bb0c0741f89e512220779ec9d4",
            "cdc4f92b911e44e1b26d8a7290c2811a",
            "6d1d93570b914387ae054fed62207c1a",
            "dc8ba01475f54170b962566f11336885",
            "1e52c2f55d5c48e6ae7ce25e1657b74e",
            "230e4cbc920e4581be8d90b7de63dc8a",
            "3d8d731d48df486787519d88d77ea5ff",
            "677014d898e2489ca779386a67139f7f",
            "42cc915ffaab492d8d2476974c7564a8",
            "7eb5a5c4a1e94bc6b23ed6042d9ddedc",
            "192e75a70dff466da2ac80ea0530372f",
            "70f2595845054d67b3f39d933d6a9dac",
            "534b972d5f0841f0aa48514ff349b163",
            "c90d167c97724028b2aa8ef70ea730f5",
            "f12f221689d64f6593eb9b7dadfdf3b5",
            "61cd49ff8988467da76437f60eed4ca0",
            "1a7e943fd5ec41e3a0292104f3a13138",
            "90618aba610744f9bf6462f86a9959de",
            "1ac98add40da40c7a06d210c0e477a66",
            "17999f177b8c4954ba27d66186472717",
            "0c6c873e96d14b00b2b3171ffa616c6b",
            "7efdd61f159f42f3a3fd1beb3402e345",
            "48ae62e20cb94ffd88cb3ff15414049b",
            "70fc87d8975b4c6a97a630f395ef2882",
            "9981922ab236454a9a92060e0a66a380",
            "1bed3e8d2a494eadac6afa06ec739eb3",
            "84f72b92be304246a514e32ab6a6c8cd",
            "3f8b01d6d4184e6ba0eeec5a4d33b248",
            "fb467c05d94740f09959976253b123d0",
            "8f8d3f71faed4aab8b42c957d5529636",
            "a65e3f89868d4e30bbe098a14bbd5851",
            "b72120e99603471b8960fa74fc0f5666",
            "119f03c47c82442a9cac73d14001c684",
            "36f98f3bdd924e03a44695c0648d0a67",
            "59d6d92496fc4cc7a93fcf2015e413e9",
            "2c04d00dcdab4849a62bb66e49f29f9a",
            "c55f218cd2d4477f8ecc5dc73ecdc848",
            "2416eb44e24f4de38f4943f7af05c6b0",
            "b9cc4ab085db4481acf2cdae02d0713b",
            "ee80638e8fea4e1aa3cf595c2703fa71",
            "bee31cf7fd57416abaeda07707f850a6",
            "2e803a3870544a91b0713d5f3792d3cc"
          ]
        },
        "id": "s1sSJ1a-RI7z",
        "outputId": "e9ce7843-c902-4ab0-d1d5-19787fa504ee"
      },
      "execution_count": 12,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "/usr/local/lib/python3.12/dist-packages/huggingface_hub/utils/_auth.py:94: UserWarning: \n",
            "The secret `HF_TOKEN` does not exist in your Colab secrets.\n",
            "To authenticate with the Hugging Face Hub, create a token in your settings tab (https://huggingface.co/settings/tokens), set it as secret in your Google Colab and restart your session.\n",
            "You will be able to reuse this secret in all of your notebooks.\n",
            "Please note that authentication is recommended but still optional to access public models or datasets.\n",
            "  warnings.warn(\n"
          ]
        },
        {
          "output_type": "display_data",
          "data": {
            "text/plain": [
              "tokenizer_config.json: 0.00B [00:00, ?B/s]"
            ],
            "application/vnd.jupyter.widget-view+json": {
              "version_major": 2,
              "version_minor": 0,
              "model_id": "77571eed282a45acb60290b4450b4849"
            }
          },
          "metadata": {}
        },
        {
          "output_type": "display_data",
          "data": {
            "text/plain": [
              "vocab.json: 0.00B [00:00, ?B/s]"
            ],
            "application/vnd.jupyter.widget-view+json": {
              "version_major": 2,
              "version_minor": 0,
              "model_id": "790fb99c0eb1473783be787fae775fee"
            }
          },
          "metadata": {}
        },
        {
          "output_type": "display_data",
          "data": {
            "text/plain": [
              "merges.txt: 0.00B [00:00, ?B/s]"
            ],
            "application/vnd.jupyter.widget-view+json": {
              "version_major": 2,
              "version_minor": 0,
              "model_id": "3e816a3761e845cc8b91504a4dc52eab"
            }
          },
          "metadata": {}
        },
        {
          "output_type": "display_data",
          "data": {
            "text/plain": [
              "tokenizer.json: 0.00B [00:00, ?B/s]"
            ],
            "application/vnd.jupyter.widget-view+json": {
              "version_major": 2,
              "version_minor": 0,
              "model_id": "f14c88e3f5144513ad823dd4c24d24a0"
            }
          },
          "metadata": {}
        },
        {
          "output_type": "display_data",
          "data": {
            "text/plain": [
              "config.json:   0%|          | 0.00/660 [00:00<?, ?B/s]"
            ],
            "application/vnd.jupyter.widget-view+json": {
              "version_major": 2,
              "version_minor": 0,
              "model_id": "7eb5a5c4a1e94bc6b23ed6042d9ddedc"
            }
          },
          "metadata": {}
        },
        {
          "output_type": "display_data",
          "data": {
            "text/plain": [
              "model.safetensors:   0%|          | 0.00/3.09G [00:00<?, ?B/s]"
            ],
            "application/vnd.jupyter.widget-view+json": {
              "version_major": 2,
              "version_minor": 0,
              "model_id": "0c6c873e96d14b00b2b3171ffa616c6b"
            }
          },
          "metadata": {}
        },
        {
          "output_type": "display_data",
          "data": {
            "text/plain": [
              "generation_config.json:   0%|          | 0.00/242 [00:00<?, ?B/s]"
            ],
            "application/vnd.jupyter.widget-view+json": {
              "version_major": 2,
              "version_minor": 0,
              "model_id": "b72120e99603471b8960fa74fc0f5666"
            }
          },
          "metadata": {}
        }
      ]
    },
    {
      "cell_type": "markdown",
      "source": [
        "## **4.2 Prepare Input**\n",
        "Using qa_extraction_messages from Block 3 (Pydantic schema)"
      ],
      "metadata": {
        "id": "MXpCYmGXrM7n"
      }
    },
    {
      "cell_type": "code",
      "source": [
        "text = tokenizer.apply_chat_template(qa_extraction_messages, tokenize=False, aydd_generation_prompt=True)\n",
        "model_inputs = tokenizer([text], return_tensors=\"pt\").to(device)"
      ],
      "metadata": {
        "id": "M9eMhtAAkaAb"
      },
      "execution_count": 13,
      "outputs": []
    },
    {
      "cell_type": "markdown",
      "source": [
        "## 4.3 Generate Response\n"
      ],
      "metadata": {
        "id": "H0X9uB_wsGll"
      }
    },
    {
      "cell_type": "code",
      "source": [
        "generated_ids = model.generate(\n",
        "    model_inputs.input_ids,\n",
        "    max_new_tokens=1024,\n",
        "    do_sample=False,\n",
        "    top_k=None,\n",
        "    temperature=None,\n",
        "    top_p=None\n",
        ")"
      ],
      "metadata": {
        "id": "TfebtxhtsX6V",
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "outputId": "e3aa403b-4389-48f4-aeae-b8e71a8a8fe2"
      },
      "execution_count": 14,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask is not set and cannot be inferred from input because pad token is same as eos token. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n"
          ]
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "generated_ids = [\n",
        "    output_ids[len(input_ids):]\n",
        "    for input_ids, output_ids in zip(model_inputs.input_ids, generated_ids)\n",
        "]\n",
        "\n",
        "response = tokenizer.batch_decode(generated_ids, skip_special_tokens=True)[0]\n"
      ],
      "metadata": {
        "id": "x4cMIy0TsLV2"
      },
      "execution_count": 15,
      "outputs": []
    },
    {
      "cell_type": "code",
      "source": [
        "print(response)"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "eKOliuuQslNu",
        "outputId": "650c5c7d-cb59-48a0-d471-b549ec6ae533"
      },
      "execution_count": 16,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "system\n",
            "{\n",
            "  \"answer\": \"The specific biomarker concentrations suggested for evaluating long-term vaccine activity include IL-6, TNF-alpha, and IFN-gamma.\",\n",
            "  \"confidence\": 1.0\n",
            "}\n"
          ]
        }
      ]
    },
    {
      "cell_type": "markdown",
      "source": [
        "Base model hallucinates generic medical patterns due to over-generalization, failing to capture the specific evidence-based details present in our niche corpus.\n",
        "# **5. QA Dataset Generation**\n",
        "This block is responsible for generating high-quality question-answer pairs from your documents, forming the core dataset for fine-tuning your LLM.\n",
        "\n",
        "."
      ],
      "metadata": {
        "id": "IPkhRh5rzFoi"
      }
    },
    {
      "cell_type": "code",
      "source": [
        "!pip install -q -U google-generativeai"
      ],
      "metadata": {
        "id": "ze7ZU9h_v2lG"
      },
      "execution_count": null,
      "outputs": []
    },
    {
      "cell_type": "code",
      "source": [
        "## Remmber to put it in config\n",
        "import google.generativeai as genai\n",
        "from google.colab import userdata\n",
        "\n",
        "genai.configure(api_key=userdata.get('covid_key'))\n",
        "model = genai.GenerativeModel(\"models/gemini-2.5-flash-lite\")"
      ],
      "metadata": {
        "id": "HAnJCSPIvgdt"
      },
      "execution_count": null,
      "outputs": []
    },
    {
      "cell_type": "markdown",
      "source": [
        "## 5.1 Single Page QA Generation\n",
        "\n",
        "Generate QA pairs from one page at a time using the Gemini/LLM model.\n"
      ],
      "metadata": {
        "id": "Tifxpcs2zPro"
      }
    },
    {
      "cell_type": "code",
      "source": [
        "# Install and configure Gemini API\n",
        "!pip install -q -U google-generativeai\n",
        "\n",
        "import google.generativeai as genai\n",
        "from google.colab import userdata\n",
        "import json\n",
        "from typing import List\n",
        "from pydantic import BaseModel, Field\n",
        "\n",
        "# Load your API key from Colab userdata\n",
        "genai.configure(api_key=userdata.get('covid_key'))\n",
        "model = genai.GenerativeModel(\"models/gemini-2.5-flash-lite\")\n",
        "\n",
        "# Pydantic schemas\n",
        "class QAPair(BaseModel):\n",
        "    question: str = Field(..., description=\"A clear question based on the context\")\n",
        "    answer: str = Field(..., description=\"An accurate answer supported by the context\")\n",
        "    confidence: float = Field(..., description=\"Model confidence between 0 and 1\")\n",
        "    source: str = Field(..., description=\"The filename of the PDF\")\n",
        "    page: int = Field(..., description=\"The page number where the answer was found\")\n",
        "\n",
        "class PageExtraction(BaseModel):\n",
        "    qa_pairs: List[QAPair] = Field(..., description=\"List of 5 QA pairs from the text\")\n",
        "\n",
        "# Example for a single document\n",
        "test_doc = documents[0]\n",
        "\n",
        "qa_generation_messages = [\n",
        "    {\n",
        "        \"role\": \"system\",\n",
        "        \"content\": \"\\n\".join([\n",
        "            \"You are a dataset generator for a Covid19 Question Answering system.\",\n",
        "            \"Generate FIVE high-quality questions and answers strictly based on the provided context.\",\n",
        "            \"Each answer MUST be strictly grounded in the text.\",\n",
        "            \"Include the source filename and page number for each QA pair.\",\n",
        "            \"Return ONLY valid JSON following the provided Pydantic schema.\",\n",
        "            \"Do not add explanations or extra text.\"\n",
        "        ])\n",
        "    },\n",
        "    {\n",
        "        \"role\": \"user\",\n",
        "        \"content\": f\"\"\"\n",
        "## Context:\n",
        "{test_doc['text'].strip()}\n",
        "\n",
        "## Source:\n",
        "{test_doc['metadata']['source']}\n",
        "\n",
        "## Page:\n",
        "{test_doc['metadata']['page']}\n",
        "\n",
        "## Pydantic Schema:\n",
        "{json.dumps(PageExtraction.model_json_schema(), ensure_ascii=False)}\n",
        "\n",
        "## QA Pair:\n",
        "```json\n",
        "\"\"\"\n",
        "    }\n",
        "]\n",
        "\n",
        "prompt = \"\\n\".join([\n",
        "    qa_generation_messages[0][\"content\"],\n",
        "    \"\",\n",
        "    qa_generation_messages[1][\"content\"],\n",
        "    \"\",\n",
        "    \"```json\"\n",
        "])\n",
        "\n",
        "\n",
        "response = model.generate_content(prompt)\n",
        "print(response.text)\n"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 905
        },
        "id": "JRZ3Al8XIXbO",
        "outputId": "01ea737f-516d-4754-b296-491f555d5c84"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "ERROR:tornado.access:503 POST /v1beta/models/gemini-2.5-flash:generateContent?%24alt=json%3Benum-encoding%3Dint (::1) 1968.68ms\n",
            "ERROR:tornado.access:503 POST /v1beta/models/gemini-2.5-flash:generateContent?%24alt=json%3Benum-encoding%3Dint (::1) 2448.41ms\n",
            "ERROR:tornado.access:503 POST /v1beta/models/gemini-2.5-flash:generateContent?%24alt=json%3Benum-encoding%3Dint (::1) 706.81ms\n",
            "ERROR:tornado.access:503 POST /v1beta/models/gemini-2.5-flash:generateContent?%24alt=json%3Benum-encoding%3Dint (::1) 809.83ms\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "```json\n",
            "{\n",
            "  \"qa_pairs\": [\n",
            "    {\n",
            "      \"question\": \"What is the overall risk and antigenic advantage associated with the XEC variant?\",\n",
            "      \"answer\": \"Overall risk XEC is growing rapidly but possesses minimal antigenic advantage in evading previous immunity.\",\n",
            "      \"confidence\": 1.0,\n",
            "      \"source\": \"WHO_XEC_Variant_Risk.pdf\",\n",
            "      \"page\": 3\n",
            "    },\n",
            "    {\n",
            "      \"question\": \"Does the XEC variant cause higher disease severity compared to other circulating variants?\",\n",
            "      \"answer\": \"There are no reports to suggest that the associated disease severity is higher as compared to other circulating variants.\",\n",
            "      \"confidence\": 1.0,\n",
            "      \"source\": \"WHO_XEC_Variant_Risk.pdf\",\n",
            "      \"page\": 3\n",
            "    },\n",
            "    {\n",
            "      \"question\": \"How many XEC sequences were available globally in epidemiological week 47 (11 to 17 November 2024), and what percentage did they represent?\",\n",
            "      \"answer\": \"There are currently 13,331 XEC sequences available from 50 countries, representing 36.8% of the globally available sequences in epidemiological week 47, (11 to 17 November 2024).\",\n",
            "      \"confidence\": 1.0,\n",
            "      \"source\": \"WHO_XEC_Variant_Risk.pdf\",\n",
            "      \"page\": 3\n",
            "    },\n",
            "    {\n",
            "      \"question\": \"What was the prevalence of XEC four weeks prior to epidemiological week 47, specifically in week 44 (28 October to 3 November 2024)?\",\n",
            "      \"answer\": \"This is a significant rise in prevalence from 26.9% four weeks prior in epidemiological week 44 (28 October to 3 November 2024).\",\n",
            "      \"confidence\": 1.0,\n",
            "      \"source\": \"WHO_XEC_Variant_Risk.pdf\",\n",
            "      \"page\": 3\n",
            "    },\n",
            "    {\n",
            "      \"question\": \"What was the estimated relative effective reproduction number (Re) of XEC compared to KP.3.1.1 in August 2024?\",\n",
            "      \"answer\": \"In August 2024, the relative effective reproduction number (Re) of XEC was estimated to be 1.13-fold higher than that of KP.3.1.1, the most prevalent SARS-CoV-2 variant globally then and at present.\",\n",
            "      \"confidence\": 1.0,\n",
            "      \"source\": \"WHO_XEC_Variant_Risk.pdf\",\n",
            "      \"page\": 3\n",
            "    }\n",
            "  ]\n",
            "}\n",
            "```\n",
            "{'question': 'What is the overall risk and antigenic advantage associated with the XEC variant?', 'answer': 'Overall risk XEC is growing rapidly but possesses minimal antigenic advantage in evading previous immunity.', 'confidence': 1.0, 'source': 'WHO_XEC_Variant_Risk.pdf', 'page': 3}\n",
            "{'question': 'Does the XEC variant cause higher disease severity compared to other circulating variants?', 'answer': 'There are no reports to suggest that the associated disease severity is higher as compared to other circulating variants.', 'confidence': 1.0, 'source': 'WHO_XEC_Variant_Risk.pdf', 'page': 3}\n",
            "{'question': 'How many XEC sequences were available globally in epidemiological week 47 (11 to 17 November 2024), and what percentage did they represent?', 'answer': 'There are currently 13,331 XEC sequences available from 50 countries, representing 36.8% of the globally available sequences in epidemiological week 47, (11 to 17 November 2024).', 'confidence': 1.0, 'source': 'WHO_XEC_Variant_Risk.pdf', 'page': 3}\n",
            "{'question': 'What was the prevalence of XEC four weeks prior to epidemiological week 47, specifically in week 44 (28 October to 3 November 2024)?', 'answer': 'This is a significant rise in prevalence from 26.9% four weeks prior in epidemiological week 44 (28 October to 3 November 2024).', 'confidence': 1.0, 'source': 'WHO_XEC_Variant_Risk.pdf', 'page': 3}\n",
            "{'question': 'What was the estimated relative effective reproduction number (Re) of XEC compared to KP.3.1.1 in August 2024?', 'answer': 'In August 2024, the relative effective reproduction number (Re) of XEC was estimated to be 1.13-fold higher than that of KP.3.1.1, the most prevalent SARS-CoV-2 variant globally then and at present.', 'confidence': 1.0, 'source': 'WHO_XEC_Variant_Risk.pdf', 'page': 3}\n"
          ]
        }
      ]
    },
    {
      "cell_type": "markdown",
      "source": [
        "## 5.2 Batch QA Generation\n",
        "\n",
        "Generate QA pairs across multiple pages with batching."
      ],
      "metadata": {
        "id": "sckO0059z6g1"
      }
    },
    {
      "cell_type": "code",
      "source": [
        "import json\n",
        "import time\n",
        "from tqdm.auto import tqdm\n",
        "from google.api_core.exceptions import TooManyRequests\n",
        "class QAPair(BaseModel):\n",
        "    question: str = Field(..., description=\"A clear question based on the context\")\n",
        "    answer: str = Field(..., description=\"An accurate answer supported by the context\")\n",
        "    confidence: float = Field(..., description=\"Model confidence between 0 and 1\")\n",
        "    source: str = Field(..., description=\"The filename of the PDF\")\n",
        "    page: int = Field(..., description=\"The page number where the answer was found\")\n",
        "\n",
        "class PageExtraction(BaseModel):\n",
        "# I wanna to extract 20 different questions from each page (5 for each page)\n",
        "    qa_pairs: List[QAPair] = Field(...,  description=\"List of 20 QA pairs from the text\")\n",
        "\n",
        "# Output file\n",
        "output_path = Path(\"covid_qa_dataset.jsonl\")\n",
        "output_path.write_text(\"\", encoding=\"utf-8\")  # empty file before starting\n",
        "\n",
        "RETRY_DELAY = 40  # seconds to wait on rate limit\n",
        "MAX_RETRIES = 3\n",
        "BATCH_SIZE = 4   # number of pages per request\n",
        "\n",
        "# Build prompt from a batch of documents\n",
        "def build_prompt(batch):\n",
        "    context_parts = []\n",
        "    for doc in batch:\n",
        "        context_parts.append(f\"## Page {doc['metadata']['page']} from {doc['metadata']['source']}:\")\n",
        "        context_parts.append(doc['text'].strip())\n",
        "    context_text = \"\\n\\n\".join(context_parts)\n",
        "\n",
        "    qa_generation_messages = [\n",
        "        {\n",
        "            \"role\": \"system\",\n",
        "            \"content\": \"\\n\".join([\n",
        "                \"You are a dataset generator for a Covid19 Question Answering system.\",\n",
        "                \"Generate Twenty high-quality questions and answers strictly based on the provided context.\",\n",
        "                \"Each answer MUST be strictly grounded in the text.\",\n",
        "                \"Include the source filename and page number for each QA pair.\",\n",
        "                \"Return ONLY valid JSON following the provided Pydantic schema.\",\n",
        "                \"Do not add explanations or extra text.\"\n",
        "            ])\n",
        "        },\n",
        "        {\n",
        "            \"role\": \"user\",\n",
        "            \"content\": f\"\"\"\n",
        "## Context:\n",
        "{context_text}\n",
        "\n",
        "## Pydantic Schema:\n",
        "{json.dumps(PageExtraction.model_json_schema(), ensure_ascii=False)}\n",
        "\n",
        "## QA Pair:\n",
        "```json\n",
        "\"\"\"\n",
        "        }\n",
        "    ]\n",
        "    prompt = \"\\n\".join([qa_generation_messages[0][\"content\"], \"\", qa_generation_messages[1][\"content\"], \"\", \"```json\"])\n",
        "    return prompt\n",
        "\n",
        "# Process in batches\n",
        "batched_documents = [documents[i:i+BATCH_SIZE] for i in range(0, len(documents), BATCH_SIZE)]\n",
        "\n",
        "#Save QA pairs into JSONL format as a frozen artifact for reuse in fine-tuning.\n",
        "for batch in tqdm(batched_documents, desc=\"Processing batches\"):\n",
        "    prompt = build_prompt(batch)\n",
        "\n",
        "    for attempt in range(MAX_RETRIES):\n",
        "        try:\n",
        "            response = model.generate_content(prompt)\n",
        "            qa_batch = parse_json(response.text)\n",
        "\n",
        "            if qa_batch and \"qa_pairs\" in qa_batch:\n",
        "                # Save QA pairs to JSONL\n",
        "                with open(output_path, \"a\", encoding=\"utf-8\") as f:\n",
        "                    for pair in qa_batch[\"qa_pairs\"]:\n",
        "                        f.write(json.dumps(pair, ensure_ascii=False) + \"\\n\")\n",
        "                break  # success, move to next batch\n",
        "            else:\n",
        "                print(f\"Bad JSON in batch starting with page {batch[0]['metadata']['page']}\")\n",
        "                print(response.text)\n",
        "                break  # skip if JSON invalid\n",
        "\n",
        "        except TooManyRequests:\n",
        "            print(f\"Rate limit hit. Retrying in {RETRY_DELAY}s...\")\n",
        "            time.sleep(RETRY_DELAY)\n",
        "    else:\n",
        "        print(f\"Skipping batch starting with page {batch[0]['metadata']['page']} after {MAX_RETRIES} retries.\")\n",
        "\n",
        "print(f\"All QA pairs saved to {output_path} successfully!\")\n"
      ],
      "metadata": {
        "id": "GTWg0xDsZf3T"
      },
      "execution_count": null,
      "outputs": []
    },
    {
      "cell_type": "markdown",
      "source": [
        "## 5.3 Display Generated QA Dataset"
      ],
      "metadata": {
        "id": "toDhTnVf00Wm"
      }
    },
    {
      "cell_type": "code",
      "source": [
        "with open(output_path, \"r\", encoding=\"utf-8\") as f:\n",
        "    for line_num, line in enumerate(f, 1):\n",
        "        if line.strip():\n",
        "            data = json.loads(line)\n",
        "            print(f\"--- QA Pair {line_num} ---\")\n",
        "            print(json.dumps(data, indent=2, ensure_ascii=False))\n",
        "            print(\"\\n\")"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "ZjNwyaFxsMz3",
        "outputId": "bf3bce74-99ff-4a11-c647-4cba0690cea7"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "--- QA Pair 1 ---\n",
            "{\n",
            "  \"question\": \"What is the current assessment of the overall risk posed by the XEC variant?\",\n",
            "  \"answer\": \"The overall risk of XEC is growing rapidly, but it possesses minimal antigenic advantage in evading previous immunity. There is a significant increase in cases attributable to XEC infections, but the associated disease severity is not reported to be higher compared to other circulating variants.\",\n",
            "  \"confidence\": 1,\n",
            "  \"source\": \"WHO_XEC_Variant_Risk.pdf\",\n",
            "  \"page\": 3\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 2 ---\n",
            "{\n",
            "  \"question\": \"Are there any indications that XEC infections are more severe than those caused by other Omicron descendent lineages?\",\n",
            "  \"answer\": \"No, the available evidence on XEC does not suggest additional public health risks relative to the other currently circulating Omicron descendent lineages, nor are there reports to suggest that the associated disease severity is higher.\",\n",
            "  \"confidence\": 1,\n",
            "  \"source\": \"WHO_XEC_Variant_Risk.pdf\",\n",
            "  \"page\": 3\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 3 ---\n",
            "{\n",
            "  \"question\": \"What is the growth advantage of XEC based on available sequences?\",\n",
            "  \"answer\": \"There are currently 13,331 XEC sequences available from 50 countries, representing 36.8% of the globally available sequences in epidemiological week 47 (November 11 to 17, 2024). This indicates a significant rise in prevalence from 26.9% four weeks prior.\",\n",
            "  \"confidence\": 1,\n",
            "  \"source\": \"WHO_XEC_Variant_Risk.pdf\",\n",
            "  \"page\": 3\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 4 ---\n",
            "{\n",
            "  \"question\": \"How does the prevalence of XEC compare to KP.3.1.1?\",\n",
            "  \"answer\": \"While XEC is increasing in prevalence, the most prevalent SARS-CoV-2 variant, KP.3.1.1, is gradually declining globally and across WHO regions.\",\n",
            "  \"confidence\": 1,\n",
            "  \"source\": \"WHO_XEC_Variant_Risk.pdf\",\n",
            "  \"page\": 3\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 5 ---\n",
            "{\n",
            "  \"question\": \"What was the estimated relative effective reproduction number (Re) of XEC compared to KP.3.1.1 in August 2024?\",\n",
            "  \"answer\": \"In August 2024, the relative effective reproduction number (Re) of XEC was estimated to be 1.13-fold higher than that of KP.3.1.1.\",\n",
            "  \"confidence\": 1,\n",
            "  \"source\": \"WHO_XEC_Variant_Risk.pdf\",\n",
            "  \"page\": 3\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 6 ---\n",
            "{\n",
            "  \"question\": \"Which vaccine type was shown to provide the lowest protection against Omicron-associated infection?\",\n",
            "  \"answer\": \"AstraZeneca was shown to cater the lowest protection against Omicron-associated infection.\",\n",
            "  \"confidence\": 1,\n",
            "  \"source\": \"Vaccine_Efficacy_Omicron_vs_Delta.pdf\",\n",
            "  \"page\": 12\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 7 ---\n",
            "{\n",
            "  \"question\": \"What was the effect of mRNA boosters on vaccine effectiveness?\",\n",
            "  \"answer\": \"mRNA boosters reestablished effectiveness to be on par with 3-dose mRNA courses, irrespective of the primary course.\",\n",
            "  \"confidence\": 1,\n",
            "  \"source\": \"Vaccine_Efficacy_Omicron_vs_Delta.pdf\",\n",
            "  \"page\": 12\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 8 ---\n",
            "{\n",
            "  \"question\": \"What did the investigation into vaccine effectiveness in children reveal regarding the Pfizer vaccine?\",\n",
            "  \"answer\": \"Investigation of vaccine effectiveness in children revealed greatly lower protection conferred by the Pfizer vaccine against those aged 5–11 years old, calling for revision of dosage and dose-intervals in this age group.\",\n",
            "  \"confidence\": 1,\n",
            "  \"source\": \"Vaccine_Efficacy_Omicron_vs_Delta.pdf\",\n",
            "  \"page\": 12\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 9 ---\n",
            "{\n",
            "  \"question\": \"What is a consensus recommendation for protecting populations against rapid resurgence of severe COVID-19 infection?\",\n",
            "  \"answer\": \"Consensus recommendation included promoting the administration of boosters to protect populations and healthcare systems against rapid resurgence of severe COVID-19 infection by reestablishing waning protection in the short- and middle-term.\",\n",
            "  \"confidence\": 1,\n",
            "  \"source\": \"Vaccine_Efficacy_Omicron_vs_Delta.pdf\",\n",
            "  \"page\": 12\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 10 ---\n",
            "{\n",
            "  \"question\": \"What is an urgent need highlighted in the article regarding COVID-19 vaccines?\",\n",
            "  \"answer\": \"There is an urgent need for renewed efforts to develop, manufacture, and administer en masse novel, broad-acting, next-generation vaccines to curb the ongoing and future surges of the COVID-19 pandemic.\",\n",
            "  \"confidence\": 1,\n",
            "  \"source\": \"Vaccine_Efficacy_Omicron_vs_Delta.pdf\",\n",
            "  \"page\": 12\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 11 ---\n",
            "{\n",
            "  \"question\": \"What are some of the limitations of the study regarding vaccine effectiveness assessment?\",\n",
            "  \"answer\": \"The study's limitations include heterogeneous methodologies and target populations between analyzed studies, making it difficult to compare results from different age groups, follow-up periods, and vaccine types. Dose number, vaccination status, definition of severity levels, and the use of proxies like SGTF or community-based strain predominance also complicate assessment.\",\n",
            "  \"confidence\": 1,\n",
            "  \"source\": \"Vaccine_Efficacy_Omicron_vs_Delta.pdf\",\n",
            "  \"page\": 12\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 12 ---\n",
            "{\n",
            "  \"question\": \"What does the study suggest as a potentially effective approach to evaluate platelet activity after vaccination?\",\n",
            "  \"answer\": \"The study suggests that measuring the concentrations of platelet aggregates and platelet-leukocyte aggregates is a potentially effective approach to evaluate platelet activity after vaccination.\",\n",
            "  \"confidence\": 1,\n",
            "  \"source\": \"Pfizer_Platelet_LongTerm_Study.pdf\",\n",
            "  \"page\": 4\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 13 ---\n",
            "{\n",
            "  \"question\": \"What type of vaccine was the focus of the longitudinal examination of platelet activity in healthy subjects?\",\n",
            "  \"answer\": \"The study focused on the Pfizer-BioNTech (BNT162b2) vaccine.\",\n",
            "  \"confidence\": 1,\n",
            "  \"source\": \"Pfizer_Platelet_LongTerm_Study.pdf\",\n",
            "  \"page\": 4\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 14 ---\n",
            "{\n",
            "  \"question\": \"Were blood sampling periods and frequencies consistent in the study on platelet activity?\",\n",
            "  \"answer\": \"No, the blood sampling period and frequency were not consistent, as blood samples were taken from each healthy subject at the timing when they were able to cooperate on this study.\",\n",
            "  \"confidence\": 1,\n",
            "  \"source\": \"Pfizer_Platelet_LongTerm_Study.pdf\",\n",
            "  \"page\": 4\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 15 ---\n",
            "{\n",
            "  \"question\": \"What are the demographics of the healthy subjects in the platelet activity study?\",\n",
            "  \"answer\": \"The demographics of the healthy subjects are: age 25–63, n = 4 (male), n = 7 (female).\",\n",
            "  \"confidence\": 1,\n",
            "  \"source\": \"Pfizer_Platelet_LongTerm_Study.pdf\",\n",
            "  \"page\": 4\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 16 ---\n",
            "{\n",
            "  \"question\": \"Was the interaction between platelets and leukocytes significantly activated by vaccinations in the study?\",\n",
            "  \"answer\": \"No, Figure 2E shows that the interaction between platelets and leukocytes was not significantly activated by the vaccinations.\",\n",
            "  \"confidence\": 1,\n",
            "  \"source\": \"Pfizer_Platelet_LongTerm_Study.pdf\",\n",
            "  \"page\": 4\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 17 ---\n",
            "{\n",
            "  \"question\": \"What is the purpose of the CoVast study mentioned in the text?\",\n",
            "  \"answer\": \"The CoVast study is a multi-center prospective cohort study for active surveillance of COVID-19 vaccines and side effects.\",\n",
            "  \"confidence\": 1,\n",
            "  \"source\": \"Long_Term_Side_Effects_Medics.pdf\",\n",
            "  \"page\": 7\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 18 ---\n",
            "{\n",
            "  \"question\": \"What is the web address provided for information on the Comirnaty and Pfizer-BioNTech COVID-19 Vaccine from the U.S. Food & Drug Administration?\",\n",
            "  \"answer\": \"The web address provided is: https://www.fda.gov/emergency-preparedness-and-response/coronavirus-disease-2019-covid-19/comirnaty-and-pfizer-biontech-covid-19-vaccine.\",\n",
            "  \"confidence\": 1,\n",
            "  \"source\": \"Long_Term_Side_Effects_Medics.pdf\",\n",
            "  \"page\": 7\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 19 ---\n",
            "{\n",
            "  \"question\": \"What is the title of WHO Science in 5 episode #64?\",\n",
            "  \"answer\": \"The title of WHO Science in 5 episode #64 is 'Why are experts concerned about Omicron?'.\",\n",
            "  \"confidence\": 1,\n",
            "  \"source\": \"Long_Term_Side_Effects_Medics.pdf\",\n",
            "  \"page\": 7\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 20 ---\n",
            "{\n",
            "  \"question\": \"What is the topic of the BMJ article by Male V. published in 2021?\",\n",
            "  \"answer\": \"The topic of the BMJ article by Male V. published in 2021 is 'Menstrual changes after covid-19 vaccination'.\",\n",
            "  \"confidence\": 1,\n",
            "  \"source\": \"Long_Term_Side_Effects_Medics.pdf\",\n",
            "  \"page\": 7\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 21 ---\n",
            "{\n",
            "  \"question\": \"What are some previously identified side effects of vaccines such as influenza, hepatitis, and HPV?\",\n",
            "  \"answer\": \"The link between influenza, hepatitis, and HPV vaccines with demyelinating syndromes has been discovered, and the injection of influenza vaccine is a reason for the incidence of narcolepsy in young people.\",\n",
            "  \"confidence\": 0.9,\n",
            "  \"source\": \"COVID_Vaccine_Neuro_Effects.pdf\",\n",
            "  \"page\": 2\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 22 ---\n",
            "{\n",
            "  \"question\": \"Why is it necessary to closely monitor the adverse effects of COVID-19 vaccines?\",\n",
            "  \"answer\": \"Because COVID-19 vaccines are urgently approved, meaning they do not complete the standard clinical trials, the adverse effects of each vaccine should be closely monitored.\",\n",
            "  \"confidence\": 0.95,\n",
            "  \"source\": \"COVID_Vaccine_Neuro_Effects.pdf\",\n",
            "  \"page\": 2\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 23 ---\n",
            "{\n",
            "  \"question\": \"According to the CDC, VAERS, and EMA databases, what is the short-term outcome of COVID-19 vaccination?\",\n",
            "  \"answer\": \"According to data from the CDC, VAERS, and EMA databases, the short-term outcome of COVID-19 vaccination is promising.\",\n",
            "  \"confidence\": 0.95,\n",
            "  \"source\": \"COVID_Vaccine_Neuro_Effects.pdf\",\n",
            "  \"page\": 2\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 24 ---\n",
            "{\n",
            "  \"question\": \"What is VST in the context of COVID-19 vaccination side effects?\",\n",
            "  \"answer\": \"VST is the most severe disorder that should be diagnosed and controlled immediately.\",\n",
            "  \"confidence\": 0.9,\n",
            "  \"source\": \"COVID_Vaccine_Neuro_Effects.pdf\",\n",
            "  \"page\": 2\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 25 ---\n",
            "{\n",
            "  \"question\": \"What are the common mild neurological effects of the COVID-19 vaccine?\",\n",
            "  \"answer\": \"Mild neurological effects of the COVID-19 vaccine include weakness, numbness, headache, dizziness, imbalance, fatigue, muscle spasms, joint pain, and restless leg syndrome.\",\n",
            "  \"confidence\": 0.9,\n",
            "  \"source\": \"COVID_Vaccine_Neuro_Effects.pdf\",\n",
            "  \"page\": 2\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 26 ---\n",
            "{\n",
            "  \"question\": \"What are some less common mild neurological effects of the COVID-19 vaccine?\",\n",
            "  \"answer\": \"Tremors, tinnitus, and herpes zoster are less common mild neurological effects of the COVID-19 vaccine.\",\n",
            "  \"confidence\": 0.9,\n",
            "  \"source\": \"COVID_Vaccine_Neuro_Effects.pdf\",\n",
            "  \"page\": 2\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 27 ---\n",
            "{\n",
            "  \"question\": \"List some severe neurological complications following COVID-19 vaccination.\",\n",
            "  \"answer\": \"Severe neurological complications included Bell’s palsy, Guillain–Barre syndrome (GBS), stroke, seizures, anaphylaxis, and demyelinating syndromes such as transverse myelitis and acute encephalomyelitis.\",\n",
            "  \"confidence\": 0.9,\n",
            "  \"source\": \"COVID_Vaccine_Neuro_Effects.pdf\",\n",
            "  \"page\": 2\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 28 ---\n",
            "{\n",
            "  \"question\": \"Which of the severe neurological complications is considered the most dangerous?\",\n",
            "  \"answer\": \"Among the severe neurological complications listed, transverse myelitis and acute encephalomyelitis, which are demyelinating syndromes, are mentioned.\",\n",
            "  \"confidence\": 0.85,\n",
            "  \"source\": \"COVID_Vaccine_Neuro_Effects.pdf\",\n",
            "  \"page\": 2\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 29 ---\n",
            "{\n",
            "  \"question\": \"According to reports in the VAERS database, when do neurological complications following COVID-19 vaccination usually appear?\",\n",
            "  \"answer\": \"Complications usually appear within one day to 1 month after injection.\",\n",
            "  \"confidence\": 0.95,\n",
            "  \"source\": \"COVID_Vaccine_Neuro_Effects.pdf\",\n",
            "  \"page\": 2\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 30 ---\n",
            "{\n",
            "  \"question\": \"Why do women have a higher incidence of neurological complications after vaccination?\",\n",
            "  \"answer\": \"Women have the highest incidence of neurological complications because they induce a stronger immune response against foreign antigens, which can lead to the targeting of self-antigens and lead to autoimmune disorders.\",\n",
            "  \"confidence\": 0.95,\n",
            "  \"source\": \"COVID_Vaccine_Neuro_Effects.pdf\",\n",
            "  \"page\": 2\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 31 ---\n",
            "{\n",
            "  \"question\": \"When are adverse reactions after the second dose of the vaccine reported more frequently compared to the first dose?\",\n",
            "  \"answer\": \"Adverse reactions after the second dose of the vaccine are reported more than in the first dose.\",\n",
            "  \"confidence\": 0.95,\n",
            "  \"source\": \"COVID_Vaccine_Neuro_Effects.pdf\",\n",
            "  \"page\": 2\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 32 ---\n",
            "{\n",
            "  \"question\": \"What was the effectiveness of primary Janssen vaccination in preventing Delta and Omicron-associated symptomatic hospital admissions according to Lewnard et al.?\",\n",
            "  \"answer\": \"Lewnard et al. showed that compared to unvaccinated, primary Janssen vaccination was effective at preventing both Delta and Omicron-associated symptomatic hospital admissions that were tested in an outpatient setting, although protection against Omicron was lower versus Delta.\",\n",
            "  \"confidence\": 0.9,\n",
            "  \"source\": \"Vaccine_Efficacy_Omicron_vs_Delta.pdf\",\n",
            "  \"page\": 10\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 33 ---\n",
            "{\n",
            "  \"question\": \"What is the reported effectiveness of full Janssen vaccination followed by an mRNA booster against Delta and Omicron symptomatic hospitalizations?\",\n",
            "  \"answer\": \"Full Janssen vaccination followed by an mRNA booster was effective at preventing both Delta and Omicron associated symptomatic hospitalizations tested in outpatient settings compared to only the primary series, although protection against Delta was greater than that against Omicron.\",\n",
            "  \"confidence\": 0.9,\n",
            "  \"source\": \"Vaccine_Efficacy_Omicron_vs_Delta.pdf\",\n",
            "  \"page\": 10\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 34 ---\n",
            "{\n",
            "  \"question\": \"How effective are Pfizer boosters against COVID-19 related severe or fatal disease compared to full vaccination?\",\n",
            "  \"answer\": \"Pfizer boosters were shown to prevent COVID-19 related severe or fatal disease with greater VE (76.5%) compared to full vaccination.\",\n",
            "  \"confidence\": 0.9,\n",
            "  \"source\": \"Vaccine_Efficacy_Omicron_vs_Delta.pdf\",\n",
            "  \"page\": 10\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 35 ---\n",
            "{\n",
            "  \"question\": \"What was the effectiveness of partial Moderna vaccination against Omicron-associated severe, critical, or fatal disease according to Chemaitelly et al.?\",\n",
            "  \"answer\": \"Chemaitelly et al. reported that partial Moderna vaccination could successfully prevent (100.0%) all Omicron-associated severe, critical, or fatal disease (WHO definitions), however, this was likely a result of insufficient cases in the cohort.\",\n",
            "  \"confidence\": 0.9,\n",
            "  \"source\": \"Vaccine_Efficacy_Omicron_vs_Delta.pdf\",\n",
            "  \"page\": 10\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 36 ---\n",
            "{\n",
            "  \"question\": \"What is the effectiveness of full vaccination with Moderna at 1-6 months and by ≥7 months after the 2nd dose?\",\n",
            "  \"answer\": \"Full vaccination with Moderna provided good protection (87.1%); however, this quickly decreased to 68.4% by ≥7 months after 2nd dose.\",\n",
            "  \"confidence\": 0.9,\n",
            "  \"source\": \"Vaccine_Efficacy_Omicron_vs_Delta.pdf\",\n",
            "  \"page\": 10\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 37 ---\n",
            "{\n",
            "  \"question\": \"What was the effectiveness of the initial Pfizer VE of primary series in children aged 12-15 years during periods of Delta predominance?\",\n",
            "  \"answer\": \"During periods of Delta predominance, the initial Pfizer VE of primary series in children aged 12-15 years was 92%.\",\n",
            "  \"confidence\": 0.9,\n",
            "  \"source\": \"Vaccine_Efficacy_Omicron_vs_Delta.pdf\",\n",
            "  \"page\": 10\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 38 ---\n",
            "{\n",
            "  \"question\": \"What was the effectiveness of the primary Pfizer series against Omicron infection by ≥150 days in children aged 12-17 years?\",\n",
            "  \"answer\": \"The primary series offered no protection against Omicron infection by ≥150 days in both the 12–15 and 16–17-year-old cohorts.\",\n",
            "  \"confidence\": 0.95,\n",
            "  \"source\": \"Vaccine_Efficacy_Omicron_vs_Delta.pdf\",\n",
            "  \"page\": 10\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 39 ---\n",
            "{\n",
            "  \"question\": \"How effective were boosters against Omicron in children aged 5-17 years?\",\n",
            "  \"answer\": \"Boosters reestablished efficacy back to 81% against Omicron ≥7 days after vaccination.\",\n",
            "  \"confidence\": 0.9,\n",
            "  \"source\": \"Vaccine_Efficacy_Omicron_vs_Delta.pdf\",\n",
            "  \"page\": 10\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 40 ---\n",
            "{\n",
            "  \"question\": \"What are the standard clinical laboratory tests performed on blood samples before and after the third vaccine dose in the study?\",\n",
            "  \"answer\": \"Hematological tests including leukocyte count, neutrophil count, lymphocyte count, eosinophil count, basophil count, red cell count, platelet count, MPV, PDW, and IPF were performed.\",\n",
            "  \"confidence\": 0.95,\n",
            "  \"source\": \"Pfizer_Platelet_LongTerm_Study.pdf\",\n",
            "  \"page\": 6\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 41 ---\n",
            "{\n",
            "  \"question\": \"What is a major concern regarding the long-term effects of COVID infection?\",\n",
            "  \"answer\": \"The long-term side effects of COVID infection are a major concern.\",\n",
            "  \"confidence\": 1,\n",
            "  \"source\": \"COVID_Vaccine_Safety_Facts.pdf\",\n",
            "  \"page\": 3\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 42 ---\n",
            "{\n",
            "  \"question\": \"What percentage of people who have COVID might experience side effects?\",\n",
            "  \"answer\": \"Up to 10 percent of people who have COVID experience side effects.\",\n",
            "  \"confidence\": 1,\n",
            "  \"source\": \"COVID_Vaccine_Safety_Facts.pdf\",\n",
            "  \"page\": 3\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 43 ---\n",
            "{\n",
            "  \"question\": \"What are some examples of side effects experienced by people who have COVID?\",\n",
            "  \"answer\": \"Examples of side effects include difficulty thinking, pain, tiredness, loss of taste and depression.\",\n",
            "  \"confidence\": 1,\n",
            "  \"source\": \"COVID_Vaccine_Safety_Facts.pdf\",\n",
            "  \"page\": 3\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 44 ---\n",
            "{\n",
            "  \"question\": \"What is the most troubling unknown for Goepfert regarding COVID infection side effects?\",\n",
            "  \"answer\": \"Goepfert finds it most troubling that it is not known why these symptoms occur, how long they will last, or if there are effective ways to treat them.\",\n",
            "  \"confidence\": 1,\n",
            "  \"source\": \"COVID_Vaccine_Safety_Facts.pdf\",\n",
            "  \"page\": 3\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 45 ---\n",
            "{\n",
            "  \"question\": \"How should the risks of rare side effects from COVID vaccines be weighed?\",\n",
            "  \"answer\": \"The rare side effects identified with COVID vaccines have to be weighed against the known, higher risks from contracting COVID.\",\n",
            "  \"confidence\": 1,\n",
            "  \"source\": \"COVID_Vaccine_Safety_Facts.pdf\",\n",
            "  \"page\": 3\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 46 ---\n",
            "{\n",
            "  \"question\": \"What are early indications regarding the Delta mutation of COVID and its effect on patients?\",\n",
            "  \"answer\": \"Early indications are that Delta infections bring more severe side effects than other forms of COVID, but that vaccines are still protective against Delta.\",\n",
            "  \"confidence\": 1,\n",
            "  \"source\": \"COVID_Vaccine_Safety_Facts.pdf\",\n",
            "  \"page\": 3\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 47 ---\n",
            "{\n",
            "  \"question\": \"What is considered the most troubling unknown concerning COVID by Goepfert?\",\n",
            "  \"answer\": \"The most troubling unknown is COVID infection and the growing evidence of persistent symptoms from what has become known as “long COVID.”\",\n",
            "  \"confidence\": 1,\n",
            "  \"source\": \"COVID_Vaccine_Safety_Facts.pdf\",\n",
            "  \"page\": 3\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 48 ---\n",
            "{\n",
            "  \"question\": \"As of mid-June, what were the approximate daily COVID case and death reports in Alabama?\",\n",
            "  \"answer\": \"As of mid-June, there were still nearly 250 new COVID cases diagnosed and nearly 10 deaths reported statewide per day in Alabama.\",\n",
            "  \"confidence\": 1,\n",
            "  \"source\": \"COVID_Vaccine_Safety_Facts.pdf\",\n",
            "  \"page\": 3\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 49 ---\n",
            "{\n",
            "  \"question\": \"Under what authorization are COVID vaccines currently being distributed?\",\n",
            "  \"answer\": \"COVID vaccines are currently being distributed under Emergency Use Authorizations.\",\n",
            "  \"confidence\": 1,\n",
            "  \"source\": \"COVID_Vaccine_Safety_Facts.pdf\",\n",
            "  \"page\": 3\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 50 ---\n",
            "{\n",
            "  \"question\": \"What is stated about the safety data available for COVID vaccines compared to other vaccines?\",\n",
            "  \"answer\": \"Because so many people have been vaccinated, there is far more safety data available for COVID vaccines than for any other vaccine.\",\n",
            "  \"confidence\": 1,\n",
            "  \"source\": \"COVID_Vaccine_Safety_Facts.pdf\",\n",
            "  \"page\": 3\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 51 ---\n",
            "{\n",
            "  \"question\": \"What neurological complications are reported for the AstraZeneca vaccine?\",\n",
            "  \"answer\": \"Neurological complications reported for the AstraZeneca vaccine include Headache, Cerebral venous sinus thrombosis, Transverse myelitis, GBS, Bell’s palsy, Acute disseminated encephalomyelitis, Intracerebral hemorrhage, Ischemic stroke, Encephalopathy, Parsonage–Turner syndrome, Herpes zoster, Tinnitus and cochleopathy, Seizures, and Unilateral and bilateral optic neuritis.\",\n",
            "  \"confidence\": 1,\n",
            "  \"source\": \"COVID_Vaccine_Neuro_Effects.pdf\",\n",
            "  \"page\": 4\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 52 ---\n",
            "{\n",
            "  \"question\": \"What neurological complications are reported for the Johnson & Johnson vaccine?\",\n",
            "  \"answer\": \"Neurological complications reported for the Johnson & Johnson vaccine include Cerebral venous sinus thrombosis, Transverse myelitis, GBS, and Transient ischemic attack.\",\n",
            "  \"confidence\": 1,\n",
            "  \"source\": \"COVID_Vaccine_Neuro_Effects.pdf\",\n",
            "  \"page\": 4\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 53 ---\n",
            "{\n",
            "  \"question\": \"What neurological complications are reported for Sputnik vaccines?\",\n",
            "  \"answer\": \"Neurological complications reported for Sputnik vaccines include Headache and Multiple sclerosis.\",\n",
            "  \"confidence\": 1,\n",
            "  \"source\": \"COVID_Vaccine_Neuro_Effects.pdf\",\n",
            "  \"page\": 4\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 54 ---\n",
            "{\n",
            "  \"question\": \"Which types of vaccines can cause exacerbation or early manifestation of MS and neuromyelitis optica?\",\n",
            "  \"answer\": \"mRNA-based vaccines can cause exacerbation or early manifestation of MS and neuromyelitis optica.\",\n",
            "  \"confidence\": 1,\n",
            "  \"source\": \"COVID_Vaccine_Neuro_Effects.pdf\",\n",
            "  \"page\": 4\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 55 ---\n",
            "{\n",
            "  \"question\": \"What is the major type of vaccine associated with the majority of demyelinating syndromes?\",\n",
            "  \"answer\": \"The majority of demyelinating syndromes are related to mRNA-based vaccines.\",\n",
            "  \"confidence\": 1,\n",
            "  \"source\": \"COVID_Vaccine_Neuro_Effects.pdf\",\n",
            "  \"page\": 4\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 56 ---\n",
            "{\n",
            "  \"question\": \"What are some reported side effects of COVID-19 vaccination affecting cranial and peripheral nerves?\",\n",
            "  \"answer\": \"Reported side effects include Bell’s palsy, abducens nerve palsy, impaired vision, olfactory, hearing, Guillain–Barre syndrome (GBS), small fiber neuropathy, Parsonage–Turner syndrome, and herpes zoster.\",\n",
            "  \"confidence\": 1,\n",
            "  \"source\": \"COVID_Vaccine_Neuro_Effects.pdf\",\n",
            "  \"page\": 4\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 57 ---\n",
            "{\n",
            "  \"question\": \"Which vaccines are more commonly associated with Bell’s palsy and small fiber neuropathy?\",\n",
            "  \"answer\": \"Bell’s palsy and small fiber neuropathy are more commonly observed in mRNA-based vaccines.\",\n",
            "  \"confidence\": 1,\n",
            "  \"source\": \"COVID_Vaccine_Neuro_Effects.pdf\",\n",
            "  \"page\": 4\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 58 ---\n",
            "{\n",
            "  \"question\": \"Which type of vaccine is more common in the elderly after vaccination with GBS?\",\n",
            "  \"answer\": \"GBS is more common in the elderly after vaccination with adenovirus-based vaccines.\",\n",
            "  \"confidence\": 1,\n",
            "  \"source\": \"COVID_Vaccine_Neuro_Effects.pdf\",\n",
            "  \"page\": 4\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 59 ---\n",
            "{\n",
            "  \"question\": \"What nerve issues have been reported in association with the Pfizer vaccine?\",\n",
            "  \"answer\": \"There have been many reports of the Pfizer vaccine being associated with olfactory, visual, auditory nerve issues, and sometimes abducens nerve palsy.\",\n",
            "  \"confidence\": 1,\n",
            "  \"source\": \"COVID_Vaccine_Neuro_Effects.pdf\",\n",
            "  \"page\": 4\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 60 ---\n",
            "{\n",
            "  \"question\": \"What is a possible explanation for herpes zoster occurring after COVID-19 vaccination?\",\n",
            "  \"answer\": \"The varicella-zoster virus CD8 killer cells, after vaccination, may be temporarily unable to control VZV due to changes in CD8 cells, leading to a recurrence of VZV and subsequent herpes zoster.\",\n",
            "  \"confidence\": 1,\n",
            "  \"source\": \"COVID_Vaccine_Neuro_Effects.pdf\",\n",
            "  \"page\": 4\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 61 ---\n",
            "{\n",
            "  \"question\": \"What is the purpose of adding anti-CD45-PC7 to the blood sample?\",\n",
            "  \"answer\": \"Anti-CD45-PC7 is added to the blood sample to ensure the detection of all platelets or platelet aggregates in the sample.\",\n",
            "  \"confidence\": 1,\n",
            "  \"source\": \"Pfizer_Platelet_LongTerm_Study.pdf\",\n",
            "  \"page\": 5\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 62 ---\n",
            "{\n",
            "  \"question\": \"Why is fixation with paraformaldehyde necessary for platelet samples?\",\n",
            "  \"answer\": \"Without fixation, platelet aggregates in the sample would be dismantled. Therefore, the fixation process is performed at least within 4 hours after the blood draw.\",\n",
            "  \"confidence\": 1,\n",
            "  \"source\": \"Pfizer_Platelet_LongTerm_Study.pdf\",\n",
            "  \"page\": 5\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 63 ---\n",
            "{\n",
            "  \"question\": \"What is the optical source used in the FDM microscope?\",\n",
            "  \"answer\": \"The FDM microscope is based on a spatially distributed optical frequency comb as the optical source.\",\n",
            "  \"confidence\": 1,\n",
            "  \"source\": \"Pfizer_Platelet_LongTerm_Study.pdf\",\n",
            "  \"page\": 5\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 64 ---\n",
            "{\n",
            "  \"question\": \"How is a spatial-profile-encoded image retrieved using the FDM microscope?\",\n",
            "  \"answer\": \"A spatial-profile-encoded image can be retrieved by performing Fourier transformation on the time-domain waveform detected by the single-pixel detector.\",\n",
            "  \"confidence\": 1,\n",
            "  \"source\": \"Pfizer_Platelet_LongTerm_Study.pdf\",\n",
            "  \"page\": 5\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 65 ---\n",
            "{\n",
            "  \"question\": \"What is the line scan rate of the FDM microscope?\",\n",
            "  \"answer\": \"The line scan rate is 3 MHz.\",\n",
            "  \"confidence\": 1,\n",
            "  \"source\": \"Pfizer_Platelet_LongTerm_Study.pdf\",\n",
            "  \"page\": 5\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 66 ---\n",
            "{\n",
            "  \"question\": \"What is the spatial resolution of the FDM microscope?\",\n",
            "  \"answer\": \"The spatial resolution is 0.8 μm.\",\n",
            "  \"confidence\": 1,\n",
            "  \"source\": \"Pfizer_Platelet_LongTerm_Study.pdf\",\n",
            "  \"page\": 5\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 67 ---\n",
            "{\n",
            "  \"question\": \"What is the field of view of the FDM microscope?\",\n",
            "  \"answer\": \"The field of view is 53.6 μm × 53.6 μm.\",\n",
            "  \"confidence\": 1,\n",
            "  \"source\": \"Pfizer_Platelet_LongTerm_Study.pdf\",\n",
            "  \"page\": 5\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 68 ---\n",
            "{\n",
            "  \"question\": \"How is image acquisition triggered in the FDM microscope for platelets?\",\n",
            "  \"answer\": \"Fluorescence emitted from platelets labeled by anti-CD61-PE is collected and used for triggering image acquisitions.\",\n",
            "  \"confidence\": 1,\n",
            "  \"source\": \"Pfizer_Platelet_LongTerm_Study.pdf\",\n",
            "  \"page\": 5\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 69 ---\n",
            "{\n",
            "  \"question\": \"What defines an 'event' in the context of image acquisition throughput for the FDM microscope?\",\n",
            "  \"answer\": \"An event is defined as a single platelet or a platelet aggregate, as red blood cells, leukocytes, and cell debris were not detected as events.\",\n",
            "  \"confidence\": 1,\n",
            "  \"source\": \"Pfizer_Platelet_LongTerm_Study.pdf\",\n",
            "  \"page\": 5\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 70 ---\n",
            "{\n",
            "  \"question\": \"How were COVID-19 patients clinically diagnosed for this study?\",\n",
            "  \"answer\": \"The COVID-19 patients used in this study were clinically diagnosed with COVID-19 based on their reverse transcription polymerase chain reaction (RT-PCR) test results.\",\n",
            "  \"confidence\": 1,\n",
            "  \"source\": \"Pfizer_Platelet_LongTerm_Study.pdf\",\n",
            "  \"page\": 5\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 71 ---\n",
            "{\n",
            "  \"question\": \"What was the total number of practitioners who participated in the study on long-term adverse events of vaccines?\",\n",
            "  \"answer\": \"A total of 505 practitioners participated in the study.\",\n",
            "  \"confidence\": 1,\n",
            "  \"source\": \"Long_Term_Side_Effects_Medics.pdf\",\n",
            "  \"page\": 2\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 72 ---\n",
            "{\n",
            "  \"question\": \"Which COVID-19 vaccines were excluded from the main study sample, and why?\",\n",
            "  \"answer\": \"Moderna, Johnson and Johnson, and Sputnik vaccines were excluded because only seven participants received one of these vaccines, leaving a total of 498 participants for the study.\",\n",
            "  \"confidence\": 1,\n",
            "  \"source\": \"Long_Term_Side_Effects_Medics.pdf\",\n",
            "  \"page\": 2\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 73 ---\n",
            "{\n",
            "  \"question\": \"What was the age range of the participants in the study?\",\n",
            "  \"answer\": \"The age range of the participants was 22–71 years.\",\n",
            "  \"confidence\": 1,\n",
            "  \"source\": \"Long_Term_Side_Effects_Medics.pdf\",\n",
            "  \"page\": 2\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 74 ---\n",
            "{\n",
            "  \"question\": \"What percentage of participants in the study were dentists and physicians?\",\n",
            "  \"answer\": \"53.4% were dentists and 46.6% were physicians.\",\n",
            "  \"confidence\": 1,\n",
            "  \"source\": \"Long_Term_Side_Effects_Medics.pdf\",\n",
            "  \"page\": 2\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 75 ---\n",
            "{\n",
            "  \"question\": \"What was the definition of a 'long-term adverse event' (LTAE) used in the questionnaire?\",\n",
            "  \"answer\": \"A LTAE was explained as 'a symptom that continued more than one month after vaccine administration'.\",\n",
            "  \"confidence\": 1,\n",
            "  \"source\": \"Long_Term_Side_Effects_Medics.pdf\",\n",
            "  \"page\": 2\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 76 ---\n",
            "{\n",
            "  \"question\": \"What statistical analysis method was used to investigate significant differences in adverse events between vaccine types?\",\n",
            "  \"answer\": \"General linear model (multivariate analysis of variance - MANOVA) was carried out to investigate significant differences in adverse events between vaccine types with least significant difference (LSD) post-hoc test.\",\n",
            "  \"confidence\": 1,\n",
            "  \"source\": \"Long_Term_Side_Effects_Medics.pdf\",\n",
            "  \"page\": 2\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 77 ---\n",
            "{\n",
            "  \"question\": \"What are the potential severe allergic reaction symptoms associated with the Johnson & Johnson COVID-19 vaccine?\",\n",
            "  \"answer\": \"Symptoms include difficulty breathing, swelling of face and throat, fast heartbeat, bad rash all over your body, dizziness, and weakness.\",\n",
            "  \"confidence\": 1,\n",
            "  \"source\": \"jj_vaccine_risks.pdf\",\n",
            "  \"page\": 2\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 78 ---\n",
            "{\n",
            "  \"question\": \"What is Guillain-Barre Syndrome, and when have cases been reported after Johnson & Johnson vaccination?\",\n",
            "  \"answer\": \"Guillain-Barre Syndrome is an illness where the body's immune system damages nerve cells, causing muscle weaknesses or paralysis. Cases have largely been reported about 2 weeks after vaccination with the Johnson & Johnson COVID-19 vaccine, mostly in males aged 50 years and older.\",\n",
            "  \"confidence\": 1,\n",
            "  \"source\": \"jj_vaccine_risks.pdf\",\n",
            "  \"page\": 2\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 79 ---\n",
            "{\n",
            "  \"question\": \"Under what conditions is the use of the Johnson & Johnson COVID-19 vaccine limited in the US?\",\n",
            "  \"answer\": \"Its use is limited to people aged 18 and older who cannot receive other COVID-19 vaccines due to medical reasons, have limited access to other vaccines, or elect to receive it because they would otherwise not receive a COVID-19 vaccine.\",\n",
            "  \"confidence\": 1,\n",
            "  \"source\": \"jj_vaccine_risks.pdf\",\n",
            "  \"page\": 2\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 80 ---\n",
            "{\n",
            "  \"question\": \"What is the effectiveness of a booster Moderna dose against symptomatic Omicron infection compared to primary series only?\",\n",
            "  \"answer\": \"Moderna boosters were 47.3% (95% CI: 40.7–53.3) effective against symptomatic Omicron infection compared to primary series only.\",\n",
            "  \"confidence\": 1,\n",
            "  \"source\": \"Vaccine_Efficacy_Omicron_vs_Delta.pdf\",\n",
            "  \"page\": 17\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 81 ---\n",
            "{\n",
            "  \"question\": \"What is the most reported Long-Term Adverse Event (LTAE) among vaccinated physicians and dentists?\",\n",
            "  \"answer\": \"The most reported LTAE was fatigue, and its related symptoms of myalgia, arthralgia, dizziness, and headache.\",\n",
            "  \"confidence\": 1,\n",
            "  \"source\": \"Long_Term_Side_Effects_Medics.pdf\",\n",
            "  \"page\": 5\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 82 ---\n",
            "{\n",
            "  \"question\": \"Which vaccine type showed a statistically significant association with fatigue and related symptoms?\",\n",
            "  \"answer\": \"The SP vaccine was significantly associated, as approximately one in two participants complaining of fatigue and related symptoms had received the full vaccination protocol of the SP vaccine.\",\n",
            "  \"confidence\": 1,\n",
            "  \"source\": \"Long_Term_Side_Effects_Medics.pdf\",\n",
            "  \"page\": 5\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 83 ---\n",
            "{\n",
            "  \"question\": \"What was the estimated incidence of vaccinated physicians and dentists developing LTAEs after receiving at least two doses of PB, SP, or AZ vaccines?\",\n",
            "  \"answer\": \"Approximately 16% of vaccinated physicians and dentists developed LTAEs after receiving at least two doses of the PB, SP, or AZ vaccines.\",\n",
            "  \"confidence\": 1,\n",
            "  \"source\": \"Long_Term_Side_Effects_Medics.pdf\",\n",
            "  \"page\": 5\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 84 ---\n",
            "{\n",
            "  \"question\": \"What were some of the adverse events that can be explained by known mechanisms?\",\n",
            "  \"answer\": \"Some adverse events that can be explained include thrombosis, paresthesia, and herpes zoster.\",\n",
            "  \"confidence\": 1,\n",
            "  \"source\": \"Long_Term_Side_Effects_Medics.pdf\",\n",
            "  \"page\": 5\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 85 ---\n",
            "{\n",
            "  \"question\": \"Which vaccine type showed a significant difference in fatigue-related adverse events compared to the SP vaccine?\",\n",
            "  \"answer\": \"The PB vaccine showed a significant difference in fatigue-related adverse events compared to the SP vaccine.\",\n",
            "  \"confidence\": 1,\n",
            "  \"source\": \"Long_Term_Side_Effects_Medics.pdf\",\n",
            "  \"page\": 5\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 86 ---\n",
            "{\n",
            "  \"question\": \"What is the significance of the P value of 0.048* for the 'Vaccine (protocol)' category in Table 3?\",\n",
            "  \"answer\": \"The P value of 0.048* indicates a statistically significant difference in the occurrence of fatigue and fatigue-related adverse events among different vaccine protocols.\",\n",
            "  \"confidence\": 1,\n",
            "  \"source\": \"Long_Term_Side_Effects_Medics.pdf\",\n",
            "  \"page\": 5\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 87 ---\n",
            "{\n",
            "  \"question\": \"Did COVID-19 infection after vaccination in the study lead to long-term manifestations in most participants?\",\n",
            "  \"answer\": \"No, all participants who developed COVID-19 after vaccination did not develop long-term manifestations, except for five participants who developed either fatigue, menstrual abnormalities, or memory problems.\",\n",
            "  \"confidence\": 1,\n",
            "  \"source\": \"Long_Term_Side_Effects_Medics.pdf\",\n",
            "  \"page\": 5\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 88 ---\n",
            "{\n",
            "  \"question\": \"What percentage of participants reported receiving the SP vaccine protocol and complained of fatigue and related symptoms?\",\n",
            "  \"answer\": \"Approximately one in two participants complaining of fatigue and related symptoms have received the full vaccination protocol of the SP vaccine.\",\n",
            "  \"confidence\": 1,\n",
            "  \"source\": \"Long_Term_Side_Effects_Medics.pdf\",\n",
            "  \"page\": 5\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 89 ---\n",
            "{\n",
            "  \"question\": \"What was the reported vaccine effectiveness of partial AstraZeneca vaccination against symptomatic Delta infection?\",\n",
            "  \"answer\": \"Partial AstraZeneca vaccination protected against symptomatic Delta infection with a mean VE of 42.9%.\",\n",
            "  \"confidence\": 1,\n",
            "  \"source\": \"Vaccine_Efficacy_Omicron_vs_Delta.pdf\",\n",
            "  \"page\": 9\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 90 ---\n",
            "{\n",
            "  \"question\": \"How did the effectiveness of 2-dose vaccination against Omicron drop by the third-dose eligibility period (>=25 weeks)?\",\n",
            "  \"answer\": \"By the third-dose eligibility period (>=25 weeks), the effectiveness of 2-dose vaccination against Omicron had dropped to -2.7%.\",\n",
            "  \"confidence\": 1,\n",
            "  \"source\": \"Vaccine_Efficacy_Omicron_vs_Delta.pdf\",\n",
            "  \"page\": 9\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 91 ---\n",
            "{\n",
            "  \"question\": \"What was the vaccine effectiveness of the primary Pfizer series against Omicron-period hospitalization in South Africa?\",\n",
            "  \"answer\": \"The VE of the primary Pfizer series against Omicron-period hospitalization was 70%, compared to 93% in Delta periods.\",\n",
            "  \"confidence\": 1,\n",
            "  \"source\": \"Vaccine_Efficacy_Omicron_vs_Delta.pdf\",\n",
            "  \"page\": 9\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 92 ---\n",
            "{\n",
            "  \"question\": \"According to a study in South California, how much more likely was Omicron infection compared to Delta infection when vaccinated with a Janssen primary series boosted by mRNA vaccine?\",\n",
            "  \"answer\": \"When vaccinated with a Janssen primary series and further mRNA vaccine-boosted, the odds of Omicron infection were about 2.32 times more likely than Delta infection compared to when unvaccinated.\",\n",
            "  \"confidence\": 1,\n",
            "  \"source\": \"Vaccine_Efficacy_Omicron_vs_Delta.pdf\",\n",
            "  \"page\": 9\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 93 ---\n",
            "{\n",
            "  \"question\": \"What was the vaccine effectiveness of a Pfizer booster dose following a primary series of AstraZeneca in preventing Omicron infection in hemodialysis patients?\",\n",
            "  \"answer\": \"A Pfizer booster dose following a primary series of AstraZeneca was protective in preventing Omicron infection in hemodialysis patients with a VE of 47%.\",\n",
            "  \"confidence\": 1,\n",
            "  \"source\": \"Vaccine_Efficacy_Omicron_vs_Delta.pdf\",\n",
            "  \"page\": 9\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 94 ---\n",
            "{\n",
            "  \"question\": \"What was the effectiveness of full vaccination against symptomatic Omicron BA.1 in the first 3 months after the 2nd dose, according to a study in Qatar?\",\n",
            "  \"answer\": \"Full vaccination against Omicron BA.1 was 71% effective in the first 3 months following the 2nd dose compared to unvaccinated.\",\n",
            "  \"confidence\": 1,\n",
            "  \"source\": \"Vaccine_Efficacy_Omicron_vs_Delta.pdf\",\n",
            "  \"page\": 8\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 95 ---\n",
            "{\n",
            "  \"question\": \"How did booster vaccinations affect vaccine effectiveness against Omicron and Delta variants one month after booster administration?\",\n",
            "  \"answer\": \"Booster vaccination reestablished VE to 54.6% against Omicron and to 81.2% against Delta during a 1-month follow-up.\",\n",
            "  \"confidence\": 1,\n",
            "  \"source\": \"Vaccine_Efficacy_Omicron_vs_Delta.pdf\",\n",
            "  \"page\": 8\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 96 ---\n",
            "{\n",
            "  \"question\": \"Which variant is currently the only SARS-CoV-2 variant under monitoring (VUM) with increasing prevalence globally?\",\n",
            "  \"answer\": \"XEC is currently the only SARS-CoV-2 variant under monitoring (VUM) with increasing prevalence globally.\",\n",
            "  \"confidence\": 1,\n",
            "  \"source\": \"WHO_XEC_Variant_Risk.pdf\",\n",
            "  \"page\": 1\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 97 ---\n",
            "{\n",
            "  \"question\": \"What is the evaluated additional public health risk posed by the XEC variant at the global level?\",\n",
            "  \"answer\": \"Considering the available evidence, the additional public health risk posed by XEC is evaluated as low at the global level.\",\n",
            "  \"confidence\": 1,\n",
            "  \"source\": \"WHO_XEC_Variant_Risk.pdf\",\n",
            "  \"page\": 1\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 98 ---\n",
            "{\n",
            "  \"question\": \"When was XEC designated as a Variant Under Monitoring (VUM) by the WHO?\",\n",
            "  \"answer\": \"XEC was designated as a VUM on 24 September 2024.\",\n",
            "  \"confidence\": 1,\n",
            "  \"source\": \"WHO_XEC_Variant_Risk.pdf\",\n",
            "  \"page\": 1\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 99 ---\n",
            "{\n",
            "  \"question\": \"What percentage of globally available SARS-CoV-2 sequences were XEC in epidemiological week 47 (November 18 to 24, 2024)?\",\n",
            "  \"answer\": \"As of November 24, 2024, XEC represented 36.8% of the globally available sequences in epidemiological week 47.\",\n",
            "  \"confidence\": 1,\n",
            "  \"source\": \"WHO_XEC_Variant_Risk.pdf\",\n",
            "  \"page\": 1\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 100 ---\n",
            "{\n",
            "  \"question\": \"Which two regions showed a consistent increase in XEC prevalence between epidemiological weeks 44 and 47 of 2024?\",\n",
            "  \"answer\": \"The Western Pacific region (WPR) and the European region (EUR) showed a consistent increase in XEC prevalence.\",\n",
            "  \"confidence\": 1,\n",
            "  \"source\": \"WHO_XEC_Variant_Risk.pdf\",\n",
            "  \"page\": 1\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 101 ---\n",
            "{\n",
            "  \"question\": \"What is the primary aim of the study published in Long_Term_Side_Effects_Medics.pdf?\",\n",
            "  \"answer\": \"This study aims to explore long-term adverse events reported by physicians and dentists who received at least two COVID-19 vaccine doses.\",\n",
            "  \"confidence\": 0.9,\n",
            "  \"source\": \"Long_Term_Side_Effects_Medics.pdf\",\n",
            "  \"page\": 1\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 102 ---\n",
            "{\n",
            "  \"question\": \"How many practitioners' data were included in the study from Long_Term_Side_Effects_Medics.pdf?\",\n",
            "  \"answer\": \"Data of a total of 498 practitioners were included.\",\n",
            "  \"confidence\": 0.95,\n",
            "  \"source\": \"Long_Term_Side_Effects_Medics.pdf\",\n",
            "  \"page\": 1\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 103 ---\n",
            "{\n",
            "  \"question\": \"What was the age range of the participants in the study?\",\n",
            "  \"answer\": \"Age ranged from 22 to 71 years (mean age= 35.75 ± 11.74).\",\n",
            "  \"confidence\": 0.95,\n",
            "  \"source\": \"Long_Term_Side_Effects_Medics.pdf\",\n",
            "  \"page\": 1\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 104 ---\n",
            "{\n",
            "  \"question\": \"What was the gender distribution among the participants in the study?\",\n",
            "  \"answer\": \"There was a female majority (N = 348, 69.9%).\",\n",
            "  \"confidence\": 0.95,\n",
            "  \"source\": \"Long_Term_Side_Effects_Medics.pdf\",\n",
            "  \"page\": 1\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 105 ---\n",
            "{\n",
            "  \"question\": \"Which were the most frequently administered vaccines in the study?\",\n",
            "  \"answer\": \"The most frequently administered vaccines were Pfizer-BioNtech, Sinopharm and AstraZeneca vaccines.\",\n",
            "  \"confidence\": 0.95,\n",
            "  \"source\": \"Long_Term_Side_Effects_Medics.pdf\",\n",
            "  \"page\": 1\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 106 ---\n",
            "{\n",
            "  \"question\": \"What percentage of participants reported Long-Term Adverse Events (LTAEs)?\",\n",
            "  \"answer\": \"A total of 80 (16.0%) participants reported LTAEs.\",\n",
            "  \"confidence\": 0.95,\n",
            "  \"source\": \"Long_Term_Side_Effects_Medics.pdf\",\n",
            "  \"page\": 1\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 107 ---\n",
            "{\n",
            "  \"question\": \"What were the main LTAEs reported by participants?\",\n",
            "  \"answer\": \"The main LTAEs reported were mainly fatigue, menstrual disturbances, myalgia, arthralgia, dizziness, and headache.\",\n",
            "  \"confidence\": 0.95,\n",
            "  \"source\": \"Long_Term_Side_Effects_Medics.pdf\",\n",
            "  \"page\": 1\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 108 ---\n",
            "{\n",
            "  \"question\": \"Was there a statistically significant association between LTAEs and age, gender, or medical history in the study?\",\n",
            "  \"answer\": \"There was no statistically significant association between LTAEs and: age, gender, or medical history (P > .05).\",\n",
            "  \"confidence\": 0.95,\n",
            "  \"source\": \"Long_Term_Side_Effects_Medics.pdf\",\n",
            "  \"page\": 1\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 109 ---\n",
            "{\n",
            "  \"question\": \"Which vaccine showed a significant association with the collective symptoms of fatigue, myalgia, arthralgia, dizziness, and headache?\",\n",
            "  \"answer\": \"The collective symptoms of fatigue, myalgia, arthralgia, dizziness, and headache were significantly associated with Sinopharm vaccine (P = .04).\",\n",
            "  \"confidence\": 0.95,\n",
            "  \"source\": \"Long_Term_Side_Effects_Medics.pdf\",\n",
            "  \"page\": 1\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 110 ---\n",
            "{\n",
            "  \"question\": \"According to the study, what proportion of COVID-19 vaccine recipients may complain of LTAEs?\",\n",
            "  \"answer\": \"Less than 20% of COVID-19 vaccine recipients may complain of LTAEs.\",\n",
            "  \"confidence\": 0.95,\n",
            "  \"source\": \"Long_Term_Side_Effects_Medics.pdf\",\n",
            "  \"page\": 1\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 111 ---\n",
            "{\n",
            "  \"question\": \"What role do factors like age, gender, and medical status seem to play in the development of LTAEs?\",\n",
            "  \"answer\": \"It seems that factors such as age, gender, and medical status play a negligible role in development of these AEs.\",\n",
            "  \"confidence\": 0.95,\n",
            "  \"source\": \"Long_Term_Side_Effects_Medics.pdf\",\n",
            "  \"page\": 1\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 112 ---\n",
            "{\n",
            "  \"question\": \"Which vaccine showed the highest significant association with LTAEs, followed by AstraZeneca?\",\n",
            "  \"answer\": \"Sinopharm vaccine showed the highest significant association with these AEs followed by AstraZeneca vaccine.\",\n",
            "  \"confidence\": 0.95,\n",
            "  \"source\": \"Long_Term_Side_Effects_Medics.pdf\",\n",
            "  \"page\": 1\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 113 ---\n",
            "{\n",
            "  \"question\": \"What is the main topic of the research paper in Long_Term_Side_Effects_Medics.pdf?\",\n",
            "  \"answer\": \"The research paper discusses long-term adverse events of three COVID-19 vaccines as reported by vaccinated physicians and dentists.\",\n",
            "  \"confidence\": 0.9,\n",
            "  \"source\": \"Long_Term_Side_Effects_Medics.pdf\",\n",
            "  \"page\": 1\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 114 ---\n",
            "{\n",
            "  \"question\": \"What are the three main platforms utilized by the COVID-19 vaccines mentioned in the introduction?\",\n",
            "  \"answer\": \"The three main platforms are Pfizer-BioNtech (RNA-based), AstraZeneca (Adenoviral vector-based), and Sinopharm (inactivated virus).\",\n",
            "  \"confidence\": 0.95,\n",
            "  \"source\": \"Long_Term_Side_Effects_Medics.pdf\",\n",
            "  \"page\": 1\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 115 ---\n",
            "{\n",
            "  \"question\": \"What was the reported efficacy range of the mentioned COVID-19 vaccines in reducing COVID-19 related risks?\",\n",
            "  \"answer\": \"These vaccines have been reported to have efficacy rates ranging from 79% to 95% in reducing risk of moderate to severe illness, hospitalization, and deaths related to COVID-19.\",\n",
            "  \"confidence\": 0.95,\n",
            "  \"source\": \"Long_Term_Side_Effects_Medics.pdf\",\n",
            "  \"page\": 1\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 116 ---\n",
            "{\n",
            "  \"question\": \"What were the typical duration and nature of early reported side effects of COVID-19 vaccines?\",\n",
            "  \"answer\": \"Early reports on these vaccines concluded that their side effects are mostly acute in nature, with a duration ranging from 1 to 10 days. Side effects were described as local effects in the injection site and systemic transient manifestations in the form of fatigue, headache, fever, among others.\",\n",
            "  \"confidence\": 0.95,\n",
            "  \"source\": \"Long_Term_Side_Effects_Medics.pdf\",\n",
            "  \"page\": 1\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 117 ---\n",
            "{\n",
            "  \"question\": \"What is considered an important obstacle against efforts to distribute vaccines to eligible candidates?\",\n",
            "  \"answer\": \"Potential side effects of vaccines, and concerns about their safety profile represent important obstacles against efforts to distribute vaccines among eligible candidates.\",\n",
            "  \"confidence\": 0.95,\n",
            "  \"source\": \"Long_Term_Side_Effects_Medics.pdf\",\n",
            "  \"page\": 1\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 118 ---\n",
            "{\n",
            "  \"question\": \"What factors have influenced public trust in vaccines, leading to hesitancy?\",\n",
            "  \"answer\": \"Public trust in vaccines has been influenced by several political and social factors with concerns over the relatively rapid production, and claims of inadequate testing and monitoring of vaccine safety.\",\n",
            "  \"confidence\": 0.95,\n",
            "  \"source\": \"Long_Term_Side_Effects_Medics.pdf\",\n",
            "  \"page\": 1\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 119 ---\n",
            "{\n",
            "  \"question\": \"Why is it important to make reports on long-term or delayed effects of vaccines available?\",\n",
            "  \"answer\": \"It is important that such reports are made available to the public as well as scientific community. More importantly, these data should be provided in a transparent and evidence-based approach.\",\n",
            "  \"confidence\": 0.95,\n",
            "  \"source\": \"Long_Term_Side_Effects_Medics.pdf\",\n",
            "  \"page\": 1\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 120 ---\n",
            "{\n",
            "  \"question\": \"What does Table 1 from Long_Term_Side_Effects_Medics.pdf present?\",\n",
            "  \"answer\": \"Table 1 presents a cross tabulation of adverse events with age, gender, systemic disease category, and individual systemic diseases.\",\n",
            "  \"confidence\": 0.9,\n",
            "  \"source\": \"Long_Term_Side_Effects_Medics.pdf\",\n",
            "  \"page\": 4\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 121 ---\n",
            "{\n",
            "  \"question\": \"What were the highest and lowest reported vaccine effectiveness (VE) values against Omicron infection for full Pfizer vaccination, and for what time periods?\",\n",
            "  \"answer\": \"The highest reported VE for full Pfizer vaccination against Omicron infection was 83.1 (95% CI: 78.2–86.9) between 7–13 days after vaccination, and the lowest was -3 (95% CI: -30–18) after more than 150 days after vaccination.\",\n",
            "  \"confidence\": 0.9,\n",
            "  \"source\": \"Vaccine_Efficacy_Omicron_vs_Delta.pdf\",\n",
            "  \"page\": 4\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 122 ---\n",
            "{\n",
            "  \"question\": \"What was the reported vaccine effectiveness (VE) of a Moderna booster against Omicron infection, and when was this measured?\",\n",
            "  \"answer\": \"The Moderna booster VE against Omicron was reported as 34.9 (95% CI: 14.6–50.4) more than 6 weeks after vaccination.\",\n",
            "  \"confidence\": 0.9,\n",
            "  \"source\": \"Vaccine_Efficacy_Omicron_vs_Delta.pdf\",\n",
            "  \"page\": 6\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 123 ---\n",
            "{\n",
            "  \"question\": \"According to the provided text, what is the level of risk associated with antibody escape for the XEC variant?\",\n",
            "  \"answer\": \"The level of risk for antibody escape for the XEC variant is estimated to be low, as it is suggested to have limited immune evasion relative to co-circulating variants.\",\n",
            "  \"confidence\": 0.9,\n",
            "  \"source\": \"WHO_XEC_Variant_Risk.pdf\",\n",
            "  \"page\": 5\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 124 ---\n",
            "{\n",
            "  \"question\": \"What was the vaccine effectiveness of partial Pfizer vaccination against Omicron infection in the first month after primary vaccination, and how did it compare to the Delta variant?\",\n",
            "  \"answer\": \"In the first month after primary vaccination, the VE against Omicron infection with partial Pfizer vaccination was 55.2% (95% CI: 23.5 to 73.7), while against the Delta variant, it was 86.7% (95% CI: 84.6 to 88.6).\",\n",
            "  \"confidence\": 0.9,\n",
            "  \"source\": \"Vaccine_Efficacy_Omicron_vs_Delta.pdf\",\n",
            "  \"page\": 15\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 125 ---\n",
            "{\n",
            "  \"question\": \"What was the vaccine effectiveness of AstraZeneca booster against Omicron infection?\",\n",
            "  \"answer\": \"The AstraZeneca booster VE against Omicron was reported as 47 (95% CI: 2–70).\",\n",
            "  \"confidence\": 0.9,\n",
            "  \"source\": \"Vaccine_Efficacy_Omicron_vs_Delta.pdf\",\n",
            "  \"page\": 6\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 126 ---\n",
            "{\n",
            "  \"question\": \"What were the highest and lowest reported vaccine effectiveness (VE) values against Omicron infection for full Moderna vaccination, and for what time periods?\",\n",
            "  \"answer\": \"The highest reported VE for full Moderna vaccination against Omicron infection was 75.1 (95% CI: 70.8–78.7) between 2–4 weeks after vaccination, and the lowest was -39.3 (95% CI: -61.6 - -20.0) between 91–150 days after vaccination.\",\n",
            "  \"confidence\": 0.9,\n",
            "  \"source\": \"Vaccine_Efficacy_Omicron_vs_Delta.pdf\",\n",
            "  \"page\": 4\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 127 ---\n",
            "{\n",
            "  \"question\": \"How did the vaccine effectiveness (VE) of Pfizer/BioNTech vaccination against Omicron infection change over time after full vaccination, and how did this compare to the Delta variant?\",\n",
            "  \"answer\": \"Following full vaccination, the VE against Omicron infection decreased from 51% (95% CI: 0.50–0.52) at 1 month to 89% (95% CI: 0.88–0.90) at 3 months. In contrast, for the Delta variant, the VE was 18.3% (95% CI: 0.171–0.196) at 1 month, 30.3% (95% CI: 0.292–0.313) at 2 months, and 46.2% (95% CI: 0.454–0.470) at 3 months.\",\n",
            "  \"confidence\": 0.9,\n",
            "  \"source\": \"Vaccine_Efficacy_Omicron_vs_Delta.pdf\",\n",
            "  \"page\": 15\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 128 ---\n",
            "{\n",
            "  \"question\": \"What was the reported vaccine effectiveness (VE) of a Pfizer booster against Omicron infection, and for what time period was this measured?\",\n",
            "  \"answer\": \"The reported VE of a Pfizer booster against Omicron infection was 3.6 (95% CI: 0.6–6.5) 4 months before infection (using 5 months post-vaccination as a reference).\",\n",
            "  \"confidence\": 0.9,\n",
            "  \"source\": \"Vaccine_Efficacy_Omicron_vs_Delta.pdf\",\n",
            "  \"page\": 4\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 129 ---\n",
            "{\n",
            "  \"question\": \"What was the highest reported vaccine effectiveness (VE) against Omicron infection using a combination of Moderna for full vaccination and Pfizer as a booster?\",\n",
            "  \"answer\": \"The highest reported VE against Omicron infection using a combination of Moderna for full vaccination and Pfizer as a booster was 74 (95% CI: 73.1–74.9) one week after vaccination.\",\n",
            "  \"confidence\": 0.9,\n",
            "  \"source\": \"Vaccine_Efficacy_Omicron_vs_Delta.pdf\",\n",
            "  \"page\": 6\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 130 ---\n",
            "{\n",
            "  \"question\": \"What were the highest and lowest reported vaccine effectiveness (VE) values against Omicron infection for partial Pfizer vaccination, and for what time periods?\",\n",
            "  \"answer\": \"The highest reported VE for partial Pfizer vaccination against Omicron infection was 51.4 (95% CI: 42.7–58.8) in 16–17 year olds, and the lowest was 9.5 (95% CI: -39.8–41.3) between 0–13 days after vaccination.\",\n",
            "  \"confidence\": 0.9,\n",
            "  \"source\": \"Vaccine_Efficacy_Omicron_vs_Delta.pdf\",\n",
            "  \"page\": 4\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 131 ---\n",
            "{\n",
            "  \"question\": \"What was the vaccine effectiveness (VE) of a Pfizer or Moderna booster against Omicron infection, and what were the timeframes associated with these values?\",\n",
            "  \"answer\": \"The Pfizer or Moderna booster VE ranged from 78 (95% CI: 67–85) more than 4 months after vaccination to 91 (95% CI: 88–93) less than 2 months after vaccination against Omicron.\",\n",
            "  \"confidence\": 0.9,\n",
            "  \"source\": \"Vaccine_Efficacy_Omicron_vs_Delta.pdf\",\n",
            "  \"page\": 6\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 132 ---\n",
            "{\n",
            "  \"question\": \"What was the vaccine effectiveness (VE) of the Janssen booster against Omicron infection, and within what timeframe was this measured?\",\n",
            "  \"answer\": \"The Janssen booster VE against Omicron was 85 (95% CI: 54–95) between 27–87 days after vaccination.\",\n",
            "  \"confidence\": 0.9,\n",
            "  \"source\": \"Vaccine_Efficacy_Omicron_vs_Delta.pdf\",\n",
            "  \"page\": 6\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 133 ---\n",
            "{\n",
            "  \"question\": \"According to the text, what is the level of risk associated with increased disease severity for the XEC variant?\",\n",
            "  \"answer\": \"The level of risk for elevated disease severity associated with the XEC variant is currently assessed as low, as there are no reports indicating such an association.\",\n",
            "  \"confidence\": 0.9,\n",
            "  \"source\": \"WHO_XEC_Variant_Risk.pdf\",\n",
            "  \"page\": 5\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 134 ---\n",
            "{\n",
            "  \"question\": \"What were the highest and lowest reported vaccine effectiveness (VE) values against Omicron infection for partial Moderna vaccination, and for what time periods?\",\n",
            "  \"answer\": \"The highest reported VE for partial Moderna vaccination against Omicron infection was 47.9 (95% CI: 43.1–52.3) between 1–3 weeks after vaccination, and the lowest was -16.8 (95% CI: -137.8–42.6) more than 14 days after vaccination.\",\n",
            "  \"confidence\": 0.9,\n",
            "  \"source\": \"Vaccine_Efficacy_Omicron_vs_Delta.pdf\",\n",
            "  \"page\": 4\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 135 ---\n",
            "{\n",
            "  \"question\": \"How was the identification of variants, specifically Omicron, confirmed in the studies discussed?\",\n",
            "  \"answer\": \"Variants were confirmed as Omicron using whole-genome sequencing or a novel variant-specific PCR test. In other cases, S-gene target failure (SGTF) was used as a proxy for Omicron (BA.1) based on the del69/70 mutation in the S-gene. Some studies also designated variants by matching PCR test dates with national variant trends, and in Qatar, viral genome sequencing and multiplex RT-PCR variant screening were used, complemented by deep sequencing of wastewater samples.\",\n",
            "  \"confidence\": 0.9,\n",
            "  \"source\": \"Vaccine_Efficacy_Omicron_vs_Delta.pdf\",\n",
            "  \"page\": 15\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 136 ---\n",
            "{\n",
            "  \"question\": \"What was the vaccine effectiveness of full vaccination with Pfizer against Omicron and Delta variants?\",\n",
            "  \"answer\": \"Full Pfizer VE against Omicron ranged from -3 (95% CI: -30–18) to 83.1 (95% CI: 78.2–86.9), while against Delta it was 93 (95% CI: 90–94).\",\n",
            "  \"confidence\": 0.9,\n",
            "  \"source\": \"Vaccine_Efficacy_Omicron_vs_Delta.pdf\",\n",
            "  \"page\": 6\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 137 ---\n",
            "{\n",
            "  \"question\": \"What was the vaccine effectiveness of full vaccination with Moderna against Omicron and Delta variants?\",\n",
            "  \"answer\": \"The full Moderna VE was 84.5 (95% CI: 23–96.9) against Omicron and 99 (95% CI: 93.9–99) against Delta.\",\n",
            "  \"confidence\": 0.9,\n",
            "  \"source\": \"Vaccine_Efficacy_Omicron_vs_Delta.pdf\",\n",
            "  \"page\": 6\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 138 ---\n",
            "{\n",
            "  \"question\": \"What were the vaccine effectiveness (VE) values for partial Pfizer vaccination against Omicron and Delta infections in the 16–17 year old age group during the 14–20 days post-vaccination period?\",\n",
            "  \"answer\": \"For the 16–17 year old age group, partial Pfizer VE was 51.4 (95% CI: 42.7–58.8) against Omicron infection between 14–20 days post-vaccination, and 75.9 (95% CI: 74.3–77.3) against Delta infection during the same timeframe.\",\n",
            "  \"confidence\": 0.9,\n",
            "  \"source\": \"Vaccine_Efficacy_Omicron_vs_Delta.pdf\",\n",
            "  \"page\": 4\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 139 ---\n",
            "{\n",
            "  \"question\": \"What was the reported vaccine effectiveness (VE) of a Moderna booster against Omicron and Delta variants?\",\n",
            "  \"answer\": \"The Moderna booster VE was reported as 99.2 (95% CI: 76.3–100) against Omicron and 99.7 (95% CI: 96.5–100) against Delta.\",\n",
            "  \"confidence\": 0.9,\n",
            "  \"source\": \"Vaccine_Efficacy_Omicron_vs_Delta.pdf\",\n",
            "  \"page\": 6\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 140 ---\n",
            "{\n",
            "  \"question\": \"What was the vaccine effectiveness of full vaccination with AstraZeneca against Omicron and Delta variants, and for what time periods?\",\n",
            "  \"answer\": \"The full VE with AstraZeneca against Omicron ranged from -2.7 (95% CI: -4.2 - -1.2) after more than 25 weeks to 48.9 (39.2–57.1) between 2–4 weeks after vaccination. Against Delta, it ranged from 43.5 (95% CI: 42.4–44.5) after more than 25 weeks to 82.8 (95% CI: 74.5–88.4) between 2–4 weeks after vaccination.\",\n",
            "  \"confidence\": 0.9,\n",
            "  \"source\": \"Vaccine_Efficacy_Omicron_vs_Delta.pdf\",\n",
            "  \"page\": 4\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 141 ---\n",
            "{\n",
            "  \"question\": \"What is the reported incidence of long-term adverse events (LTAEs) among COVID-19 vaccine recipients?\",\n",
            "  \"answer\": \"Approximately one in six COVID-19 vaccine recipients may complain of long-term adverse events.\",\n",
            "  \"confidence\": 0.9,\n",
            "  \"source\": \"Long_Term_Side_Effects_Medics.pdf\",\n",
            "  \"page\": 6\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 142 ---\n",
            "{\n",
            "  \"question\": \"What is the most common type of long-term adverse event (LTAE) reported after COVID-19 vaccination?\",\n",
            "  \"answer\": \"The most common LTAEs are mostly fatigue related.\",\n",
            "  \"confidence\": 0.95,\n",
            "  \"source\": \"Long_Term_Side_Effects_Medics.pdf\",\n",
            "  \"page\": 6\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 143 ---\n",
            "{\n",
            "  \"question\": \"Were menstrual abnormalities reported in females of reproductive age after COVID-19 vaccination?\",\n",
            "  \"answer\": \"Yes, approximately 5% of females in the reproductive age reported menstrual abnormalities after COVID-19 vaccination.\",\n",
            "  \"confidence\": 0.95,\n",
            "  \"source\": \"Long_Term_Side_Effects_Medics.pdf\",\n",
            "  \"page\": 6\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 144 ---\n",
            "{\n",
            "  \"question\": \"Are menstrual abnormalities after COVID-19 vaccines temporary and short-lived?\",\n",
            "  \"answer\": \"Yes, menstrual abnormalities reported after receiving both mRNA and adenovirus vector COVID-19 vaccines were temporary and short-lived, and no adverse effects concerning fertility were noticed.\",\n",
            "  \"confidence\": 0.95,\n",
            "  \"source\": \"Long_Term_Side_Effects_Medics.pdf\",\n",
            "  \"page\": 6\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 145 ---\n",
            "{\n",
            "  \"question\": \"Has the Pfizer-BioNTech vaccine been associated with persistent fatigue and aluminum adjuvants?\",\n",
            "  \"answer\": \"No firm causal relationship between persistent fatigue and aluminum adjuvants was ever established, and among COVID-19 vaccines, the Pfizer-BioNTech vaccine seems to be the least associated with LTAEs.\",\n",
            "  \"confidence\": 0.9,\n",
            "  \"source\": \"Long_Term_Side_Effects_Medics.pdf\",\n",
            "  \"page\": 6\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 146 ---\n",
            "{\n",
            "  \"question\": \"What type of vaccine was associated with persistent myalgia and arthralgia in older adults in Korea?\",\n",
            "  \"answer\": \"Myalgia and arthralgia persisting for approximately six weeks were noticed among a group of older adults who received the AZ vaccine in Korea.\",\n",
            "  \"confidence\": 0.95,\n",
            "  \"source\": \"Long_Term_Side_Effects_Medics.pdf\",\n",
            "  \"page\": 6\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 147 ---\n",
            "{\n",
            "  \"question\": \"What is a possible delayed presentation associated with adenovirus-based vaccines like AZ?\",\n",
            "  \"answer\": \"Headache may be a delayed presentation associated with thrombotic complications in recipients of adenovirus-based vaccines such as AZ.\",\n",
            "  \"confidence\": 0.95,\n",
            "  \"source\": \"Long_Term_Side_Effects_Medics.pdf\",\n",
            "  \"page\": 6\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 148 ---\n",
            "{\n",
            "  \"question\": \"Which vaccine was significantly associated with poor concentration as an adverse effect?\",\n",
            "  \"answer\": \"Poor concentration was the only significantly associated AE with AZ vaccine.\",\n",
            "  \"confidence\": 0.95,\n",
            "  \"source\": \"Long_Term_Side_Effects_Medics.pdf\",\n",
            "  \"page\": 6\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 149 ---\n",
            "{\n",
            "  \"question\": \"What are the two rare but serious side effects of COVID-19 vaccines identified in a large global study?\",\n",
            "  \"answer\": \"The two rare but serious side effects identified are transverse myelitis and acute disseminated encephalomyelitis.\",\n",
            "  \"confidence\": 0.95,\n",
            "  \"source\": \"Rare_Vaccine_Side_Effects.pdf\",\n",
            "  \"page\": 1\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 150 ---\n",
            "{\n",
            "  \"question\": \"Which vaccine showed a statistically significant increase in Guillain-Barré syndrome within 42 days after the first dose?\",\n",
            "  \"answer\": \"There was a statistically significant increase in Guillain-Barré syndrome within 42 days after the first dose of the AstraZeneca vaccine.\",\n",
            "  \"confidence\": 0.95,\n",
            "  \"source\": \"Rare_Vaccine_Side_Effects.pdf\",\n",
            "  \"page\": 1\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 151 ---\n",
            "{\n",
            "  \"question\": \"What is the observed to expected ratio for Guillain-Barré syndrome after the first dose of AstraZeneca vaccine in a large global study?\",\n",
            "  \"answer\": \"The observed to expected ratio for Guillain-Barré syndrome after the first dose of the AstraZeneca vaccine was 2.49.\",\n",
            "  \"confidence\": 0.95,\n",
            "  \"source\": \"Rare_Vaccine_Side_Effects.pdf\",\n",
            "  \"page\": 1\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 152 ---\n",
            "{\n",
            "  \"question\": \"What is cerebral venous sinus thrombosis (CVST) and which vaccine is associated with an increased risk?\",\n",
            "  \"answer\": \"Cerebral venous sinus thrombosis (CVST) is a rare side effect, and an increased risk was observed following the first dose of the AstraZeneca vaccine.\",\n",
            "  \"confidence\": 0.95,\n",
            "  \"source\": \"Rare_Vaccine_Side_Effects.pdf\",\n",
            "  \"page\": 1\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 153 ---\n",
            "{\n",
            "  \"question\": \"Which vaccines are associated with an increased risk of myocarditis and pericarditis?\",\n",
            "  \"answer\": \"The study confirmed significantly higher risks of myocarditis following the first, second, and third doses of the Pfizer and Moderna vaccines, as well as pericarditis after the first and fourth dose of the Moderna vaccine, and third dose of AstraZeneca vaccine.\",\n",
            "  \"confidence\": 0.9,\n",
            "  \"source\": \"Rare_Vaccine_Side_Effects.pdf\",\n",
            "  \"page\": 1\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 154 ---\n",
            "{\n",
            "  \"question\": \"Are acute disseminated encephalomyelitis (ADEM) and transverse myelitis associated with mRNA COVID-19 vaccines?\",\n",
            "  \"answer\": \"No associations were observed between mRNA COVID-19 vaccines and either acute disseminated encephalomyelitis (ADEM) or transverse myelitis.\",\n",
            "  \"confidence\": 0.95,\n",
            "  \"source\": \"Rare_Vaccine_Side_Effects.pdf\",\n",
            "  \"page\": 1\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 155 ---\n",
            "{\n",
            "  \"question\": \"What are the absolute risks of acute disseminated encephalomyelitis (ADEM) and transverse myelitis per million vaccine doses for the AstraZeneca vaccine?\",\n",
            "  \"answer\": \"The absolute risk is extremely small, with 0.78 per million vaccine doses for acute disseminated encephalomyelitis (ADEM) and 1.82 per million vaccine doses for transverse myelitis.\",\n",
            "  \"confidence\": 0.9,\n",
            "  \"source\": \"Rare_Vaccine_Side_Effects.pdf\",\n",
            "  \"page\": 1\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 156 ---\n",
            "{\n",
            "  \"question\": \"What is myocarditis and pericarditis and what can cause them?\",\n",
            "  \"answer\": \"Myocarditis is inflammation of the heart muscle and pericarditis is inflammation of the tissue forming a sac around the heart. These conditions are usually caused by viral infections including COVID-19, but they are also very rare and serious side effects of the COVID-19 vaccines.\",\n",
            "  \"confidence\": 0.95,\n",
            "  \"source\": \"covid_side_effects.pdf\",\n",
            "  \"page\": 2\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 157 ---\n",
            "{\n",
            "  \"question\": \"When do symptoms of myocarditis or pericarditis linked to the vaccine generally appear?\",\n",
            "  \"answer\": \"Symptoms of myocarditis or pericarditis linked to the vaccine generally appear within a few days, and mostly within the first few weeks after having the vaccine.\",\n",
            "  \"confidence\": 0.95,\n",
            "  \"source\": \"covid_side_effects.pdf\",\n",
            "  \"page\": 2\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 158 ---\n",
            "{\n",
            "  \"question\": \"In which age group and gender is the risk of myocarditis highest after COVID-19 vaccination?\",\n",
            "  \"answer\": \"The risk of myocarditis is highest in people aged 16 to 30 years, particularly 16 to 18 years, and is higher in men.\",\n",
            "  \"confidence\": 0.95,\n",
            "  \"source\": \"covid_side_effects.pdf\",\n",
            "  \"page\": 2\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 159 ---\n",
            "{\n",
            "  \"question\": \"What are some symptoms of myocarditis and pericarditis?\",\n",
            "  \"answer\": \"Symptoms include tightness, heaviness, discomfort or pain in your chest or neck, difficulty breathing or catching your breath, feeling faint or dizzy or light-headed, and fluttering, racing or pounding heart, or feeling like it is 'skipping beats'.\",\n",
            "  \"confidence\": 0.95,\n",
            "  \"source\": \"covid_side_effects.pdf\",\n",
            "  \"page\": 2\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 160 ---\n",
            "{\n",
            "  \"question\": \"How long should people be watched after receiving a COVID-19 vaccine due to the risk of severe allergic reactions?\",\n",
            "  \"answer\": \"People are watched for around 15 minutes after their vaccine because serious allergic reactions or anaphylaxis are rare but serious.\",\n",
            "  \"confidence\": 0.95,\n",
            "  \"source\": \"covid_side_effects.pdf\",\n",
            "  \"page\": 2\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 161 ---\n",
            "{\n",
            "  \"question\": \"What percentage of COVID-19 vaccinated physicians and dentists reported symptomatic infections after their second dose?\",\n",
            "  \"answer\": \"33 out of 41 subjects (78.5%) contracted symptomatic infections after their second dose.\",\n",
            "  \"confidence\": 1,\n",
            "  \"source\": \"Long_Term_Side_Effects_Medics.pdf\",\n",
            "  \"page\": 3\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 162 ---\n",
            "{\n",
            "  \"question\": \"What was the most frequently reported long-term adverse event (LTAE) among the entire sample of vaccinated physicians and dentists?\",\n",
            "  \"answer\": \"Fatigue was the most frequently reported LTAE, affecting 32 individuals (6.4% of the sample).\",\n",
            "  \"confidence\": 1,\n",
            "  \"source\": \"Long_Term_Side_Effects_Medics.pdf\",\n",
            "  \"page\": 3\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 163 ---\n",
            "{\n",
            "  \"question\": \"Which specific LTAE was reported by 15 out of 314 menstruating women?\",\n",
            "  \"answer\": \"Menstrual disturbances were reported by 15 out of 314 menstruating women.\",\n",
            "  \"confidence\": 1,\n",
            "  \"source\": \"Long_Term_Side_Effects_Medics.pdf\",\n",
            "  \"page\": 3\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 164 ---\n",
            "{\n",
            "  \"question\": \"List three adverse events that were reported only once among COVID-19 vaccinated physicians and dentists.\",\n",
            "  \"answer\": \"Anorexia, dry mouth, and periodontitis are three adverse events that were reported only once.\",\n",
            "  \"confidence\": 1,\n",
            "  \"source\": \"Long_Term_Side_Effects_Medics.pdf\",\n",
            "  \"page\": 3\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 165 ---\n",
            "{\n",
            "  \"question\": \"Which three LTAEs were reported in recipients of PB and SP vaccines?\",\n",
            "  \"answer\": \"Thrombosis, bleeding tendency, and left arm paresthesia were reported in recipients of PB and SP vaccines.\",\n",
            "  \"confidence\": 1,\n",
            "  \"source\": \"Long_Term_Side_Effects_Medics.pdf\",\n",
            "  \"page\": 3\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 166 ---\n",
            "{\n",
            "  \"question\": \"Was there a significant association between reported LTAEs and gender, age groups, or history of systemic diseases?\",\n",
            "  \"answer\": \"No, cross-tabulation showed no significant association of reported LTAEs with gender, age groups, or history of systemic diseases.\",\n",
            "  \"confidence\": 1,\n",
            "  \"source\": \"Long_Term_Side_Effects_Medics.pdf\",\n",
            "  \"page\": 3\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 167 ---\n",
            "{\n",
            "  \"question\": \"What was the average age of participants who reported fatigue and related symptoms?\",\n",
            "  \"answer\": \"The mean age of participants reporting fatigue and related symptoms was 35.91 ± 11.26 years.\",\n",
            "  \"confidence\": 1,\n",
            "  \"source\": \"Long_Term_Side_Effects_Medics.pdf\",\n",
            "  \"page\": 3\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 168 ---\n",
            "{\n",
            "  \"question\": \"Did the effectiveness of partial Pfizer/BioNTech vaccination against symptomatic Omicron infection decrease over time compared to Delta infection?\",\n",
            "  \"answer\": \"Yes, protection against symptomatic Omicron infection was less robust (31.5%) compared to Delta infection (peak VE of 72.3%) at the same time point from the first dose.\",\n",
            "  \"confidence\": 1,\n",
            "  \"source\": \"Vaccine_Efficacy_Omicron_vs_Delta.pdf\",\n",
            "  \"page\": 16\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 169 ---\n",
            "{\n",
            "  \"question\": \"What was the peak vaccine efficacy (VE) of a second dose of Pfizer/BioNTech against symptomatic Delta infection and Omicron infection, respectively, 2-4 weeks after the second dose?\",\n",
            "  \"answer\": \"A second dose of Pfizer/BioNTech achieved a peak VE of 90.9% against Delta and 65.5% against Omicron, 2-4 weeks after the second dose.\",\n",
            "  \"confidence\": 1,\n",
            "  \"source\": \"Vaccine_Efficacy_Omicron_vs_Delta.pdf\",\n",
            "  \"page\": 16\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 170 ---\n",
            "{\n",
            "  \"question\": \"By 25 weeks after the second dose, what was the estimated vaccine efficacy of Pfizer/BioNTech against Delta and Omicron infections?\",\n",
            "  \"answer\": \"By 25 weeks, the efficacy against Delta had dropped to 62.7% and against Omicron to 8.8%.\",\n",
            "  \"confidence\": 1,\n",
            "  \"source\": \"Vaccine_Efficacy_Omicron_vs_Delta.pdf\",\n",
            "  \"page\": 16\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 171 ---\n",
            "{\n",
            "  \"question\": \"What was the effectiveness of a Pfizer/BioNTech booster dose against symptomatic Delta and Omicron infections, respectively?\",\n",
            "  \"answer\": \"A Pfizer/BioNTech booster dose was 92.3% effective against Delta and 66.9% effective against Omicron.\",\n",
            "  \"confidence\": 1,\n",
            "  \"source\": \"Vaccine_Efficacy_Omicron_vs_Delta.pdf\",\n",
            "  \"page\": 16\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 172 ---\n",
            "{\n",
            "  \"question\": \"According to the Accorsi et al. study, what was the adjusted odds ratio (aOR) of being boosted with Pfizer/BioNTech against Omicron symptomatic infection compared to unvaccinated individuals?\",\n",
            "  \"answer\": \"The adjusted odds ratio (aOR) of being boosted with Pfizer/BioNTech against Omicron symptomatic infection compared to unvaccinated individuals was 0.35.\",\n",
            "  \"confidence\": 1,\n",
            "  \"source\": \"Vaccine_Efficacy_Omicron_vs_Delta.pdf\",\n",
            "  \"page\": 16\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 173 ---\n",
            "{\n",
            "  \"question\": \"In the Patalon et al. study, how did the Pfizer/BioNTech booster VE against Omicron infection change with time since vaccination?\",\n",
            "  \"answer\": \"The Pfizer/BioNTech booster VE against Omicron infection decreased each month from vaccination, with a peak VE of 53.4% for those boosted one month prior and a VE of 3.6% for those boosted four months prior.\",\n",
            "  \"confidence\": 1,\n",
            "  \"source\": \"Vaccine_Efficacy_Omicron_vs_Delta.pdf\",\n",
            "  \"page\": 16\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 174 ---\n",
            "{\n",
            "  \"question\": \"What was the effectiveness of partial Moderna vaccination against symptomatic BA.1 and BA.2 Omicron infections, respectively, at 1 and 2 months after the first dose in the Chemaitelly et al. study?\",\n",
            "  \"answer\": \"Partial Moderna vaccination was 39.2% effective against BA.1 and 36.1% effective against BA.2 symptomatic infection at 14 days after the first dose.\",\n",
            "  \"confidence\": 1,\n",
            "  \"source\": \"Vaccine_Efficacy_Omicron_vs_Delta.pdf\",\n",
            "  \"page\": 16\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 175 ---\n",
            "{\n",
            "  \"question\": \"According to the Šmíd et al. study, what were the hazard ratios (HRs) for Omicron infections associated with full Moderna vaccination at 1, 2, and 3 months after the last dose?\",\n",
            "  \"answer\": \"Full Moderna vaccination was associated with HRs of 0.51, 0.59, and 0.80 at 1, 2, and 3 months following full vaccination, respectively, for Omicron infections.\",\n",
            "  \"confidence\": 1,\n",
            "  \"source\": \"Vaccine_Efficacy_Omicron_vs_Delta.pdf\",\n",
            "  \"page\": 16\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 176 ---\n",
            "{\n",
            "  \"question\": \"What are some reported neurological complications associated with mRNA-based vaccines like Pfizer?\",\n",
            "  \"answer\": \"Reported neurological complications for mRNA-based vaccines include headache, first manifestation of multiple sclerosis, transverse myelitis, GBS, Bell’s palsy, acute disseminated encephalomyelitis, neuromyelitis optica, small fiber neuropathy, encephalopathy, olfactory dysfunction and phantosmia, tinnitus and cochleopathy, abducens nerve palsy, Parsonage–Turner syndrome, seizures, herpes zoster, akathisia, delirium, intracerebral hemorrhage, ischemic stroke, and transient ischemic attack.\",\n",
            "  \"confidence\": 1,\n",
            "  \"source\": \"COVID_Vaccine_Neuro_Effects.pdf\",\n",
            "  \"page\": 5\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 177 ---\n",
            "{\n",
            "  \"question\": \"Which neurological complication is reported for both Pfizer and Moderna mRNA-based vaccines?\",\n",
            "  \"answer\": \"Transverse myelitis and Bell's palsy are reported neurological complications for both Pfizer and Moderna mRNA-based vaccines.\",\n",
            "  \"confidence\": 1,\n",
            "  \"source\": \"COVID_Vaccine_Neuro_Effects.pdf\",\n",
            "  \"page\": 5\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 178 ---\n",
            "{\n",
            "  \"question\": \"Which specific neurological complication is noted as being 'more about Pfizer' in the context of adverse effects?\",\n",
            "  \"answer\": \"The first manifestation of multiple sclerosis is noted as being 'more about Pfizer'.\",\n",
            "  \"confidence\": 1,\n",
            "  \"source\": \"COVID_Vaccine_Neuro_Effects.pdf\",\n",
            "  \"page\": 5\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 179 ---\n",
            "{\n",
            "  \"question\": \"What is Long Post-COVID Vaccination Syndrome (LPCVS) defined as?\",\n",
            "  \"answer\": \"LPCVS is defined as side effects to SARS-CoV-2 vaccinations that persist for more than 4 weeks with no or minimal abnormal findings on clinical or instrumental investigations.\",\n",
            "  \"confidence\": 1,\n",
            "  \"source\": \"Clinical Analysis of Long Post-COVID Vaccination Syndrome (LPCVS).pdf\",\n",
            "  \"page\": 1\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 180 ---\n",
            "{\n",
            "  \"question\": \"How long did it take for three patients with LPCVS to partially recover after vaccination, and what kind of therapy did they receive?\",\n",
            "  \"answer\": \"The three patients with LPCVS partially recovered within 6–8 months after vaccination and received only symptomatic therapy.\",\n",
            "  \"confidence\": 1,\n",
            "  \"source\": \"Clinical Analysis of Long Post-COVID Vaccination Syndrome (LPCVS).pdf\",\n",
            "  \"page\": 1\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 181 ---\n",
            "{\n",
            "  \"question\": \"What is the general consensus from national experts regarding the benefits and risks of COVID-19 vaccines?\",\n",
            "  \"answer\": \"Based on careful review by national experts, the benefits of COVID-19 vaccines far outweigh the risks.\",\n",
            "  \"confidence\": 1.0,\n",
            "  \"source\": \"jj_vaccine_risks.pdf\",\n",
            "  \"page\": 1\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 182 ---\n",
            "{\n",
            "  \"question\": \"What is the CDC's updated recommendation as of December 16, 2021, concerning COVID-19 vaccines?\",\n",
            "  \"answer\": \"As of 12/16/21, the CDC endorses updated recommendations from the ACIP, expressing a medical preference for individuals to receive an mRNA COVID-19 vaccine (Pfizer or Moderna) over Johnson & Johnson's vaccine.\",\n",
            "  \"confidence\": 1.0,\n",
            "  \"source\": \"jj_vaccine_risks.pdf\",\n",
            "  \"page\": 1\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 183 ---\n",
            "{\n",
            "  \"question\": \"Under what circumstances is the Johnson & Johnson COVID-19 vaccine recommended to be used according to the CDC?\",\n",
            "  \"answer\": \"The Johnson & Johnson vaccine should be used in limited settings as outlined in the document.\",\n",
            "  \"confidence\": 1.0,\n",
            "  \"source\": \"jj_vaccine_risks.pdf\",\n",
            "  \"page\": 1\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 184 ---\n",
            "{\n",
            "  \"question\": \"What age group is authorized for emergency use of the Johnson & Johnson COVID-19 vaccine?\",\n",
            "  \"answer\": \"The Johnson & Johnson COVID-19 vaccine has Emergency Use Authorization for people aged 18 and older.\",\n",
            "  \"confidence\": 1.0,\n",
            "  \"source\": \"jj_vaccine_risks.pdf\",\n",
            "  \"page\": 1\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 185 ---\n",
            "{\n",
            "  \"question\": \"How is the Johnson & Johnson COVID-19 vaccine administered?\",\n",
            "  \"answer\": \"This vaccine is a single dose injected into the muscle.\",\n",
            "  \"confidence\": 1.0,\n",
            "  \"source\": \"jj_vaccine_risks.pdf\",\n",
            "  \"page\": 1\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 186 ---\n",
            "{\n",
            "  \"question\": \"What are some reasons an individual might not be medically able to take another COVID-19 vaccine besides Johnson & Johnson?\",\n",
            "  \"answer\": \"Some individuals are not medically able to take another COVID-19 vaccine, for example, some people may have had a severe allergic reaction after a previous dose.\",\n",
            "  \"confidence\": 1.0,\n",
            "  \"source\": \"jj_vaccine_risks.pdf\",\n",
            "  \"page\": 1\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 187 ---\n",
            "{\n",
            "  \"question\": \"Under what conditions might someone choose to receive the Johnson & Johnson COVID-19 vaccine?\",\n",
            "  \"answer\": \"Some individuals elect to receive the Johnson & Johnson COVID-19 Vaccine because they would otherwise not receive a COVID-19 vaccine, or they would remain unvaccinated for COVID-19 and have limited access to other COVID-19 vaccines.\",\n",
            "  \"confidence\": 1.0,\n",
            "  \"source\": \"jj_vaccine_risks.pdf\",\n",
            "  \"page\": 1\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 188 ---\n",
            "{\n",
            "  \"question\": \"What advice is given to individuals considering COVID-19 vaccination options, particularly if they are considering the Johnson & Johnson vaccine?\",\n",
            "  \"answer\": \"We recommend these individuals discuss COVID-19 vaccination options with a medical provider.\",\n",
            "  \"confidence\": 1.0,\n",
            "  \"source\": \"jj_vaccine_risks.pdf\",\n",
            "  \"page\": 1\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 189 ---\n",
            "{\n",
            "  \"question\": \"What are common side effects after receiving the Johnson & Johnson COVID-19 vaccine?\",\n",
            "  \"answer\": \"Common side effects may include pain or swelling at the injection site, headache, fatigue, muscle aches, nausea, or fever. These side effects should go away within a few days.\",\n",
            "  \"confidence\": 1.0,\n",
            "  \"source\": \"jj_vaccine_risks.pdf\",\n",
            "  \"page\": 1\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 190 ---\n",
            "{\n",
            "  \"question\": \"What rare risk has been associated with the Johnson & Johnson COVID-19 vaccine?\",\n",
            "  \"answer\": \"There have been rare occurrences of blood clots (involving blood vessels in the brain, abdomen, and legs) as well as low levels of blood cells that help your body stop bleeding, in some people who have received the Johnson & Johnson COVID-19 vaccine.\",\n",
            "  \"confidence\": 1.0,\n",
            "  \"source\": \"jj_vaccine_risks.pdf\",\n",
            "  \"page\": 1\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 191 ---\n",
            "{\n",
            "  \"question\": \"When did symptoms of the rare blood clot risk typically begin after receiving the Johnson & Johnson COVID-19 vaccine?\",\n",
            "  \"answer\": \"In people who developed these blood clots, symptoms began approximately 1–2 weeks after vaccination.\",\n",
            "  \"confidence\": 1.0,\n",
            "  \"source\": \"jj_vaccine_risks.pdf\",\n",
            "  \"page\": 1\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 192 ---\n",
            "{\n",
            "  \"question\": \"Which age and gender group has reported the highest incidence of the rare blood clot risk associated with the Johnson & Johnson vaccine?\",\n",
            "  \"answer\": \"Reporting has been highest for females ages 30 to 49 years old.\",\n",
            "  \"confidence\": 1.0,\n",
            "  \"source\": \"jj_vaccine_risks.pdf\",\n",
            "  \"page\": 1\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 193 ---\n",
            "{\n",
            "  \"question\": \"What are some symptoms to watch for in the 1-2 weeks after receiving the Johnson & Johnson vaccine that could indicate a blood clot issue?\",\n",
            "  \"answer\": \"For one to two weeks after receiving the vaccine, be on the lookout for shortness of breath, chest pain, leg swelling, persistent abdominal pain, severe headaches or blurred vision, easy bruising, or tiny blood spots under the skin beyond the site of the injection.\",\n",
            "  \"confidence\": 1.0,\n",
            "  \"source\": \"jj_vaccine_risks.pdf\",\n",
            "  \"page\": 1\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 194 ---\n",
            "{\n",
            "  \"question\": \"Are the rare blood clots associated with the Pfizer or Moderna vaccines?\",\n",
            "  \"answer\": \"To date, these rare blood clots have not been associated with the Pfizer or Moderna vaccines.\",\n",
            "  \"confidence\": 1.0,\n",
            "  \"source\": \"jj_vaccine_risks.pdf\",\n",
            "  \"page\": 1\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 195 ---\n",
            "{\n",
            "  \"question\": \"What is the definition of platelet aggregate concentration in the context of the Pfizer-BioNTech study?\",\n",
            "  \"answer\": \"The concentration of platelet aggregates is defined as the ratio of the number of acquired images containing platelet aggregates to the total number of acquired images for each blood sample and serves as a direct indicator of platelet activity.\",\n",
            "  \"confidence\": 1.0,\n",
            "  \"source\": \"Pfizer_Platelet_LongTerm_Study.pdf\",\n",
            "  \"page\": 3\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 196 ---\n",
            "{\n",
            "  \"question\": \"What was the typical concentration of platelet aggregates observed in healthy subjects over 11 months during the Pfizer-BioNTech study?\",\n",
            "  \"answer\": \"The concentration of platelet aggregates in all subjects remained low (less than 4%), with modest transient variations within each subject.\",\n",
            "  \"confidence\": 1.0,\n",
            "  \"source\": \"Pfizer_Platelet_LongTerm_Study.pdf\",\n",
            "  \"page\": 3\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 197 ---\n",
            "{\n",
            "  \"question\": \"Did the study find significant or persisting trends in platelet aggregate data following vaccine administration?\",\n",
            "  \"answer\": \"No significant or persisting trends were found following vaccine administration, suggesting that any effect of vaccinations on platelet turnover, activation, or aggregation was insignificant.\",\n",
            "  \"confidence\": 1.0,\n",
            "  \"source\": \"Pfizer_Platelet_LongTerm_Study.pdf\",\n",
            "  \"page\": 3\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 198 ---\n",
            "{\n",
            "  \"question\": \"What is the overall finding regarding the long-term effects of Pfizer-BioNTech vaccinations on platelet activity?\",\n",
            "  \"answer\": \"These results indicate that the vaccinations did not have long-term effects on platelet activity.\",\n",
            "  \"confidence\": 1.0,\n",
            "  \"source\": \"Pfizer_Platelet_LongTerm_Study.pdf\",\n",
            "  \"page\": 3\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 199 ---\n",
            "{\n",
            "  \"question\": \"How effective was the primary Pfizer/BioNTech series against Omicron-period hospitalization in South Africa, according to Collie et al.?\",\n",
            "  \"answer\": \"The VE of the primary Pfizer/BioNTech series against Omicron-period hospitalization was 70% (95% CI: 62–76).\",\n",
            "  \"confidence\": 1.0,\n",
            "  \"source\": \"Vaccine_Efficacy_Omicron_vs_Delta.pdf\",\n",
            "  \"page\": 20\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 200 ---\n",
            "{\n",
            "  \"question\": \"What was the effectiveness of the primary Pfizer/BioNTech series against Delta-period hospitalization in South Africa, according to Collie et al.?\",\n",
            "  \"answer\": \"Compared to unvaccinated individuals, the VE against Delta-period hospitalization was 93% (95% CI: 90–94).\",\n",
            "  \"confidence\": 1.0,\n",
            "  \"source\": \"Vaccine_Efficacy_Omicron_vs_Delta.pdf\",\n",
            "  \"page\": 20\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 201 ---\n",
            "{\n",
            "  \"question\": \"What was the vaccine effectiveness (VE) against Omicron infection less than 2 months after the latest dose, according to the study by Šmíd et al.?\",\n",
            "  \"answer\": \"Full vaccination protection against Omicron infection was 43% (95% CI: 42–44) just <2 months after the latest dose.\",\n",
            "  \"confidence\": 1,\n",
            "  \"source\": \"Vaccine_Efficacy_Omicron_vs_Delta.pdf\",\n",
            "  \"page\": 19\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 202 ---\n",
            "{\n",
            "  \"question\": \"How did the vaccine effectiveness against Omicron infection change more than 2 months after the latest dose, according to Šmíd et al.?\",\n",
            "  \"answer\": \"Full vaccination protection against Omicron infection declined to as low as 9% (95% CI: 8–10) after >2 months.\",\n",
            "  \"confidence\": 1,\n",
            "  \"source\": \"Vaccine_Efficacy_Omicron_vs_Delta.pdf\",\n",
            "  \"page\": 19\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 203 ---\n",
            "{\n",
            "  \"question\": \"What was the vaccine effectiveness against Omicron infection recently after receiving an mRNA booster dose, according to Šmíd et al.?\",\n",
            "  \"answer\": \"Receiving an mRNA booster dose increased protection to 56% (95% CI: 55–56) recently.\",\n",
            "  \"confidence\": 1,\n",
            "  \"source\": \"Vaccine_Efficacy_Omicron_vs_Delta.pdf\",\n",
            "  \"page\": 19\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 204 ---\n",
            "{\n",
            "  \"question\": \"How did the effectiveness of an mRNA booster dose against Omicron infection decline after more than 2 months, according to Šmíd et al.?\",\n",
            "  \"answer\": \"Protection from an mRNA booster dose declined to 21% (95% CI: 19–23) after >2 months.\",\n",
            "  \"confidence\": 1,\n",
            "  \"source\": \"Vaccine_Efficacy_Omicron_vs_Delta.pdf\",\n",
            "  \"page\": 19\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 205 ---\n",
            "{\n",
            "  \"question\": \"What were the reported vaccine effectiveness (VE) figures against Delta infection for full vaccination (prior to booster) according to Šmíd et al.?\",\n",
            "  \"answer\": \"The reported VE against Delta infection were 73% (95% CI: 72–74) for full vaccination.\",\n",
            "  \"confidence\": 1,\n",
            "  \"source\": \"Vaccine_Efficacy_Omicron_vs_Delta.pdf\",\n",
            "  \"page\": 19\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 206 ---\n",
            "{\n",
            "  \"question\": \"How did Pfizer/BioNTech boosters compare to Moderna boosters in reducing the risk of Delta variant infection at 1 month post-inoculation?\",\n",
            "  \"answer\": \"Pfizer/BioNTech boosters had HRs of 0.101 (95% CI: 0.096–0.105) at 1 month, while Moderna boosters had HRs of 0.078 (95% CI: 0.069–0.089) at the same time period.\",\n",
            "  \"confidence\": 1,\n",
            "  \"source\": \"Vaccine_Efficacy_Omicron_vs_Delta.pdf\",\n",
            "  \"page\": 19\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 207 ---\n",
            "{\n",
            "  \"question\": \"What were the hazard ratios (HRs) associated with Pfizer/BioNTech boosters against Omicron infection at 1 month since inoculation?\",\n",
            "  \"answer\": \"Pfizer/BioNTech boosters were associated with HRs of 0.42 (95% CI: 0.41–0.42) against Omicron infection at 1 month since inoculation.\",\n",
            "  \"confidence\": 1,\n",
            "  \"source\": \"Vaccine_Efficacy_Omicron_vs_Delta.pdf\",\n",
            "  \"page\": 19\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 208 ---\n",
            "{\n",
            "  \"question\": \"What were the hazard ratios (HRs) associated with Moderna boosters against Omicron infection at 2 months since inoculation?\",\n",
            "  \"answer\": \"Moderna boosters were associated with HRs of 0.67 (95% CI: 0.62–0.71) against Omicron infection at 2 months since inoculation.\",\n",
            "  \"confidence\": 1,\n",
            "  \"source\": \"Vaccine_Efficacy_Omicron_vs_Delta.pdf\",\n",
            "  \"page\": 19\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 209 ---\n",
            "{\n",
            "  \"question\": \"In the Delta-Omicron BA.1 period, what was the vaccine effectiveness (VE) against Delta infection after primary vaccination at 7+ months from the last dose?\",\n",
            "  \"answer\": \"In the Delta-Omicron BA.1 period, VE against Delta infection was 71% (95% CI: 69–73) at 7+ months from the last dose of primary vaccination.\",\n",
            "  \"confidence\": 1,\n",
            "  \"source\": \"Vaccine_Efficacy_Omicron_vs_Delta.pdf\",\n",
            "  \"page\": 19\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 210 ---\n",
            "{\n",
            "  \"question\": \"In the Delta-Omicron BA.1 period, what was the vaccine effectiveness (VE) against Omicron BA.1 infection after primary vaccination?\",\n",
            "  \"answer\": \"In the Delta-Omicron BA.1 period, primary vaccination was associated with substantially lower VEs of 22% (95% CI: 18–26) against Omicron BA.1 infection.\",\n",
            "  \"confidence\": 1,\n",
            "  \"source\": \"Vaccine_Efficacy_Omicron_vs_Delta.pdf\",\n",
            "  \"page\": 19\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 211 ---\n",
            "{\n",
            "  \"question\": \"In the Omicron BA.1-BA.2 period, what was the vaccine effectiveness (VE) against BA.1 infection at 7+ months after primary vaccination?\",\n",
            "  \"answer\": \"In the Omicron BA.1-BA.2 period, VE was 39% (95% CI: 36–42) against BA.1 at 7+ months after primary vaccination.\",\n",
            "  \"confidence\": 1,\n",
            "  \"source\": \"Vaccine_Efficacy_Omicron_vs_Delta.pdf\",\n",
            "  \"page\": 19\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 212 ---\n",
            "{\n",
            "  \"question\": \"In the Omicron BA.1-BA.2 period, what was the vaccine effectiveness (VE) against BA.2 infection at 1 month after booster vaccination?\",\n",
            "  \"answer\": \"In the Omicron BA.1-BA.2 period, VE was 61% (95% CI: 58–63) against BA.2 at 1 month after booster vaccination.\",\n",
            "  \"confidence\": 1,\n",
            "  \"source\": \"Vaccine_Efficacy_Omicron_vs_Delta.pdf\",\n",
            "  \"page\": 19\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 213 ---\n",
            "{\n",
            "  \"question\": \"How did the vaccine effectiveness (VE) of a booster compare to the primary series against Omicron-BA.1 infection?\",\n",
            "  \"answer\": \"The VE of the booster was 46% (95% CI: 42–50) against Omicron-BA.1, compared to the primary series which had a VE of 22% (95% CI: 18–26) in the Delta-Omicron BA.1 period.\",\n",
            "  \"confidence\": 0.9,\n",
            "  \"source\": \"Vaccine_Efficacy_Omicron_vs_Delta.pdf\",\n",
            "  \"page\": 19\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 214 ---\n",
            "{\n",
            "  \"question\": \"In the Delta-Omicron BA.1 period, what was the vaccine effectiveness (VE) against Delta infection following mRNA-booster vaccination?\",\n",
            "  \"answer\": \"Following mRNA-booster vaccination in the Delta-Omicron BA.1 period, VE against Delta infection increased to 94% (95% CI: 94–96).\",\n",
            "  \"confidence\": 1,\n",
            "  \"source\": \"Vaccine_Efficacy_Omicron_vs_Delta.pdf\",\n",
            "  \"page\": 19\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 215 ---\n",
            "{\n",
            "  \"question\": \"In the Omicron BA.1-BA.2 period, what was the vaccine effectiveness (VE) against BA.1 infection 1 month after booster vaccination?\",\n",
            "  \"answer\": \"In the Omicron BA.1-BA.2 period, VE was 69% (95% CI: 67–70) against BA.1 at 1 month after booster vaccination.\",\n",
            "  \"confidence\": 1,\n",
            "  \"source\": \"Vaccine_Efficacy_Omicron_vs_Delta.pdf\",\n",
            "  \"page\": 19\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 216 ---\n",
            "{\n",
            "  \"question\": \"What was the adjusted hazard ratio (HR) for mRNA-booster vaccination against any confirmed SARS-CoV-2 infection in the NBA cohort study?\",\n",
            "  \"answer\": \"The adjusted HR was 0.43 (95% CI: 0.35–0.53) for mRNA-booster vaccination against any confirmed SARS-CoV-2 infection.\",\n",
            "  \"confidence\": 1,\n",
            "  \"source\": \"Vaccine_Efficacy_Omicron_vs_Delta.pdf\",\n",
            "  \"page\": 19\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 217 ---\n",
            "{\n",
            "  \"question\": \"What was the adjusted hazard ratio (HR) for mRNA-booster vaccination against symptomatic infection in the NBA cohort study?\",\n",
            "  \"answer\": \"The adjusted HR was 0.39 (95% CI: 0.30–0.50) for mRNA-booster vaccination against symptomatic infection.\",\n",
            "  \"confidence\": 1,\n",
            "  \"source\": \"Vaccine_Efficacy_Omicron_vs_Delta.pdf\",\n",
            "  \"page\": 19\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 218 ---\n",
            "{\n",
            "  \"question\": \"In the Danish registry-based study, what was the odds ratio (OR) for Delta variant infection among the unvaccinated or partially vaccinated relative to those fully vaccinated?\",\n",
            "  \"answer\": \"The odds ratio (OR) was 2.31 (95% CI: 2.09–2.55) for Delta variant infection among the unvaccinated or partially vaccinated relative to those fully vaccinated.\",\n",
            "  \"confidence\": 1,\n",
            "  \"source\": \"Vaccine_Efficacy_Omicron_vs_Delta.pdf\",\n",
            "  \"page\": 19\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 219 ---\n",
            "{\n",
            "  \"question\": \"In the Danish registry-based study, what was the odds ratio (OR) for Omicron infection between the unvaccinated/partially vaccinated and fully vaccinated groups?\",\n",
            "  \"answer\": \"There was no significant difference in the odds of Omicron infection between the unvaccinated/partially vaccinated and fully vaccinated groups.\",\n",
            "  \"confidence\": 1,\n",
            "  \"source\": \"Vaccine_Efficacy_Omicron_vs_Delta.pdf\",\n",
            "  \"page\": 19\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 220 ---\n",
            "{\n",
            "  \"question\": \"According to the Danish registry-based study, how did receiving a booster vaccination affect the odds of Omicron infection?\",\n",
            "  \"answer\": \"Receiving a booster significantly reduced infection susceptibility to Omicron with an OR of 0.54 (95% CI: 0.40–0.71).\",\n",
            "  \"confidence\": 1,\n",
            "  \"source\": \"Vaccine_Efficacy_Omicron_vs_Delta.pdf\",\n",
            "  \"page\": 19\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 221 ---\n",
            "{\n",
            "  \"question\": \"What does the WHO and its Technical Advisory Group on COVID-19 Vaccine Composition (TAG-CO-VAC) do?\",\n",
            "  \"answer\": \"WHO and its Technical Advisory Group on COVID-19 Vaccine Composition (TAG-CO-VAC) regularly assess the impact of variants on the performance of COVID-19 vaccines to inform decisions on updates to vaccine composition.\",\n",
            "  \"confidence\": 0.9,\n",
            "  \"source\": \"WHO_XEC_Variant_Risk.pdf\",\n",
            "  \"page\": 2\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 222 ---\n",
            "{\n",
            "  \"question\": \"When did WHO decide to start attaching risk evaluations to VUM designations in addition to VOI designations?\",\n",
            "  \"answer\": \"WHO decided on 29th November 2024 to begin attaching risk evaluations to VUM designations in addition to VOI designations.\",\n",
            "  \"confidence\": 0.9,\n",
            "  \"source\": \"WHO_XEC_Variant_Risk.pdf\",\n",
            "  \"page\": 2\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 223 ---\n",
            "{\n",
            "  \"question\": \"What are the WHO Director General's latest standing recommendations for managing COVID-19?\",\n",
            "  \"answer\": \"The WHO Director General’s latest standing recommendations remain in effect from 9 August 2023 until 30 April 2025.\",\n",
            "  \"confidence\": 0.9,\n",
            "  \"source\": \"WHO_XEC_Variant_Risk.pdf\",\n",
            "  \"page\": 2\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 224 ---\n",
            "{\n",
            "  \"question\": \"What is the primary goal of the COVID-19 vaccines?\",\n",
            "  \"answer\": \"Vaccination has shown to be the most effective means for COVID-19 prevention and control.\",\n",
            "  \"confidence\": 0.9,\n",
            "  \"source\": \"Vaccine_Efficacy_Omicron_vs_Delta.pdf\",\n",
            "  \"page\": 2\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 225 ---\n",
            "{\n",
            "  \"question\": \"What do current COVID-19 vaccines target?\",\n",
            "  \"answer\": \"The current COVID-19 vaccines target S protein.\",\n",
            "  \"confidence\": 0.9,\n",
            "  \"source\": \"Vaccine_Efficacy_Omicron_vs_Delta.pdf\",\n",
            "  \"page\": 2\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 226 ---\n",
            "{\n",
            "  \"question\": \"What is the highest reported vaccine effectiveness (VE) for Pfizer in reducing infection against the Alpha variant?\",\n",
            "  \"answer\": \"The highest reported vaccine effectiveness (VE) values of Pfizer in reducing infection were 94% against Alpha.\",\n",
            "  \"confidence\": 0.9,\n",
            "  \"source\": \"Vaccine_Efficacy_Omicron_vs_Delta.pdf\",\n",
            "  \"page\": 2\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 227 ---\n",
            "{\n",
            "  \"question\": \"What was the reported VE of Moderna against hospitalization?\",\n",
            "  \"answer\": \"Moderna was found to be 100% effective against hospitalization.\",\n",
            "  \"confidence\": 0.9,\n",
            "  \"source\": \"Vaccine_Efficacy_Omicron_vs_Delta.pdf\",\n",
            "  \"page\": 2\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 228 ---\n",
            "{\n",
            "  \"question\": \"What is the highest reported VE of Sinovac against infection?\",\n",
            "  \"answer\": \"The highest VE of Sinovac was 73.8% against infection.\",\n",
            "  \"confidence\": 0.9,\n",
            "  \"source\": \"Vaccine_Efficacy_Omicron_vs_Delta.pdf\",\n",
            "  \"page\": 2\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 229 ---\n",
            "{\n",
            "  \"question\": \"What concerns were raised regarding the effectiveness of COVID-19 vaccines against Omicron?\",\n",
            "  \"answer\": \"It was observed that many of the Omicron-infected patients were fully vaccinated or boosted which raised concerns regarding the effectiveness of the COVID-19 vaccines against Omicron.\",\n",
            "  \"confidence\": 0.9,\n",
            "  \"source\": \"Vaccine_Efficacy_Omicron_vs_Delta.pdf\",\n",
            "  \"page\": 2\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 230 ---\n",
            "{\n",
            "  \"question\": \"What was the reported effectiveness of BNT162b2 against COVID-19 in adolescents?\",\n",
            "  \"answer\": \"The effectiveness of BNT162b2 against COVID-19 in adolescents was reported in a study published in Lancet Infect Dis. 2022.\",\n",
            "  \"confidence\": 0.8,\n",
            "  \"source\": \"Vaccine_Efficacy_Omicron_vs_Delta.pdf\",\n",
            "  \"page\": 14\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 231 ---\n",
            "{\n",
            "  \"question\": \"What is the association between COVID-19 booster vaccination and Omicron infection in a highly vaccinated cohort of NBA players and staff?\",\n",
            "  \"answer\": \"The association between COVID-19 booster vaccination and Omicron infection in a highly vaccinated cohort of players and staff in the National Basketball Association was studied and reported in JAMA. 2022.\",\n",
            "  \"confidence\": 0.8,\n",
            "  \"source\": \"Vaccine_Efficacy_Omicron_vs_Delta.pdf\",\n",
            "  \"page\": 14\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 232 ---\n",
            "{\n",
            "  \"question\": \"What is the comparative effectiveness of different primary vaccination courses on mRNA based booster vaccines against SARs-COV-2 infections?\",\n",
            "  \"answer\": \"A time-varying cohort analysis using trial emulation in the Virus Watch community cohort studied the comparative effectiveness of different primary vaccination courses on mRNA based booster vaccines against SARs-COV-2 infections.\",\n",
            "  \"confidence\": 0.8,\n",
            "  \"source\": \"Vaccine_Efficacy_Omicron_vs_Delta.pdf\",\n",
            "  \"page\": 14\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 233 ---\n",
            "{\n",
            "  \"question\": \"What is the necessity of Coronavirus disease 2019 (COVID-19) vaccination in persons who have already had COVID-19?\",\n",
            "  \"answer\": \"The necessity of Coronavirus disease 2019 (COVID-19) vaccination in persons who have already had COVID-19 was investigated in Clin Infect Dis. 2022.\",\n",
            "  \"confidence\": 0.8,\n",
            "  \"source\": \"Vaccine_Efficacy_Omicron_vs_Delta.pdf\",\n",
            "  \"page\": 14\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 234 ---\n",
            "{\n",
            "  \"question\": \"What is the comparison of vaccine effectiveness against the Omicron (B.1.1.529) variant in hemodialysis patients?\",\n",
            "  \"answer\": \"A comparison of vaccine effectiveness against the Omicron (B.1.1.529) variant in hemodialysis patients was published in Kidney Int Rep. 2022.\",\n",
            "  \"confidence\": 0.8,\n",
            "  \"source\": \"Vaccine_Efficacy_Omicron_vs_Delta.pdf\",\n",
            "  \"page\": 14\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 235 ---\n",
            "{\n",
            "  \"question\": \"What is the vaccine effectiveness against SARS-CoV-2 infection with the Omicron or Delta variants following a two-dose or booster BNT162b2 or mRNA-1273 vaccination series in a Danish cohort study?\",\n",
            "  \"answer\": \"A Danish cohort study in medRxiv. 2021 investigated the vaccine effectiveness against SARS-CoV-2 infection with the Omicron or Delta variants following a two-dose or booster BNT162b2 or mRNA-1273 vaccination series.\",\n",
            "  \"confidence\": 0.8,\n",
            "  \"source\": \"Vaccine_Efficacy_Omicron_vs_Delta.pdf\",\n",
            "  \"page\": 14\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 236 ---\n",
            "{\n",
            "  \"question\": \"What is the effectiveness of the BNT162b2 vaccine among children 5-11 and 12-17 years in New York after the emergence of the Omicron variant?\",\n",
            "  \"answer\": \"The effectiveness of the BNT162b2 vaccine among children 5-11 and 12-17 years in New York after the emergence of the Omicron variant was studied and reported in medRxiv. 2022.\",\n",
            "  \"confidence\": 0.8,\n",
            "  \"source\": \"Vaccine_Efficacy_Omicron_vs_Delta.pdf\",\n",
            "  \"page\": 14\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 237 ---\n",
            "{\n",
            "  \"question\": \"What is the estimated effectiveness of COVID-19 vaccines against Omicron or Delta symptomatic infection and severe outcomes?\",\n",
            "  \"answer\": \"An estimated effectiveness of COVID-19 vaccines against Omicron or Delta symptomatic infection and severe outcomes was published in JAMA Netw Open. 2022.\",\n",
            "  \"confidence\": 0.8,\n",
            "  \"source\": \"Vaccine_Efficacy_Omicron_vs_Delta.pdf\",\n",
            "  \"page\": 14\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 238 ---\n",
            "{\n",
            "  \"question\": \"What is the effectiveness of the BNT162b2 vaccine against the Omicron variant in South Africa?\",\n",
            "  \"answer\": \"The effectiveness of BNT162b2 vaccine against Omicron variant in South Africa was reported in N Engl J Med. 2022.\",\n",
            "  \"confidence\": 0.8,\n",
            "  \"source\": \"Vaccine_Efficacy_Omicron_vs_Delta.pdf\",\n",
            "  \"page\": 14\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 239 ---\n",
            "{\n",
            "  \"question\": \"What are the outcomes of SARS-CoV-2 omicron infection in residents of long-term care facilities in England (VIVALDI)?\",\n",
            "  \"answer\": \"The outcomes of SARS-CoV-2 omicron infection in residents of long-term care facilities in England (VIVALDI) were studied in a prospective, cohort study published in Lancet Heal Longev. 2022.\",\n",
            "  \"confidence\": 0.8,\n",
            "  \"source\": \"Vaccine_Efficacy_Omicron_vs_Delta.pdf\",\n",
            "  \"page\": 14\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 240 ---\n",
            "{\n",
            "  \"question\": \"What is the clinical severity of omicron lineage BA.2 infection compared with BA.1 infection in South Africa?\",\n",
            "  \"answer\": \"The clinical severity of omicron lineage BA.2 infection compared with BA.1 infection in South Africa was investigated and reported in The Lancet (London, England). 2022.\",\n",
            "  \"confidence\": 0.8,\n",
            "  \"source\": \"Vaccine_Efficacy_Omicron_vs_Delta.pdf\",\n",
            "  \"page\": 14\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 241 ---\n",
            "{\n",
            "  \"question\": \"What neurological complication was reported by McLean and Trefts 48 hours after the administration of an mRNA COVID-19 vaccine?\",\n",
            "  \"answer\": \"Transverse myelitis was reported by McLean and Trefts 48 hours after the administration of an mRNA COVID-19 vaccine.\",\n",
            "  \"confidence\": 1,\n",
            "  \"source\": \"COVID_Vaccine_Neuro_Effects.pdf\",\n",
            "  \"page\": 8\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 242 ---\n",
            "{\n",
            "  \"question\": \"According to Finsterer (2021), what condition was exacerbated eight days after vector-based COVID-19 vaccination?\",\n",
            "  \"answer\": \"Guillain-Barré Syndrome was exacerbated eight days after vector-based COVID-19 vaccination.\",\n",
            "  \"confidence\": 1,\n",
            "  \"source\": \"COVID_Vaccine_Neuro_Effects.pdf\",\n",
            "  \"page\": 8\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 243 ---\n",
            "{\n",
            "  \"question\": \"What is the reference for Guillain-Barré syndrome following the first dose of SARS-CoV-2 vaccine, described as a temporal occurrence, not a causal association?\",\n",
            "  \"answer\": \"The reference for Guillain-Barré syndrome following the first dose of SARS-CoV-2 vaccine, described as a temporal occurrence, not a causal association, is Ogbebor O, Seth H, Min Z, Bhanot N. Guillain-Barré syndrome following the first dose of SARS-CoV-2 vaccine: a temporal occurrence, not a causal association. IDCases. 2021;24: e01143.\",\n",
            "  \"confidence\": 1,\n",
            "  \"source\": \"COVID_Vaccine_Neuro_Effects.pdf\",\n",
            "  \"page\": 8\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 244 ---\n",
            "{\n",
            "  \"question\": \"Which study reported the first case of post-COVID-19 vaccine Guillain-Barré syndrome from Qatar?\",\n",
            "  \"answer\": \"Razok A, Shams A, Almeer A, Zahid M. Post-COVID-19 vaccine Guillain-Barré syndrome; first reported case from Qatar. Ann Med Surg. 2021;67: 102540 reported the first case of post-COVID-19 vaccine Guillain-Barré syndrome from Qatar.\",\n",
            "  \"confidence\": 1,\n",
            "  \"source\": \"COVID_Vaccine_Neuro_Effects.pdf\",\n",
            "  \"page\": 8\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 245 ---\n",
            "{\n",
            "  \"question\": \"What neurological complication following the Pfizer COVID-19 vaccine was reported by Waheed et al. (2021)?\",\n",
            "  \"answer\": \"Guillain-Barre syndrome following the Pfizer COVID-19 vaccine was reported by Waheed et al. (2021).\",\n",
            "  \"confidence\": 1,\n",
            "  \"source\": \"COVID_Vaccine_Neuro_Effects.pdf\",\n",
            "  \"page\": 8\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 246 ---\n",
            "{\n",
            "  \"question\": \"What condition was reported by de Terreros Caro et al. (2021) as occurring following COVID-19 vaccination?\",\n",
            "  \"answer\": \"Bell’s palsy was reported by de Terreros Caro et al. (2021) as occurring following COVID-19 vaccination.\",\n",
            "  \"confidence\": 1,\n",
            "  \"source\": \"COVID_Vaccine_Neuro_Effects.pdf\",\n",
            "  \"page\": 8\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 247 ---\n",
            "{\n",
            "  \"question\": \"Which study by Obermann et al. (2021) described Bell's palsy following COVID-19 vaccination with a high CSF antibody response?\",\n",
            "  \"answer\": \"The study by Obermann M, Krasniqi M, Ewers N, Fayad J, Haeberle U. Bell’s palsy following COVID-19 vaccination with high CSF antibody response. Neurol Sci. 2021;42(11):4397–9. described Bell's palsy following COVID-19 vaccination with a high CSF antibody response.\",\n",
            "  \"confidence\": 1,\n",
            "  \"source\": \"COVID_Vaccine_Neuro_Effects.pdf\",\n",
            "  \"page\": 8\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 248 ---\n",
            "{\n",
            "  \"question\": \"What specific type of vaccination was associated with Bell's Palsy in a patient with a history of recurrent Bell's palsy, according to Repajic et al. (2021)?\",\n",
            "  \"answer\": \"Bell’s Palsy after the second dose of Pfizer COVID-19 vaccination in a patient with a history of recurrent Bell’s palsy was reported by Repajic et al. (2021).\",\n",
            "  \"confidence\": 1,\n",
            "  \"source\": \"COVID_Vaccine_Neuro_Effects.pdf\",\n",
            "  \"page\": 8\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 249 ---\n",
            "{\n",
            "  \"question\": \"What condition was reported by Vogrig et al. (2021) to occur after SARS-CoV-2 vaccination?\",\n",
            "  \"answer\": \"Acute disseminated encephalomyelitis was reported by Vogrig et al. (2021) to occur after SARS-CoV-2 vaccination.\",\n",
            "  \"confidence\": 1,\n",
            "  \"source\": \"COVID_Vaccine_Neuro_Effects.pdf\",\n",
            "  \"page\": 8\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 250 ---\n",
            "{\n",
            "  \"question\": \"What type of dysfunction was reported by Konstantinidis et al. (2021) following coronavirus disease 2019 (COVID-19) vaccination?\",\n",
            "  \"answer\": \"Olfactory dysfunction was reported by Konstantinidis et al. (2021) following coronavirus disease 2019 (COVID-19) vaccination.\",\n",
            "  \"confidence\": 1,\n",
            "  \"source\": \"COVID_Vaccine_Neuro_Effects.pdf\",\n",
            "  \"page\": 8\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 251 ---\n",
            "{\n",
            "  \"question\": \"What is the topic of the review by Ahmed et al. (2022) concerning SARS-CoV-2 vaccines?\",\n",
            "  \"answer\": \"The topic of the review by Ahmed et al. (2022) is SARS-CoV-2 vaccine-associated-tinnitus.\",\n",
            "  \"confidence\": 1,\n",
            "  \"source\": \"COVID_Vaccine_Neuro_Effects.pdf\",\n",
            "  \"page\": 8\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 252 ---\n",
            "{\n",
            "  \"question\": \"What nerve palsy was reported by Reyes-Capo et al. (2021) to occur following COVID-19 vaccination?\",\n",
            "  \"answer\": \"Acute abducens nerve palsy was reported by Reyes-Capo et al. (2021) to occur following COVID-19 vaccination.\",\n",
            "  \"confidence\": 1,\n",
            "  \"source\": \"COVID_Vaccine_Neuro_Effects.pdf\",\n",
            "  \"page\": 8\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 253 ---\n",
            "{\n",
            "  \"question\": \"What condition was reported by Chiu et al. (2021) as occurring following COVID-19 vaccine in a report of three cases?\",\n",
            "  \"answer\": \"Herpes zoster was reported by Chiu et al. (2021) as occurring following COVID-19 vaccine.\",\n",
            "  \"confidence\": 1,\n",
            "  \"source\": \"COVID_Vaccine_Neuro_Effects.pdf\",\n",
            "  \"page\": 8\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 254 ---\n",
            "{\n",
            "  \"question\": \"What virus reactivation was reported by Rodríguez-Jiménez et al. (2021) after SARS-CoV-2 BNT162b2 mRNA vaccination?\",\n",
            "  \"answer\": \"Varicella-zoster virus reactivation was reported by Rodríguez-Jiménez et al. (2021) after SARS-CoV-2 BNT162b2 mRNA vaccination.\",\n",
            "  \"confidence\": 1,\n",
            "  \"source\": \"COVID_Vaccine_Neuro_Effects.pdf\",\n",
            "  \"page\": 8\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 255 ---\n",
            "{\n",
            "  \"question\": \"What condition was reported by Salinas and Dieppa (2021) as occurring transiently after the SARS-Cov-2 vaccine?\",\n",
            "  \"answer\": \"Transient akathisia was reported by Salinas and Dieppa (2021) as occurring transiently after the SARS-Cov-2 vaccine.\",\n",
            "  \"confidence\": 1,\n",
            "  \"source\": \"COVID_Vaccine_Neuro_Effects.pdf\",\n",
            "  \"page\": 8\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 256 ---\n",
            "{\n",
            "  \"question\": \"What type of bleeding was reported by Finsterer and Redzic (2021) as occurring following SARS-CoV-2 vaccination induced immune thrombocytopenia?\",\n",
            "  \"answer\": \"Symptomatic peduncular, cavernous bleeding was reported by Finsterer and Redzic (2021) as occurring following SARS-CoV-2 vaccination induced immune thrombocytopenia.\",\n",
            "  \"confidence\": 1,\n",
            "  \"source\": \"COVID_Vaccine_Neuro_Effects.pdf\",\n",
            "  \"page\": 8\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 257 ---\n",
            "{\n",
            "  \"question\": \"What condition was reported by Fitzsimmons and Nance (2021) as a sudden onset after COVID-19 vaccination, considered a severe rare adverse event?\",\n",
            "  \"answer\": \"Sudden onset of myelitis after COVID-19 vaccination was reported by Fitzsimmons and Nance (2021) as an under-recognized severe rare adverse event.\",\n",
            "  \"confidence\": 1,\n",
            "  \"source\": \"COVID_Vaccine_Neuro_Effects.pdf\",\n",
            "  \"page\": 8\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 258 ---\n",
            "{\n",
            "  \"question\": \"What complication was reported by Martin-Villares et al. (2022) following a single dose of mRNA SARS-CoV-2 vaccine?\",\n",
            "  \"answer\": \"Bell’s palsy was reported by Martin-Villares et al. (2022) as a complication following a single dose of mRNA SARS-CoV-2 vaccine.\",\n",
            "  \"confidence\": 1,\n",
            "  \"source\": \"COVID_Vaccine_Neuro_Effects.pdf\",\n",
            "  \"page\": 8\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 259 ---\n",
            "{\n",
            "  \"question\": \"What condition, with a dramatic response to methylprednisolone, was reported by Al-Mashdali et al. (2021) after COVID-19 vaccine?\",\n",
            "  \"answer\": \"Post-COVID-19 vaccine acute hyperactive encephalopathy with dramatic response to methylprednisolone was reported by Al-Mashdali et al. (2021).\",\n",
            "  \"confidence\": 1,\n",
            "  \"source\": \"COVID_Vaccine_Neuro_Effects.pdf\",\n",
            "  \"page\": 8\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 260 ---\n",
            "{\n",
            "  \"question\": \"What is Long Post-COVID Vaccination Syndrome (LPCVS)?\",\n",
            "  \"answer\": \"LPCVS refers to side effects of SARS-CoV-2 vaccinations lasting more than 4 weeks in some patients, which can include definite diseases or non-specific symptoms with normal or slightly abnormal instrumental findings, significantly reducing the quality of life.\",\n",
            "  \"confidence\": 1,\n",
            "  \"source\": \"Clinical Analysis of Long Post-COVID Vaccination Syndrome (LPCVS).pdf\",\n",
            "  \"page\": 3\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 261 ---\n",
            "{\n",
            "  \"question\": \"What is a global concern regarding COVID-19 vaccines?\",\n",
            "  \"answer\": \"There is a global concern about the safety of COVID-19 vaccines associated with platelet function.\",\n",
            "  \"confidence\": 1,\n",
            "  \"source\": \"Pfizer_Platelet_LongTerm_Study.pdf\",\n",
            "  \"page\": 2\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 262 ---\n",
            "{\n",
            "  \"question\": \"What did the results of the study by Zhou et al. show regarding platelet aggregation trends after COVID-19 vaccine doses?\",\n",
            "  \"answer\": \"Results show no significant or persisting platelet aggregation trends following the vaccine doses.\",\n",
            "  \"confidence\": 1,\n",
            "  \"source\": \"Pfizer_Platelet_LongTerm_Study.pdf\",\n",
            "  \"page\": 2\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 263 ---\n",
            "{\n",
            "  \"question\": \"What types of mRNA COVID-19 vaccines are mentioned in the text?\",\n",
            "  \"answer\": \"The Pfizer-BioNTech (BNT162b2) and Moderna (mRNA-1273) vaccines.\",\n",
            "  \"confidence\": 1,\n",
            "  \"source\": \"Pfizer_Platelet_LongTerm_Study.pdf\",\n",
            "  \"page\": 2\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 264 ---\n",
            "{\n",
            "  \"question\": \"What rare but serious adverse effects have been reported after administration of mRNA COVID-19 vaccines?\",\n",
            "  \"answer\": \"These effects include myocarditis, lymphadenopathy, thrombocytopenia, pulmonary embolism, and myocardial infarction.\",\n",
            "  \"confidence\": 1,\n",
            "  \"source\": \"Pfizer_Platelet_LongTerm_Study.pdf\",\n",
            "  \"page\": 2\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 265 ---\n",
            "{\n",
            "  \"question\": \"How have the effects of mRNA vaccinations on the immune response been studied?\",\n",
            "  \"answer\": \"The effects of mRNA vaccinations on the immune response, in particular the neutralizing antibody response of lymphocytes and monocytes to SARS-CoV-2, have been well studied.\",\n",
            "  \"confidence\": 1,\n",
            "  \"source\": \"Pfizer_Platelet_LongTerm_Study.pdf\",\n",
            "  \"page\": 2\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 266 ---\n",
            "{\n",
            "  \"question\": \"What is the role of platelets in the immune response?\",\n",
            "  \"answer\": \"Platelets play an important role in the immune response by releasing several mediators or expressing adhesion and immune receptors on the platelet surface.\",\n",
            "  \"confidence\": 1,\n",
            "  \"source\": \"Pfizer_Platelet_LongTerm_Study.pdf\",\n",
            "  \"page\": 2\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 267 ---\n",
            "{\n",
            "  \"question\": \"Why are the long-term effects of mRNA vaccinations on overall platelet activity poorly understood?\",\n",
            "  \"answer\": \"The long-term effects of mRNA vaccinations on overall platelet activity remain poorly understood, due to the lack of tools available to study platelet activity with high resolution and statistical accuracy.\",\n",
            "  \"confidence\": 1,\n",
            "  \"source\": \"Pfizer_Platelet_LongTerm_Study.pdf\",\n",
            "  \"page\": 2\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 268 ---\n",
            "{\n",
            "  \"question\": \"What method was used in the study to investigate the long-term effects of Pfizer-BioNTech mRNA vaccinations on platelet activity?\",\n",
            "  \"answer\": \"Image-based single-cell profiling and temporal monitoring of circulating platelet aggregates.\",\n",
            "  \"confidence\": 1,\n",
            "  \"source\": \"Pfizer_Platelet_LongTerm_Study.pdf\",\n",
            "  \"page\": 2\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 269 ---\n",
            "{\n",
            "  \"question\": \"What type of microscope was used for image acquisition in the study?\",\n",
            "  \"answer\": \"An optical frequency-division-multiplexed (FDM) microscope on a hydrodynamic-focusing microfluidic chip.\",\n",
            "  \"confidence\": 1,\n",
            "  \"source\": \"Pfizer_Platelet_LongTerm_Study.pdf\",\n",
            "  \"page\": 2\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 270 ---\n",
            "{\n",
            "  \"question\": \"How frequently was blood sampled from healthy subjects in the study?\",\n",
            "  \"answer\": \"Blood sampling was performed at a frequency of several times per month per subject.\",\n",
            "  \"confidence\": 1,\n",
            "  \"source\": \"Pfizer_Platelet_LongTerm_Study.pdf\",\n",
            "  \"page\": 2\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 271 ---\n",
            "{\n",
            "  \"question\": \"What is the purpose of reporting suspected COVID-19 vaccine side effects in New Zealand?\",\n",
            "  \"answer\": \"Reporting suspected COVID-19 vaccine side effects means the safety of COVID-19 vaccines within Aotearoa New Zealand can continue to be closely monitored.\",\n",
            "  \"confidence\": 1,\n",
            "  \"source\": \"covid_side_effects.pdf\",\n",
            "  \"page\": 3\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 272 ---\n",
            "{\n",
            "  \"question\": \"Who can report COVID-19 vaccine reactions in New Zealand?\",\n",
            "  \"answer\": \"You can report your own reactions, or reactions experienced by someone else, including tamariki (children).\",\n",
            "  \"confidence\": 1,\n",
            "  \"source\": \"covid_side_effects.pdf\",\n",
            "  \"page\": 3\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 273 ---\n",
            "{\n",
            "  \"question\": \"To which organization are suspected COVID-19 vaccine side effects reported in New Zealand?\",\n",
            "  \"answer\": \"Reactions are reported to the Centre for Adverse Reactions Monitoring (CARM).\",\n",
            "  \"confidence\": 1,\n",
            "  \"source\": \"covid_side_effects.pdf\",\n",
            "  \"page\": 3\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 274 ---\n",
            "{\n",
            "  \"question\": \"Where can one search for reported suspected adverse reactions to medicines and vaccines in New Zealand?\",\n",
            "  \"answer\": \"You can also search for reported suspected adverse reactions to medicines and vaccines on the Medsafe website.\",\n",
            "  \"confidence\": 1,\n",
            "  \"source\": \"covid_side_effects.pdf\",\n",
            "  \"page\": 3\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 275 ---\n",
            "{\n",
            "  \"question\": \"What immediate action should be taken if you have an immediate concern about your safety regarding COVID-19 or vaccination?\",\n",
            "  \"answer\": \"If you have an immediate concern about your safety, call 111 so they can assess you properly.\",\n",
            "  \"confidence\": 1,\n",
            "  \"source\": \"covid_side_effects.pdf\",\n",
            "  \"page\": 3\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 276 ---\n",
            "{\n",
            "  \"question\": \"What is the title of the review article about COVID-19 vaccine effectiveness against Omicron?\",\n",
            "  \"answer\": \"Effectiveness of the pre-Omicron COVID-19 vaccines against Omicron in reducing infection, hospitalization, severity, and mortality compared to Delta and other variants: A systematic review.\",\n",
            "  \"confidence\": 1,\n",
            "  \"source\": \"Vaccine_Efficacy_Omicron_vs_Delta.pdf\",\n",
            "  \"page\": 1\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 277 ---\n",
            "{\n",
            "  \"question\": \"Which COVID-19 variants are mentioned in the review title?\",\n",
            "  \"answer\": \"Omicron, Delta, and other variants.\",\n",
            "  \"confidence\": 1,\n",
            "  \"source\": \"Vaccine_Efficacy_Omicron_vs_Delta.pdf\",\n",
            "  \"page\": 1\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 278 ---\n",
            "{\n",
            "  \"question\": \"What is the main cause of Coronavirus Disease 2019 (COVID-19)?\",\n",
            "  \"answer\": \"The Coronavirus Disease 2019 (COVID-19) is known to be caused by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2).\",\n",
            "  \"confidence\": 1,\n",
            "  \"source\": \"Vaccine_Efficacy_Omicron_vs_Delta.pdf\",\n",
            "  \"page\": 3\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 279 ---\n",
            "{\n",
            "  \"question\": \"How many amino acid mutations are present in the spike protein of the Omicron variant?\",\n",
            "  \"answer\": \"Omicron harbors around 30 amino acid mutations in its spike (S) protein.\",\n",
            "  \"confidence\": 1,\n",
            "  \"source\": \"Vaccine_Efficacy_Omicron_vs_Delta.pdf\",\n",
            "  \"page\": 3\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 280 ---\n",
            "{\n",
            "  \"question\": \"What does the systematic review indicate about the protection from primary vaccination against Omicron infection compared to Delta and Alpha infections?\",\n",
            "  \"answer\": \"The protection from primary vaccination against Omicron infection is inferior to protection against Delta and Alpha infections and wanes faster over time.\",\n",
            "  \"confidence\": 1,\n",
            "  \"source\": \"Vaccine_Efficacy_Omicron_vs_Delta.pdf\",\n",
            "  \"page\": 1\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 281 ---\n",
            "{\n",
            "  \"question\": \"What is the vaccine effectiveness of Pfizer/BioNTech against the Omicron variant 31-60 days after the primary vaccination series?\",\n",
            "  \"answer\": \"Vaccine effectiveness (VE) for Pfizer/BioNTech against the Omicron variant wanes as quickly as 31-60 days after the primary 2-dose series vaccination.\",\n",
            "  \"confidence\": 0.9,\n",
            "  \"source\": \"Vaccine_Efficacy_Omicron_vs_Delta.pdf\",\n",
            "  \"page\": 23\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 282 ---\n",
            "{\n",
            "  \"question\": \"How does the vaccine effectiveness of Pfizer/BioNTech against Omicron compare to Delta in adolescents aged 12-15 years, one month after vaccination?\",\n",
            "  \"answer\": \"Among 12-15 year olds, one-dose protection from Pfizer/BioNTech was highest at days 14-20 against both variants, with VE against Delta at 74.5% and against Omicron at 49.6%.\",\n",
            "  \"confidence\": 0.95,\n",
            "  \"source\": \"Vaccine_Efficacy_Omicron_vs_Delta.pdf\",\n",
            "  \"page\": 23\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 283 ---\n",
            "{\n",
            "  \"question\": \"What is the vaccine effectiveness of a full vaccination series of Pfizer/BioNTech against Omicron BA.1 subvariant infection after 3 to 6 months?\",\n",
            "  \"answer\": \"Consensus among large studies shows that immunity from the Pfizer/BioNTech primary series lasts for a period of between 3 and 6 months against Omicron BA.1 subvariant infection.\",\n",
            "  \"confidence\": 0.9,\n",
            "  \"source\": \"Vaccine_Efficacy_Omicron_vs_Delta.pdf\",\n",
            "  \"page\": 23\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 284 ---\n",
            "{\n",
            "  \"question\": \"What is the vaccine effectiveness of a full vaccination series of Pfizer/BioNTech against Omicron BA.2 subvariant infection after approximately 7 months?\",\n",
            "  \"answer\": \"Consensus among large studies shows that immunity from the Pfizer/BioNTech primary series lasts for about ≥7 months against Omicron BA.2 subvariant infection.\",\n",
            "  \"confidence\": 0.9,\n",
            "  \"source\": \"Vaccine_Efficacy_Omicron_vs_Delta.pdf\",\n",
            "  \"page\": 23\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 285 ---\n",
            "{\n",
            "  \"question\": \"According to Šmíd et al., how long does protection from Omicron-induced hospitalization last for partial Pfizer/BioNTech vaccination?\",\n",
            "  \"answer\": \"Šmíd et al. report that protection from Omicron-induced hospitalization waned by the first month with respect to partial Pfizer/BioNTech vaccination.\",\n",
            "  \"confidence\": 0.95,\n",
            "  \"source\": \"Vaccine_Efficacy_Omicron_vs_Delta.pdf\",\n",
            "  \"page\": 23\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 286 ---\n",
            "{\n",
            "  \"question\": \"Based on findings by Accorsi et al. and Chemaitelly et al., how long does protection from the 2-dose primary Moderna series against Omicron BA.1 infection last?\",\n",
            "  \"answer\": \"Based on findings by Accorsi et al. and Chemaitelly et al., protection catered by the 2-dose primary Moderna series against Omicron BA.1 infection is no longer significant after 6–7 months.\",\n",
            "  \"confidence\": 0.95,\n",
            "  \"source\": \"Vaccine_Efficacy_Omicron_vs_Delta.pdf\",\n",
            "  \"page\": 23\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 287 ---\n",
            "{\n",
            "  \"question\": \"How long does protection from the 2-dose primary Moderna series against Omicron BA.2 infection last, according to Accorsi et al. and Chemaitelly et al.?\",\n",
            "  \"answer\": \"Protection catered by the 2-dose primary Moderna series does not last even 1–3 months against Omicron BA.2.\",\n",
            "  \"confidence\": 0.95,\n",
            "  \"source\": \"Vaccine_Efficacy_Omicron_vs_Delta.pdf\",\n",
            "  \"page\": 23\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 288 ---\n",
            "{\n",
            "  \"question\": \"According to Andrews et al., when is primary Oxford/AstraZeneca vaccination no longer protective?\",\n",
            "  \"answer\": \"Andrews et al. report that primary Oxford/AstraZeneca vaccination is no longer protective by 25+ weeks.\",\n",
            "  \"confidence\": 0.95,\n",
            "  \"source\": \"Vaccine_Efficacy_Omicron_vs_Delta.pdf\",\n",
            "  \"page\": 23\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 289 ---\n",
            "{\n",
            "  \"question\": \"According to Šmíd et al., how long does protection against Omicron-induced hospitalization last for a 2-dose Oxford/AstraZeneca series?\",\n",
            "  \"answer\": \"Šmíd et al. report that for protection against Omicron-induced hospitalization, it swayed by 2 months for the 2-dose Oxford/AstraZeneca series.\",\n",
            "  \"confidence\": 0.95,\n",
            "  \"source\": \"Vaccine_Efficacy_Omicron_vs_Delta.pdf\",\n",
            "  \"page\": 23\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 290 ---\n",
            "{\n",
            "  \"question\": \"According to Šmíd et al., how long does full Janssen vaccination effectiveness last for protection from Omicron-associated hospitalization?\",\n",
            "  \"answer\": \"Šmíd et al. report that for protection from Omicron-associated hospitalization, full Janssen vaccination effectiveness does not last the first month.\",\n",
            "  \"confidence\": 0.95,\n",
            "  \"source\": \"Vaccine_Efficacy_Omicron_vs_Delta.pdf\",\n",
            "  \"page\": 23\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 291 ---\n",
            "{\n",
            "  \"question\": \"In the Netherlands, what proportion of Omicron cases were children aged 12-19 compared to Delta cases, according to Eggink et al.?\",\n",
            "  \"answer\": \"In the Netherlands, children aged 12–19 comprised a greater proportion of Omicron cases (26.3%) than among Delta cases (12.1%).\",\n",
            "  \"confidence\": 0.95,\n",
            "  \"source\": \"Vaccine_Efficacy_Omicron_vs_Delta.pdf\",\n",
            "  \"page\": 23\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 292 ---\n",
            "{\n",
            "  \"question\": \"What is the adjusted odds ratio (aOR) for primary vaccination using Pfizer/BioNTech, Moderna, Oxford/AstraZeneca, or Janssen against Omicron infection compared to Delta in the 12-29 age group?\",\n",
            "  \"answer\": \"The adjusted odds ratio (aOR) for primary vaccination using Pfizer/BioNTech, Moderna, Oxford/AstraZeneca, or Janssen was 4.1 (95% CI: 3.9–4.4) against Omicron infection compared to Delta in the 12–29 age group.\",\n",
            "  \"confidence\": 0.95,\n",
            "  \"source\": \"Vaccine_Efficacy_Omicron_vs_Delta.pdf\",\n",
            "  \"page\": 23\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 293 ---\n",
            "{\n",
            "  \"question\": \"According to Buchan et al., when is protection against symptomatic Omicron infection by a primary series of only mRNA vaccines or a combination with Oxford/AstraZeneca no longer effective?\",\n",
            "  \"answer\": \"Buchan et al. show that protection against symptomatic Omicron infection by a primary series consisting of only mRNA vaccines or a combination of an mRNA vaccine with Oxford/AstraZeneca was no longer effective by 6 months after 2nd dose.\",\n",
            "  \"confidence\": 0.95,\n",
            "  \"source\": \"Vaccine_Efficacy_Omicron_vs_Delta.pdf\",\n",
            "  \"page\": 23\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 294 ---\n",
            "{\n",
            "  \"question\": \"According to Ferdinands et al., when is mRNA booster VE against ED/UC visits during Omicron-predominated periods no longer effective?\",\n",
            "  \"answer\": \"Ferdinands et al. show that mRNA booster VE against laboratory-confirmed ED/UC visits during Omicron-predominated periods was no longer effective by ≥5 months since the 3rd dose.\",\n",
            "  \"confidence\": 0.95,\n",
            "  \"source\": \"Vaccine_Efficacy_Omicron_vs_Delta.pdf\",\n",
            "  \"page\": 23\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 295 ---\n",
            "{\n",
            "  \"question\": \"What is the effectiveness of full vaccination with Pfizer or Moderna against Omicron infection after more than 14 days, and how does it compare to Delta?\",\n",
            "  \"answer\": \"Full vaccination with Pfizer or Moderna had a VE of 75% (95% CI: 52–87) for Omicron vs 93% (95% CI: 85–97) for Delta, after more than 14 days post-vaccination.\",\n",
            "  \"confidence\": 0.95,\n",
            "  \"source\": \"Vaccine_Efficacy_Omicron_vs_Delta.pdf\",\n",
            "  \"page\": 7\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 296 ---\n",
            "{\n",
            "  \"question\": \"What is the post-booster vaccine effectiveness of Pfizer or Moderna against Omicron infection after more than 14 days, and how does it compare to Delta?\",\n",
            "  \"answer\": \"The VE increases after receiving the booster dose to 94% (95% CI: 85–98) for Omicron vs 96% (95% CI: 88–99) for Delta, after more than 14 days post-vaccination.\",\n",
            "  \"confidence\": 0.95,\n",
            "  \"source\": \"Vaccine_Efficacy_Omicron_vs_Delta.pdf\",\n",
            "  \"page\": 7\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 297 ---\n",
            "{\n",
            "  \"question\": \"How is the Omicron variant identified using whole-genome sequencing or a novel variant-specific PCR test?\",\n",
            "  \"answer\": \"Variants were confirmed as Omicron using whole-genome sequencing or a novel variant-specific PCR test.\",\n",
            "  \"confidence\": 0.95,\n",
            "  \"source\": \"Vaccine_Efficacy_Omicron_vs_Delta.pdf\",\n",
            "  \"page\": 7\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 298 ---\n",
            "{\n",
            "  \"question\": \"What is the effectiveness of full vaccination with Pfizer or Moderna against ICU admission for severe Omicron disease more than 2 months after vaccination?\",\n",
            "  \"answer\": \"Effectiveness of full vaccination with Pfizer or Moderna against severe Omicron disease ranged from 32% (95% CI: 20–43, >2 months after vaccination) for intensive care unit (ICU) admission.\",\n",
            "  \"confidence\": 0.9,\n",
            "  \"source\": \"Vaccine_Efficacy_Omicron_vs_Delta.pdf\",\n",
            "  \"page\": 7\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 299 ---\n",
            "{\n",
            "  \"question\": \"What is the effectiveness of full vaccination with Pfizer or Moderna against the progression to required use of invasive mechanical ventilation (IMV) and death for severe Omicron disease more than 2 months after vaccination?\",\n",
            "  \"answer\": \"Effectiveness of full vaccination with Pfizer or Moderna against the progression to required use of invasive mechanical ventilation (IMV) and death for severe Omicron disease ranged from 37% (95% CI: 12–55, >2 months after vaccination).\",\n",
            "  \"confidence\": 0.9,\n",
            "  \"source\": \"Vaccine_Efficacy_Omicron_vs_Delta.pdf\",\n",
            "  \"page\": 7\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 300 ---\n",
            "{\n",
            "  \"question\": \"What are the most important and common neurological complications reported after COVID-19 vaccination?\",\n",
            "  \"answer\": \"The most important and common complications are cerebrovascular disorders including cerebral venous sinus thrombosis, transient ischemic attack, intracerebral hemorrhage, ischemic stroke, and demyelinating disorders including transverse myelitis, first manifestation of MS, and neuromyelitis optica.\",\n",
            "  \"confidence\": 0.95,\n",
            "  \"source\": \"COVID_Vaccine_Neuro_Effects.pdf\",\n",
            "  \"page\": 1\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 301 ---\n",
            "{\n",
            "  \"question\": \"What is a significant neurological side effect of COVID-19 vaccines, particularly in women of childbearing age?\",\n",
            "  \"answer\": \"Cerebral venous sinus thrombosis, especially in women of childbearing age, is a significant neurological side effect reported with COVID-19 vaccines, particularly adenovirus-based ones.\",\n",
            "  \"confidence\": 0.9,\n",
            "  \"source\": \"COVID_Vaccine_Neuro_Effects.pdf\",\n",
            "  \"page\": 3\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 302 ---\n",
            "{\n",
            "  \"question\": \"What are the most common local and systemic adverse reactions to inactivated virus-based vaccines like Sinopharm?\",\n",
            "  \"answer\": \"The most common local and systemic adverse reactions to inactivated virus-based vaccines, such as Sinopharm, include injection site reactions, fatigue, fever, headache, and allergic dermatitis.\",\n",
            "  \"confidence\": 0.95,\n",
            "  \"source\": \"COVID_Vaccine_Neuro_Effects.pdf\",\n",
            "  \"page\": 3\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 303 ---\n",
            "{\n",
            "  \"question\": \"According to the WHO, are the side effects of inactivated virus-based vaccines like Sinopharm typically severe enough to require hospitalization?\",\n",
            "  \"answer\": \"No, according to the WHO, the common local and systemic adverse reactions to inactivated virus-based vaccines like Sinopharm are self-limiting and do not require hospitalization.\",\n",
            "  \"confidence\": 0.95,\n",
            "  \"source\": \"COVID_Vaccine_Neuro_Effects.pdf\",\n",
            "  \"page\": 3\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 304 ---\n",
            "{\n",
            "  \"question\": \"What is the proposed mechanism for thrombocytopenia following COVID-19 vaccination?\",\n",
            "  \"answer\": \"The proposed mechanism for thrombocytopenia is the synthesis of IgG antibodies against platelet factor 4 (PF4), which leads to platelet activation and blood clot formation in large venous arteries.\",\n",
            "  \"confidence\": 0.9,\n",
            "  \"source\": \"COVID_Vaccine_Neuro_Effects.pdf\",\n",
            "  \"page\": 3\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 305 ---\n",
            "{\n",
            "  \"question\": \"Which type of COVID-19 vaccines are most associated with causing thrombocytopenia due to the transfer of nucleic acids encoding the viral spike protein?\",\n",
            "  \"answer\": \"Adenovirus-based vaccines are most associated with causing thrombocytopenia due to the transfer of nucleic acids encoding the viral spike (S) protein.\",\n",
            "  \"confidence\": 0.95,\n",
            "  \"source\": \"COVID_Vaccine_Neuro_Effects.pdf\",\n",
            "  \"page\": 3\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 306 ---\n",
            "{\n",
            "  \"question\": \"In what age group are venous sinus thrombosis and cerebral hemorrhage more common following vaccination?\",\n",
            "  \"answer\": \"Venous sinus thrombosis and cerebral hemorrhage are more common in women between the ages of 30 and 50 than in men.\",\n",
            "  \"confidence\": 0.95,\n",
            "  \"source\": \"COVID_Vaccine_Neuro_Effects.pdf\",\n",
            "  \"page\": 3\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 307 ---\n",
            "{\n",
            "  \"question\": \"What are some examples of acute neurological disorders that can occur after COVID-19 vaccination?\",\n",
            "  \"answer\": \"Acute neurological disorders that can occur after COVID-19 vaccination include transverse myelitis, acute diffuse encephalomyelitis (ADEM), Bell’s palsy, GBS, encephalopathy, and seizures.\",\n",
            "  \"confidence\": 0.95,\n",
            "  \"source\": \"COVID_Vaccine_Neuro_Effects.pdf\",\n",
            "  \"page\": 3\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 308 ---\n",
            "{\n",
            "  \"question\": \"What is the first and most common systemic side effect of COVID-19 vaccines?\",\n",
            "  \"answer\": \"The first and most common systemic side effect of COVID-19 vaccines is headache, which can range from mild to severe and is often felt in the frontal area of the head.\",\n",
            "  \"confidence\": 0.95,\n",
            "  \"source\": \"COVID_Vaccine_Neuro_Effects.pdf\",\n",
            "  \"page\": 3\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 309 ---\n",
            "{\n",
            "  \"question\": \"What potential causes are mentioned for post-vaccination headaches?\",\n",
            "  \"answer\": \"Post-vaccination headaches can be caused by stress, vascular spasm, and intracerebral or subarachnoid hemorrhage.\",\n",
            "  \"confidence\": 0.95,\n",
            "  \"source\": \"COVID_Vaccine_Neuro_Effects.pdf\",\n",
            "  \"page\": 3\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 310 ---\n",
            "{\n",
            "  \"question\": \"Which types of COVID-19 vaccines are most likely to cause headaches?\",\n",
            "  \"answer\": \"mRNA and adenovirus-based vaccines have been reported to be most likely to cause headaches.\",\n",
            "  \"confidence\": 0.95,\n",
            "  \"source\": \"COVID_Vaccine_Neuro_Effects.pdf\",\n",
            "  \"page\": 3\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 311 ---\n",
            "{\n",
            "  \"question\": \"What is transverse myelitis and how is it typically induced after vaccination?\",\n",
            "  \"answer\": \"Transverse myelitis is an inflammation of a part of the spinal cord, usually occurring after infection, and is thought to be induced by autoimmunity developed through molecular mimicry, where viral antigens stimulate an immunological response in the spinal cord.\",\n",
            "  \"confidence\": 0.9,\n",
            "  \"source\": \"COVID_Vaccine_Neuro_Effects.pdf\",\n",
            "  \"page\": 3\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 312 ---\n",
            "{\n",
            "  \"question\": \"What are the primary mechanisms proposed for the pathogenicity of vaccines leading to neurological complications?\",\n",
            "  \"answer\": \"The two main proposed mechanisms for the pathogenicity of vaccines and the occurrence of neurological complications are ectopic immune reactions and molecular mimicry.\",\n",
            "  \"confidence\": 0.95,\n",
            "  \"source\": \"COVID_Vaccine_Neuro_Effects.pdf\",\n",
            "  \"page\": 3\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 313 ---\n",
            "{\n",
            "  \"question\": \"What effect does hyperthermia have on the brain following COVID-19 vaccination?\",\n",
            "  \"answer\": \"Following COVID-19 vaccination, hyperthermia can increase glial cell activity and increase blood-brain barrier permeability, allowing peripheral blood cells and albumin to enter the brain and disrupt osmotic balance.\",\n",
            "  \"confidence\": 0.9,\n",
            "  \"source\": \"COVID_Vaccine_Neuro_Effects.pdf\",\n",
            "  \"page\": 3\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 314 ---\n",
            "{\n",
            "  \"question\": \"What can be the consequence of inflammatory mediators entering the brain after vaccination?\",\n",
            "  \"answer\": \"The entry of inflammatory mediators secreted by peripheral blood cells into the brain can lead to the destruction of myelin and axonal degeneration, resulting in brain disorders.\",\n",
            "  \"confidence\": 0.95,\n",
            "  \"source\": \"COVID_Vaccine_Neuro_Effects.pdf\",\n",
            "  \"page\": 3\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 315 ---\n",
            "{\n",
            "  \"question\": \"What specific antibodies in the CSF may explain neurological complications like encephalopathy and seizures after vaccination?\",\n",
            "  \"answer\": \"The presence of SARS-CoV-2 spike domain S1 antibodies in CSF may explain neurological complications after vaccination, such as encephalopathy and seizures.\",\n",
            "  \"confidence\": 0.95,\n",
            "  \"source\": \"COVID_Vaccine_Neuro_Effects.pdf\",\n",
            "  \"page\": 3\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 316 ---\n",
            "{\n",
            "  \"question\": \"What is the WHO's role in tracking SARS-CoV-2 variants?\",\n",
            "  \"answer\": \"The WHO is involved in tracking SARS-CoV-2 variants.\",\n",
            "  \"confidence\": 0.95,\n",
            "  \"source\": \"WHO_XEC_Variant_Risk.pdf\",\n",
            "  \"page\": 6\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 317 ---\n",
            "{\n",
            "  \"question\": \"What does GISAID contribute to pandemic response?\",\n",
            "  \"answer\": \"GISAID plays a role in pandemic response.\",\n",
            "  \"confidence\": 0.9,\n",
            "  \"source\": \"WHO_XEC_Variant_Risk.pdf\",\n",
            "  \"page\": 6\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 318 ---\n",
            "{\n",
            "  \"question\": \"When were the Pfizer and Moderna COVID vaccines approved for emergency use in the United States?\",\n",
            "  \"answer\": \"The Pfizer and Moderna COVID vaccines were approved for emergency use in the United States in December 2020.\",\n",
            "  \"confidence\": 0.95,\n",
            "  \"source\": \"COVID_Vaccine_Safety_Facts.pdf\",\n",
            "  \"page\": 2\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 319 ---\n",
            "{\n",
            "  \"question\": \"What types of side effects are generally seen within the first two months after widespread vaccine use?\",\n",
            "  \"answer\": \"In virtually all cases, vaccine side effects are seen within the first two months after rollout, and these are typically tolerability issues like arm pain, fatigue, and headache.\",\n",
            "  \"confidence\": 0.95,\n",
            "  \"source\": \"COVID_Vaccine_Safety_Facts.pdf\",\n",
            "  \"page\": 2\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 320 ---\n",
            "{\n",
            "  \"question\": \"What rare side effect was identified with the 1976 swine flu vaccine in the United States?\",\n",
            "  \"answer\": \"The 1976 swine flu vaccine was identified in rare cases as a cause of Guillain-Barré Syndrome, with most cases occurring within eight weeks after vaccination.\",\n",
            "  \"confidence\": 0.95,\n",
            "  \"source\": \"COVID_Vaccine_Safety_Facts.pdf\",\n",
            "  \"page\": 2\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 321 ---\n",
            "{\n",
            "  \"question\": \"What are the most commonly reported reactions after getting a COVID-19 vaccine?\",\n",
            "  \"answer\": \"The most common reported reactions include pain, redness or swelling at the injection site, feeling tired or fatigued, headache, muscle aches or joint pains, chills, dizziness, swollen lymph nodes, nausea, fever, and chest discomfort.\",\n",
            "  \"confidence\": 0.9,\n",
            "  \"source\": \"covid_side_effects.pdf\",\n",
            "  \"page\": 1\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 322 ---\n",
            "{\n",
            "  \"question\": \"What should you do if you experience chest discomfort after a COVID-19 vaccine?\",\n",
            "  \"answer\": \"If you have chest discomfort, contact a healthcare provider in case it is a sign of something more serious.\",\n",
            "  \"confidence\": 0.95,\n",
            "  \"source\": \"covid_side_effects.pdf\",\n",
            "  \"page\": 1\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 323 ---\n",
            "{\n",
            "  \"question\": \"Are the side effects of the COVID-19 vaccine different for children and teenagers compared to adults?\",\n",
            "  \"answer\": \"Side effects of the COVID-19 vaccine are similar in tamariki and rangatahi to those seen in adults.\",\n",
            "  \"confidence\": 0.9,\n",
            "  \"source\": \"covid_side_effects.pdf\",\n",
            "  \"page\": 1\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 324 ---\n",
            "{\n",
            "  \"question\": \"When do COVID-19 vaccine side effects usually start?\",\n",
            "  \"answer\": \"They usually start within a day or 2 after your vaccine.\",\n",
            "  \"confidence\": 0.9,\n",
            "  \"source\": \"covid_side_effects.pdf\",\n",
            "  \"page\": 1\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 325 ---\n",
            "{\n",
            "  \"question\": \"What are some ways to feel more comfortable if you experience side effects from a COVID-19 vaccine?\",\n",
            "  \"answer\": \"You can place a cold, wet cloth or ice pack on the injection site for a short time, rest and drink plenty of fluids, and take paracetamol or ibuprofen.\",\n",
            "  \"confidence\": 0.9,\n",
            "  \"source\": \"covid_side_effects.pdf\",\n",
            "  \"page\": 1\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 326 ---\n",
            "{\n",
            "  \"question\": \"Are COVID-19 vaccine side effects a sign that the body is learning to fight the virus?\",\n",
            "  \"answer\": \"Yes, mild side effects are common and a sign that your body is learning to fight the virus.\",\n",
            "  \"confidence\": 0.9,\n",
            "  \"source\": \"covid_side_effects.pdf\",\n",
            "  \"page\": 1\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 327 ---\n",
            "{\n",
            "  \"question\": \"How long do most COVID-19 vaccine side effects typically last?\",\n",
            "  \"answer\": \"Most side effects do not last long and will not stop you from having additional doses, or going about your daily life.\",\n",
            "  \"confidence\": 0.9,\n",
            "  \"source\": \"covid_side_effects.pdf\",\n",
            "  \"page\": 1\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 328 ---\n",
            "{\n",
            "  \"question\": \"What are the names of the three COVID-19 vaccines available in the United States mentioned in the text?\",\n",
            "  \"answer\": \"The three COVID-19 vaccines available in the United States are from Pfizer, Moderna, and Johnson & Johnson.\",\n",
            "  \"confidence\": 0.95,\n",
            "  \"source\": \"COVID_Vaccine_Safety_Facts.pdf\",\n",
            "  \"page\": 1\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 329 ---\n",
            "{\n",
            "  \"question\": \"According to Paul Goepfert, M.D., what is the effectiveness of the Pfizer and Moderna vaccines against hospitalization?\",\n",
            "  \"answer\": \"According to Paul Goepfert, M.D., the Pfizer and Moderna vaccines show a 94% effectiveness against hospitalization.\",\n",
            "  \"confidence\": 0.95,\n",
            "  \"source\": \"COVID_Vaccine_Safety_Facts.pdf\",\n",
            "  \"page\": 1\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 330 ---\n",
            "{\n",
            "  \"question\": \"What percentage decrease in risk of infections do the Pfizer and Moderna vaccines provide?\",\n",
            "  \"answer\": \"The Pfizer and Moderna vaccines provide a 90% decrease in risk of infections.\",\n",
            "  \"confidence\": 0.95,\n",
            "  \"source\": \"COVID_Vaccine_Safety_Facts.pdf\",\n",
            "  \"page\": 1\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 331 ---\n",
            "{\n",
            "  \"question\": \"What is a key reason why vaccine experts are confident that COVID vaccines are safe in the long-term?\",\n",
            "  \"answer\": \"One of the reasons is that vaccines are eliminated quickly by the body, and vaccine side effects show up within weeks if at all.\",\n",
            "  \"confidence\": 0.9,\n",
            "  \"source\": \"COVID_Vaccine_Safety_Facts.pdf\",\n",
            "  \"page\": 1\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 332 ---\n",
            "{\n",
            "  \"question\": \"How do vaccines differ from medicines that people take every day in terms of their elimination from the body?\",\n",
            "  \"answer\": \"Unlike many medications taken daily, vaccines are generally one-and-done and are quickly eliminated by the body.\",\n",
            "  \"confidence\": 0.9,\n",
            "  \"source\": \"COVID_Vaccine_Safety_Facts.pdf\",\n",
            "  \"page\": 1\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 333 ---\n",
            "{\n",
            "  \"question\": \"What is a concern reported by Americans regarding COVID vaccines?\",\n",
            "  \"answer\": \"Safety is the main concern for the majority of Americans who haven't been vaccinated or are hesitant about vaccinating their children.\",\n",
            "  \"confidence\": 0.95,\n",
            "  \"source\": \"COVID_Vaccine_Safety_Facts.pdf\",\n",
            "  \"page\": 1\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 334 ---\n",
            "{\n",
            "  \"question\": \"What percentage of Gallup survey respondents in March and April 2021 wanted to confirm the vaccine was safe?\",\n",
            "  \"answer\": \"Nearly a quarter (23%) of respondents in Gallup surveys in March and April 2021 said they wanted to confirm the vaccine was safe before getting the shot.\",\n",
            "  \"confidence\": 0.95,\n",
            "  \"source\": \"COVID_Vaccine_Safety_Facts.pdf\",\n",
            "  \"page\": 1\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 335 ---\n",
            "{\n",
            "  \"question\": \"What percentage of parents surveyed by the Kaiser Family Foundation in April 2021 wanted to wait to see how the vaccine is working before vaccinating their children aged 12-15?\",\n",
            "  \"answer\": \"26% of respondents in a survey of parents with children ages 12-15 by the Kaiser Family Foundation in April 2021 said they wanted to 'wait a while to see how the vaccine is working' before deciding to get their child vaccinated.\",\n",
            "  \"confidence\": 0.95,\n",
            "  \"source\": \"COVID_Vaccine_Safety_Facts.pdf\",\n",
            "  \"page\": 1\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 336 ---\n",
            "{\n",
            "  \"question\": \"What is the primary reason given for confidence in the long-term safety of COVID vaccines?\",\n",
            "  \"answer\": \"The confidence stems from the way vaccines work, strong evidence from vaccine history, and even stronger evidence from the responses of people who have received COVID-19 vaccines worldwide during the past six months.\",\n",
            "  \"confidence\": 0.9,\n",
            "  \"source\": \"COVID_Vaccine_Safety_Facts.pdf\",\n",
            "  \"page\": 1\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 337 ---\n",
            "{\n",
            "  \"question\": \"How quickly does mRNA degrade in mRNA vaccines?\",\n",
            "  \"answer\": \"mRNA degrades incredibly rapidly in mRNA vaccines.\",\n",
            "  \"confidence\": 0.95,\n",
            "  \"source\": \"COVID_Vaccine_Safety_Facts.pdf\",\n",
            "  \"page\": 1\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 338 ---\n",
            "{\n",
            "  \"question\": \"What is the expectation regarding long-term side effects for vaccines that are quickly eliminated by the body?\",\n",
            "  \"answer\": \"You wouldn't expect any of these vaccines to have any long-term side effects.\",\n",
            "  \"confidence\": 0.95,\n",
            "  \"source\": \"COVID_Vaccine_Safety_Facts.pdf\",\n",
            "  \"page\": 1\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 339 ---\n",
            "{\n",
            "  \"question\": \"Has the emergence of long-term side effects ever occurred with any vaccine?\",\n",
            "  \"answer\": \"No, this has never occurred with any vaccine.\",\n",
            "  \"confidence\": 0.95,\n",
            "  \"source\": \"COVID_Vaccine_Safety_Facts.pdf\",\n",
            "  \"page\": 1\n",
            "}\n",
            "\n",
            "\n",
            "--- QA Pair 340 ---\n",
            "{\n",
            "  \"question\": \"Under what authorization are COVID vaccines currently being distributed in the US?\",\n",
            "  \"answer\": \"COVID vaccines are currently being distributed under Emergency Use Authorizations.\",\n",
            "  \"confidence\": 0.95,\n",
            "  \"source\": \"COVID_Vaccine_Safety_Facts.pdf\",\n",
            "  \"page\": 1\n",
            "}\n",
            "\n",
            "\n"
          ]
        }
      ]
    },
    {
      "cell_type": "markdown",
      "source": [
        "# **6. Fine-tuning Preparation**\n",
        "## 6.1 Install & Setup LLaMA-Factory\n",
        "\n",
        "Clone and install LLaMA-Factory for fine-tuning."
      ],
      "metadata": {
        "id": "Hr0TFf8fxPbN"
      }
    },
    {
      "cell_type": "code",
      "source": [
        "!git clone --depth 1 https://github.com/hiyouga/LLaMA-Factory.git\n",
        "!cd LLaMA-Factory && pip install -e ."
      ],
      "metadata": {
        "id": "LwljUkKkRtQ7"
      },
      "execution_count": null,
      "outputs": []
    },
    {
      "cell_type": "code",
      "source": [
        "## Configure API Keys\n",
        "# Load WandB and HuggingFace tokens from Colab userdata for experiment logging and model authentication.\n",
        "\n",
        "from google.colab import userdata\n",
        "import wandb\n",
        "\n",
        "wandb.login(key=userdata.get('wandb'))\n",
        "hf_token = userdata.get('huggingface')\n",
        "!huggingface-cli login --token {hf_token}"
      ],
      "metadata": {
        "id": "v9jj0wT4TdjC"
      },
      "execution_count": null,
      "outputs": []
    },
    {
      "cell_type": "markdown",
      "source": [
        "## 6.2 Define Output Schema\n",
        "\n",
        "Use GenerateAnswer Pydantic schema to enforce structured output for each QA pair.\n",
        "Comment: Guarantees JSON consistency during fine-tuning."
      ],
      "metadata": {
        "id": "UbGnbb1P7oKw"
      }
    },
    {
      "cell_type": "code",
      "source": [
        "class GenerateAnswer(BaseModel):\n",
        "    answer: str = Field(..., description=\"Final answer to the user question\")\n",
        "    confidence: float = Field(..., description=\"Model confidence between 0 and 1\")\n",
        "    source: str = Field(..., description=\"Source document name\")\n",
        "    page: int = Field(..., description=\"Page number in the document\")\n",
        "system_message = \"\\n\".join([\n",
        "    \"You are a professional NLP data parser.\",\n",
        "    \"Answer the question provided by the user following the `Output Scheme` to generate the `Output JSON`.\",\n",
        "    \"Do not generate any introduction or conclusion.\"\n",
        "])"
      ],
      "metadata": {
        "id": "G-mnO0uq4taY"
      },
      "execution_count": null,
      "outputs": []
    },
    {
      "cell_type": "markdown",
      "source": [
        "## 6.3 Load QA Dataset\n",
        "\n",
        "Convert JSONL QA pairs into LLaMA-Factory fine-tuning format."
      ],
      "metadata": {
        "id": "WNfuXFoF73t8"
      }
    },
    {
      "cell_type": "code",
      "source": [
        "sft_train_path = os.path.join(PROJECT_PATH, \"covid_qa_dataset.jsonl\")\n",
        "llm_finetuning_data = []\n",
        "\n",
        "\n",
        "\n",
        "for line in open(sft_train_path, \"r\", encoding=\"utf-8\"):\n",
        "  if line.strip() == \"\":\n",
        "        continue\n",
        "  qa_pair = json.loads(line.strip())\n",
        "  llm_finetuning_data.append({\n",
        "        \"system\": system_message,\n",
        "        \"instruction\": \"\\n\".join([\n",
        "            \"## User Question:\",\n",
        "            qa_pair[\"question\"],\n",
        "            \"\",\n",
        "            \"## Pydantic Details (Output Schema):\",\n",
        "            json.dumps(GenerateAnswer.model_json_schema(), ensure_ascii=False),\n",
        "            \"\",\n",
        "            \"## Structured Answer:\",\n",
        "        ]),\n",
        "        \"input\": \"\",\n",
        "        \"output\": \"\\n\".join([\n",
        "            \"```json\",\n",
        "            json.dumps(qa_pair, ensure_ascii=False),\n",
        "            \"```\"\n",
        "        ]),\n",
        "        \"history\": []\n",
        "    })\n",
        "\n",
        "\n",
        "random.Random(42).shuffle(llm_finetuning_data)\n",
        "len(llm_finetuning_data)"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "lZmPs0s-4Btc",
        "outputId": "fd9207ca-0b6e-4a0b-fecc-687ff5487330"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "execute_result",
          "data": {
            "text/plain": [
              "340"
            ]
          },
          "metadata": {},
          "execution_count": 33
        }
      ]
    },
    {
      "cell_type": "markdown",
      "source": [
        "## 6.4 Train/Validation Split"
      ],
      "metadata": {
        "id": "6MlEd1EX8AjP"
      }
    },
    {
      "cell_type": "code",
      "source": [
        "train_sample_sz = 300\n",
        "train_ds = llm_finetuning_data[:train_sample_sz]\n",
        "eval_ds = llm_finetuning_data[train_sample_sz:]\n",
        "import os\n",
        "from os.path import join\n",
        "\n",
        "\n",
        "# 5.5 Save LLaMA-Factory JSON Files\n",
        "# train.json and val.json inside the fine-tuning folder.\n",
        "save_path = join(PROJECT_PATH, \"data\", \"llamafactory-finetune-data\")\n",
        "os.makedirs(save_path, exist_ok=True)\n",
        "with open(join(save_path, \"train.json\"), \"w\", encoding=\"utf-8\") as f:\n",
        "    json.dump(train_ds, f, ensure_ascii=False, default=str)\n",
        "\n",
        "with open(join(save_path, \"val.json\"), \"w\", encoding=\"utf-8\") as f:\n",
        "    json.dump(eval_ds, f, ensure_ascii=False, default=str)"
      ],
      "metadata": {
        "id": "bhml_Yv28WnD"
      },
      "execution_count": null,
      "outputs": []
    },
    {
      "cell_type": "code",
      "source": [
        "join(PROJECT_PATH, \"data\", \"llamafactory-finetune-data\", \"val.json\")"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 36
        },
        "id": "-i-e1e8sWuqy",
        "outputId": "59fc1886-a44c-4370-957c-083b1f299129"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "execute_result",
          "data": {
            "text/plain": [
              "'/content/drive/MyDrive/COVID-19 Vaccine Side Effects and Safety/data/llamafactory-finetune-data/val.json'"
            ],
            "application/vnd.google.colaboratory.intrinsic+json": {
              "type": "string"
            }
          },
          "metadata": {},
          "execution_count": 35
        }
      ]
    },
    {
      "cell_type": "markdown",
      "source": [
        "# **7. LoRA Fine-tuning**\n",
        "\n",
        "Fine-tune the small LLM with LoRA using the dataset prepared in Section 6\n",
        "\n",
        "## 6.1 Configure YAML for Training\n",
        "Define model, dataset, and training hyperparameters in YAML."
      ],
      "metadata": {
        "id": "h5jzw7qg8UPh"
      }
    },
    {
      "cell_type": "code",
      "source": [
        "%%writefile \"/content/drive/MyDrive/COVID-19 Vaccine Side Effects and Safety/LLaMA-Factory/examples/train_lora/qa_finetune.yaml\"\n",
        "\n",
        "### model\n",
        "model_name_or_path: Qwen/Qwen2.5-1.5B-Instruct\n",
        "trust_remote_code: true\n",
        "\n",
        "### method\n",
        "stage: sft\n",
        "do_train: true\n",
        "finetuning_type: lora\n",
        "lora_rank: 32\n",
        "lora_target: all\n",
        "\n",
        "### dataset\n",
        "dataset: qa_finetune_train\n",
        "eval_dataset: qa_finetune_val\n",
        "template: qwen\n",
        "cutoff_len: 3500\n",
        "# max_samples: 50\n",
        "overwrite_cache: true\n",
        "preprocessing_num_workers: 16\n",
        "\n",
        "### output\n",
        "#resume_from_checkpoint: /content/drive/MyDrive/COVID-19 Vaccine Side Effects and Safety/models/checkpoint-1500\n",
        "output_dir: /content/drive/MyDrive/COVID-19 Vaccine Side Effects and Safety/models/\n",
        "logging_steps: 10\n",
        "save_steps: 500\n",
        "plot_loss: true\n",
        "overwrite_output_dir: true\n",
        "\n",
        "### train\n",
        "per_device_train_batch_size: 2\n",
        "gradient_accumulation_steps: 20\n",
        "learning_rate: 1.0e-4\n",
        "num_train_epochs: 4.0\n",
        "lr_scheduler_type: cosine\n",
        "warmup_ratio: 0.1\n",
        "bf16: true\n",
        "ddp_timeout: 180000000\n",
        "\n",
        "### eval\n",
        "per_device_eval_batch_size: 2\n",
        "eval_strategy: steps\n",
        "eval_steps: 20\n"
      ],
      "metadata": {
        "id": "36EvC4p-9LgJ",
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "outputId": "879f3431-d521-45ae-b829-1922bbf86127"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "Overwriting /content/drive/MyDrive/COVID-19 Vaccine Side Effects and Safety/LLaMA-Factory/examples/train_lora/qa_finetune.yaml\n"
          ]
        }
      ]
    },
    {
      "cell_type": "markdown",
      "source": [
        "# 7.2 Run LoRA Fine-tuning\n",
        "\n",
        "Execute LLaMA-Factory training CLI with the YAML config"
      ],
      "metadata": {
        "id": "o1Fajybj8j8v"
      }
    },
    {
      "cell_type": "code",
      "source": [
        "!cd \"/content/drive/.shortcut-targets-by-id/1_GzXpxDDuF7W4kQw4wsC-4QCgbmBihNW/COVID-19 Vaccine Side Effects and Safety/LLaMA-Factory/\" && \\\n",
        "llamafactory-cli train examples/train_lora/qa_finetune.yaml"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "RLhB3pMUrjLF",
        "outputId": "026109d0-1d20-4605-f6bd-44bec28f730e"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "2026-01-20 18:35:26.741119: E external/local_xla/xla/stream_executor/cuda/cuda_fft.cc:467] Unable to register cuFFT factory: Attempting to register factory for plugin cuFFT when one has already been registered\n",
            "WARNING: All log messages before absl::InitializeLog() is called are written to STDERR\n",
            "E0000 00:00:1768934126.773461   33804 cuda_dnn.cc:8579] Unable to register cuDNN factory: Attempting to register factory for plugin cuDNN when one has already been registered\n",
            "E0000 00:00:1768934126.783231   33804 cuda_blas.cc:1407] Unable to register cuBLAS factory: Attempting to register factory for plugin cuBLAS when one has already been registered\n",
            "W0000 00:00:1768934126.806265   33804 computation_placer.cc:177] computation placer already registered. Please check linkage and avoid linking the same target more than once.\n",
            "W0000 00:00:1768934126.806298   33804 computation_placer.cc:177] computation placer already registered. Please check linkage and avoid linking the same target more than once.\n",
            "W0000 00:00:1768934126.806307   33804 computation_placer.cc:177] computation placer already registered. Please check linkage and avoid linking the same target more than once.\n",
            "W0000 00:00:1768934126.806313   33804 computation_placer.cc:177] computation placer already registered. Please check linkage and avoid linking the same target more than once.\n",
            "[INFO|2026-01-20 18:35:36] llamafactory.hparams.parser:465 >> Process rank: 0, world size: 1, device: cuda:0, distributed training: False, compute dtype: torch.bfloat16\n",
            "[INFO|tokenization_utils_base.py:2095] 2026-01-20 18:35:36,969 >> loading file vocab.json from cache at /root/.cache/huggingface/hub/models--Qwen--Qwen2.5-1.5B-Instruct/snapshots/989aa7980e4cf806f80c7fef2b1adb7bc71aa306/vocab.json\n",
            "[INFO|tokenization_utils_base.py:2095] 2026-01-20 18:35:36,970 >> loading file merges.txt from cache at /root/.cache/huggingface/hub/models--Qwen--Qwen2.5-1.5B-Instruct/snapshots/989aa7980e4cf806f80c7fef2b1adb7bc71aa306/merges.txt\n",
            "[INFO|tokenization_utils_base.py:2095] 2026-01-20 18:35:36,970 >> loading file tokenizer.json from cache at /root/.cache/huggingface/hub/models--Qwen--Qwen2.5-1.5B-Instruct/snapshots/989aa7980e4cf806f80c7fef2b1adb7bc71aa306/tokenizer.json\n",
            "[INFO|tokenization_utils_base.py:2095] 2026-01-20 18:35:36,970 >> loading file added_tokens.json from cache at None\n",
            "[INFO|tokenization_utils_base.py:2095] 2026-01-20 18:35:36,970 >> loading file special_tokens_map.json from cache at None\n",
            "[INFO|tokenization_utils_base.py:2095] 2026-01-20 18:35:36,970 >> loading file tokenizer_config.json from cache at /root/.cache/huggingface/hub/models--Qwen--Qwen2.5-1.5B-Instruct/snapshots/989aa7980e4cf806f80c7fef2b1adb7bc71aa306/tokenizer_config.json\n",
            "[INFO|tokenization_utils_base.py:2095] 2026-01-20 18:35:36,970 >> loading file chat_template.jinja from cache at None\n",
            "[INFO|tokenization_utils_base.py:2364] 2026-01-20 18:35:37,274 >> Special tokens have been added in the vocabulary, make sure the associated word embeddings are fine-tuned or trained.\n",
            "[INFO|configuration_utils.py:765] 2026-01-20 18:35:37,826 >> loading configuration file config.json from cache at /root/.cache/huggingface/hub/models--Qwen--Qwen2.5-1.5B-Instruct/snapshots/989aa7980e4cf806f80c7fef2b1adb7bc71aa306/config.json\n",
            "[INFO|configuration_utils.py:839] 2026-01-20 18:35:37,827 >> Model config Qwen2Config {\n",
            "  \"architectures\": [\n",
            "    \"Qwen2ForCausalLM\"\n",
            "  ],\n",
            "  \"attention_dropout\": 0.0,\n",
            "  \"bos_token_id\": 151643,\n",
            "  \"dtype\": \"bfloat16\",\n",
            "  \"eos_token_id\": 151645,\n",
            "  \"hidden_act\": \"silu\",\n",
            "  \"hidden_size\": 1536,\n",
            "  \"initializer_range\": 0.02,\n",
            "  \"intermediate_size\": 8960,\n",
            "  \"layer_types\": [\n",
            "    \"full_attention\",\n",
            "    \"full_attention\",\n",
            "    \"full_attention\",\n",
            "    \"full_attention\",\n",
            "    \"full_attention\",\n",
            "    \"full_attention\",\n",
            "    \"full_attention\",\n",
            "    \"full_attention\",\n",
            "    \"full_attention\",\n",
            "    \"full_attention\",\n",
            "    \"full_attention\",\n",
            "    \"full_attention\",\n",
            "    \"full_attention\",\n",
            "    \"full_attention\",\n",
            "    \"full_attention\",\n",
            "    \"full_attention\",\n",
            "    \"full_attention\",\n",
            "    \"full_attention\",\n",
            "    \"full_attention\",\n",
            "    \"full_attention\",\n",
            "    \"full_attention\",\n",
            "    \"full_attention\",\n",
            "    \"full_attention\",\n",
            "    \"full_attention\",\n",
            "    \"full_attention\",\n",
            "    \"full_attention\",\n",
            "    \"full_attention\",\n",
            "    \"full_attention\"\n",
            "  ],\n",
            "  \"max_position_embeddings\": 32768,\n",
            "  \"max_window_layers\": 21,\n",
            "  \"model_type\": \"qwen2\",\n",
            "  \"num_attention_heads\": 12,\n",
            "  \"num_hidden_layers\": 28,\n",
            "  \"num_key_value_heads\": 2,\n",
            "  \"rms_norm_eps\": 1e-06,\n",
            "  \"rope_scaling\": null,\n",
            "  \"rope_theta\": 1000000.0,\n",
            "  \"sliding_window\": null,\n",
            "  \"tie_word_embeddings\": true,\n",
            "  \"transformers_version\": \"4.57.1\",\n",
            "  \"use_cache\": true,\n",
            "  \"use_sliding_window\": false,\n",
            "  \"vocab_size\": 151936\n",
            "}\n",
            "\n",
            "[INFO|tokenization_utils_base.py:2095] 2026-01-20 18:35:38,013 >> loading file vocab.json from cache at /root/.cache/huggingface/hub/models--Qwen--Qwen2.5-1.5B-Instruct/snapshots/989aa7980e4cf806f80c7fef2b1adb7bc71aa306/vocab.json\n",
            "[INFO|tokenization_utils_base.py:2095] 2026-01-20 18:35:38,014 >> loading file merges.txt from cache at /root/.cache/huggingface/hub/models--Qwen--Qwen2.5-1.5B-Instruct/snapshots/989aa7980e4cf806f80c7fef2b1adb7bc71aa306/merges.txt\n",
            "[INFO|tokenization_utils_base.py:2095] 2026-01-20 18:35:38,014 >> loading file tokenizer.json from cache at /root/.cache/huggingface/hub/models--Qwen--Qwen2.5-1.5B-Instruct/snapshots/989aa7980e4cf806f80c7fef2b1adb7bc71aa306/tokenizer.json\n",
            "[INFO|tokenization_utils_base.py:2095] 2026-01-20 18:35:38,014 >> loading file added_tokens.json from cache at None\n",
            "[INFO|tokenization_utils_base.py:2095] 2026-01-20 18:35:38,014 >> loading file special_tokens_map.json from cache at None\n",
            "[INFO|tokenization_utils_base.py:2095] 2026-01-20 18:35:38,014 >> loading file tokenizer_config.json from cache at /root/.cache/huggingface/hub/models--Qwen--Qwen2.5-1.5B-Instruct/snapshots/989aa7980e4cf806f80c7fef2b1adb7bc71aa306/tokenizer_config.json\n",
            "[INFO|tokenization_utils_base.py:2095] 2026-01-20 18:35:38,014 >> loading file chat_template.jinja from cache at None\n",
            "[INFO|tokenization_utils_base.py:2364] 2026-01-20 18:35:38,324 >> Special tokens have been added in the vocabulary, make sure the associated word embeddings are fine-tuned or trained.\n",
            "[INFO|2026-01-20 18:35:38] llamafactory.data.loader:143 >> Loading dataset /content/drive/MyDrive/COVID-19 Vaccine Side Effects and Safety/data/llamafactory-finetune-data/train.json...\n",
            "Converting format of dataset (num_proc=16): 100% 300/300 [00:00<00:00, 559.72 examples/s]\n",
            "[INFO|2026-01-20 18:35:39] llamafactory.data.loader:143 >> Loading dataset /content/drive/MyDrive/COVID-19 Vaccine Side Effects and Safety/data/llamafactory-finetune-data/val.json...\n",
            "Converting format of dataset (num_proc=16): 100% 40/40 [00:00<00:00, 67.82 examples/s]\n",
            "Running tokenizer on dataset (num_proc=16): 100% 300/300 [00:10<00:00, 29.26 examples/s]\n",
            "training example:\n",
            "input_ids:\n",
            "[151644, 8948, 198, 2610, 525, 264, 6584, 451, 12567, 821, 6729, 624, 16141, 279, 3405, 3897, 553, 279, 1196, 2701, 279, 1565, 5097, 43781, 63, 311, 6923, 279, 1565, 5097, 4718, 18639, 5404, 537, 6923, 894, 16800, 476, 16688, 13, 151645, 198, 151644, 872, 198, 565, 2657, 15846, 510, 3838, 374, 279, 54294, 26279, 315, 2155, 6028, 46065, 13980, 389, 77772, 3118, 56432, 39200, 2348, 68778, 82, 7658, 38957, 12, 17, 28920, 1939, 565, 5355, 67, 8159, 12309, 320, 5097, 12539, 982, 4913, 13193, 788, 5212, 9217, 788, 5212, 4684, 788, 330, 19357, 4226, 311, 279, 1196, 3405, 497, 330, 2102, 788, 330, 16141, 497, 330, 1313, 788, 330, 917, 14345, 330, 81929, 788, 5212, 4684, 788, 330, 1712, 12136, 1948, 220, 15, 323, 220, 16, 497, 330, 2102, 788, 330, 15578, 7087, 497, 330, 1313, 788, 330, 4082, 14345, 330, 2427, 788, 5212, 4684, 788, 330, 3608, 2197, 829, 497, 330, 2102, 788, 330, 3608, 497, 330, 1313, 788, 330, 917, 14345, 330, 2893, 788, 5212, 4684, 788, 330, 2665, 1372, 304, 279, 2197, 497, 330, 2102, 788, 330, 2665, 497, 330, 1313, 788, 330, 11662, 9207, 2137, 330, 6279, 788, 4383, 9217, 497, 330, 81929, 497, 330, 2427, 497, 330, 2893, 7914, 330, 2102, 788, 330, 31115, 16141, 497, 330, 1313, 788, 330, 1700, 63159, 565, 16139, 3073, 21806, 25, 151645, 198, 151644, 77091, 198, 73594, 2236, 198, 4913, 7841, 788, 330, 3838, 374, 279, 54294, 26279, 315, 2155, 6028, 46065, 13980, 389, 77772, 3118, 56432, 39200, 2348, 68778, 82, 7658, 38957, 12, 17, 28920, 31011, 330, 9217, 788, 330, 32, 882, 8273, 658, 287, 40844, 6358, 1667, 9091, 78841, 304, 279, 63992, 10357, 3942, 40844, 19476, 279, 54294, 26279, 315, 2155, 6028, 46065, 13980, 389, 77772, 3118, 56432, 39200, 2348, 68778, 82, 7658, 38957, 12, 17, 28920, 10465, 330, 81929, 788, 220, 15, 13, 23, 11, 330, 2427, 788, 330, 53, 88021, 2089, 20615, 2757, 2232, 21220, 2248, 42434, 1557, 5964, 15995, 497, 330, 2893, 788, 220, 16, 19, 532, 73594, 151645, 198]\n",
            "inputs:\n",
            "<|im_start|>system\n",
            "You are a professional NLP data parser.\n",
            "Answer the question provided by the user following the `Output Scheme` to generate the `Output JSON`.\n",
            "Do not generate any introduction or conclusion.<|im_end|>\n",
            "<|im_start|>user\n",
            "## User Question:\n",
            "What is the comparative effectiveness of different primary vaccination courses on mRNA based booster vaccines against SARs-COV-2 infections?\n",
            "\n",
            "## Pydantic Details (Output Schema):\n",
            "{\"properties\": {\"answer\": {\"description\": \"Final answer to the user question\", \"title\": \"Answer\", \"type\": \"string\"}, \"confidence\": {\"description\": \"Model confidence between 0 and 1\", \"title\": \"Confidence\", \"type\": \"number\"}, \"source\": {\"description\": \"Source document name\", \"title\": \"Source\", \"type\": \"string\"}, \"page\": {\"description\": \"Page number in the document\", \"title\": \"Page\", \"type\": \"integer\"}}, \"required\": [\"answer\", \"confidence\", \"source\", \"page\"], \"title\": \"GenerateAnswer\", \"type\": \"object\"}\n",
            "\n",
            "## Structured Answer:<|im_end|>\n",
            "<|im_start|>assistant\n",
            "```json\n",
            "{\"question\": \"What is the comparative effectiveness of different primary vaccination courses on mRNA based booster vaccines against SARs-COV-2 infections?\", \"answer\": \"A time-varying cohort analysis using trial emulation in the Virus Watch community cohort studied the comparative effectiveness of different primary vaccination courses on mRNA based booster vaccines against SARs-COV-2 infections.\", \"confidence\": 0.8, \"source\": \"Vaccine_Efficacy_Omicron_vs_Delta.pdf\", \"page\": 14}\n",
            "```<|im_end|>\n",
            "\n",
            "label_ids:\n",
            "[-100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, 73594, 2236, 198, 4913, 7841, 788, 330, 3838, 374, 279, 54294, 26279, 315, 2155, 6028, 46065, 13980, 389, 77772, 3118, 56432, 39200, 2348, 68778, 82, 7658, 38957, 12, 17, 28920, 31011, 330, 9217, 788, 330, 32, 882, 8273, 658, 287, 40844, 6358, 1667, 9091, 78841, 304, 279, 63992, 10357, 3942, 40844, 19476, 279, 54294, 26279, 315, 2155, 6028, 46065, 13980, 389, 77772, 3118, 56432, 39200, 2348, 68778, 82, 7658, 38957, 12, 17, 28920, 10465, 330, 81929, 788, 220, 15, 13, 23, 11, 330, 2427, 788, 330, 53, 88021, 2089, 20615, 2757, 2232, 21220, 2248, 42434, 1557, 5964, 15995, 497, 330, 2893, 788, 220, 16, 19, 532, 73594, 151645, 198]\n",
            "labels:\n",
            "```json\n",
            "{\"question\": \"What is the comparative effectiveness of different primary vaccination courses on mRNA based booster vaccines against SARs-COV-2 infections?\", \"answer\": \"A time-varying cohort analysis using trial emulation in the Virus Watch community cohort studied the comparative effectiveness of different primary vaccination courses on mRNA based booster vaccines against SARs-COV-2 infections.\", \"confidence\": 0.8, \"source\": \"Vaccine_Efficacy_Omicron_vs_Delta.pdf\", \"page\": 14}\n",
            "```<|im_end|>\n",
            "\n",
            "Running tokenizer on dataset (num_proc=16): 100% 40/40 [00:11<00:00,  3.62 examples/s]\n",
            "eval example:\n",
            "input_ids:\n",
            "[151644, 8948, 198, 2610, 525, 264, 6584, 451, 12567, 821, 6729, 624, 16141, 279, 3405, 3897, 553, 279, 1196, 2701, 279, 1565, 5097, 43781, 63, 311, 6923, 279, 1565, 5097, 4718, 18639, 5404, 537, 6923, 894, 16800, 476, 16688, 13, 151645, 198, 151644, 872, 198, 565, 2657, 15846, 510, 3838, 374, 10982, 911, 279, 7149, 821, 2500, 369, 19966, 39200, 7707, 311, 1008, 39200, 1939, 565, 5355, 67, 8159, 12309, 320, 5097, 12539, 982, 4913, 13193, 788, 5212, 9217, 788, 5212, 4684, 788, 330, 19357, 4226, 311, 279, 1196, 3405, 497, 330, 2102, 788, 330, 16141, 497, 330, 1313, 788, 330, 917, 14345, 330, 81929, 788, 5212, 4684, 788, 330, 1712, 12136, 1948, 220, 15, 323, 220, 16, 497, 330, 2102, 788, 330, 15578, 7087, 497, 330, 1313, 788, 330, 4082, 14345, 330, 2427, 788, 5212, 4684, 788, 330, 3608, 2197, 829, 497, 330, 2102, 788, 330, 3608, 497, 330, 1313, 788, 330, 917, 14345, 330, 2893, 788, 5212, 4684, 788, 330, 2665, 1372, 304, 279, 2197, 497, 330, 2102, 788, 330, 2665, 497, 330, 1313, 788, 330, 11662, 9207, 2137, 330, 6279, 788, 4383, 9217, 497, 330, 81929, 497, 330, 2427, 497, 330, 2893, 7914, 330, 2102, 788, 330, 31115, 16141, 497, 330, 1313, 788, 330, 1700, 63159, 565, 16139, 3073, 21806, 25, 151645, 198, 151644, 77091, 198, 73594, 2236, 198, 4913, 7841, 788, 330, 3838, 374, 10982, 911, 279, 7149, 821, 2500, 369, 19966, 39200, 7707, 311, 1008, 39200, 31011, 330, 9217, 788, 330, 17949, 773, 1657, 1251, 614, 1012, 69458, 11, 1052, 374, 3041, 803, 7149, 821, 2500, 369, 19966, 39200, 1091, 369, 894, 1008, 24467, 10465, 330, 81929, 788, 220, 16, 11, 330, 2427, 788, 330, 77963, 2334, 88021, 1098, 38618, 1400, 11359, 15995, 497, 330, 2893, 788, 220, 18, 532, 73594, 151645, 198]\n",
            "inputs:\n",
            "<|im_start|>system\n",
            "You are a professional NLP data parser.\n",
            "Answer the question provided by the user following the `Output Scheme` to generate the `Output JSON`.\n",
            "Do not generate any introduction or conclusion.<|im_end|>\n",
            "<|im_start|>user\n",
            "## User Question:\n",
            "What is stated about the safety data available for COVID vaccines compared to other vaccines?\n",
            "\n",
            "## Pydantic Details (Output Schema):\n",
            "{\"properties\": {\"answer\": {\"description\": \"Final answer to the user question\", \"title\": \"Answer\", \"type\": \"string\"}, \"confidence\": {\"description\": \"Model confidence between 0 and 1\", \"title\": \"Confidence\", \"type\": \"number\"}, \"source\": {\"description\": \"Source document name\", \"title\": \"Source\", \"type\": \"string\"}, \"page\": {\"description\": \"Page number in the document\", \"title\": \"Page\", \"type\": \"integer\"}}, \"required\": [\"answer\", \"confidence\", \"source\", \"page\"], \"title\": \"GenerateAnswer\", \"type\": \"object\"}\n",
            "\n",
            "## Structured Answer:<|im_end|>\n",
            "<|im_start|>assistant\n",
            "```json\n",
            "{\"question\": \"What is stated about the safety data available for COVID vaccines compared to other vaccines?\", \"answer\": \"Because so many people have been vaccinated, there is far more safety data available for COVID vaccines than for any other vaccine.\", \"confidence\": 1, \"source\": \"COVID_Vaccine_Safety_Facts.pdf\", \"page\": 3}\n",
            "```<|im_end|>\n",
            "\n",
            "label_ids:\n",
            "[-100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, -100, 73594, 2236, 198, 4913, 7841, 788, 330, 3838, 374, 10982, 911, 279, 7149, 821, 2500, 369, 19966, 39200, 7707, 311, 1008, 39200, 31011, 330, 9217, 788, 330, 17949, 773, 1657, 1251, 614, 1012, 69458, 11, 1052, 374, 3041, 803, 7149, 821, 2500, 369, 19966, 39200, 1091, 369, 894, 1008, 24467, 10465, 330, 81929, 788, 220, 16, 11, 330, 2427, 788, 330, 77963, 2334, 88021, 1098, 38618, 1400, 11359, 15995, 497, 330, 2893, 788, 220, 18, 532, 73594, 151645, 198]\n",
            "labels:\n",
            "```json\n",
            "{\"question\": \"What is stated about the safety data available for COVID vaccines compared to other vaccines?\", \"answer\": \"Because so many people have been vaccinated, there is far more safety data available for COVID vaccines than for any other vaccine.\", \"confidence\": 1, \"source\": \"COVID_Vaccine_Safety_Facts.pdf\", \"page\": 3}\n",
            "```<|im_end|>\n",
            "\n",
            "[INFO|configuration_utils.py:765] 2026-01-20 18:36:04,347 >> loading configuration file config.json from cache at /root/.cache/huggingface/hub/models--Qwen--Qwen2.5-1.5B-Instruct/snapshots/989aa7980e4cf806f80c7fef2b1adb7bc71aa306/config.json\n",
            "[INFO|configuration_utils.py:839] 2026-01-20 18:36:04,348 >> Model config Qwen2Config {\n",
            "  \"architectures\": [\n",
            "    \"Qwen2ForCausalLM\"\n",
            "  ],\n",
            "  \"attention_dropout\": 0.0,\n",
            "  \"bos_token_id\": 151643,\n",
            "  \"dtype\": \"bfloat16\",\n",
            "  \"eos_token_id\": 151645,\n",
            "  \"hidden_act\": \"silu\",\n",
            "  \"hidden_size\": 1536,\n",
            "  \"initializer_range\": 0.02,\n",
            "  \"intermediate_size\": 8960,\n",
            "  \"layer_types\": [\n",
            "    \"full_attention\",\n",
            "    \"full_attention\",\n",
            "    \"full_attention\",\n",
            "    \"full_attention\",\n",
            "    \"full_attention\",\n",
            "    \"full_attention\",\n",
            "    \"full_attention\",\n",
            "    \"full_attention\",\n",
            "    \"full_attention\",\n",
            "    \"full_attention\",\n",
            "    \"full_attention\",\n",
            "    \"full_attention\",\n",
            "    \"full_attention\",\n",
            "    \"full_attention\",\n",
            "    \"full_attention\",\n",
            "    \"full_attention\",\n",
            "    \"full_attention\",\n",
            "    \"full_attention\",\n",
            "    \"full_attention\",\n",
            "    \"full_attention\",\n",
            "    \"full_attention\",\n",
            "    \"full_attention\",\n",
            "    \"full_attention\",\n",
            "    \"full_attention\",\n",
            "    \"full_attention\",\n",
            "    \"full_attention\",\n",
            "    \"full_attention\",\n",
            "    \"full_attention\"\n",
            "  ],\n",
            "  \"max_position_embeddings\": 32768,\n",
            "  \"max_window_layers\": 21,\n",
            "  \"model_type\": \"qwen2\",\n",
            "  \"num_attention_heads\": 12,\n",
            "  \"num_hidden_layers\": 28,\n",
            "  \"num_key_value_heads\": 2,\n",
            "  \"rms_norm_eps\": 1e-06,\n",
            "  \"rope_scaling\": null,\n",
            "  \"rope_theta\": 1000000.0,\n",
            "  \"sliding_window\": null,\n",
            "  \"tie_word_embeddings\": true,\n",
            "  \"transformers_version\": \"4.57.1\",\n",
            "  \"use_cache\": true,\n",
            "  \"use_sliding_window\": false,\n",
            "  \"vocab_size\": 151936\n",
            "}\n",
            "\n",
            "[INFO|2026-01-20 18:36:04] llamafactory.model.model_utils.kv_cache:143 >> KV cache is disabled during training.\n",
            "[WARNING|logging.py:328] 2026-01-20 18:36:05,055 >> `torch_dtype` is deprecated! Use `dtype` instead!\n",
            "[INFO|modeling_utils.py:1172] 2026-01-20 18:36:05,062 >> loading weights file model.safetensors from cache at /root/.cache/huggingface/hub/models--Qwen--Qwen2.5-1.5B-Instruct/snapshots/989aa7980e4cf806f80c7fef2b1adb7bc71aa306/model.safetensors\n",
            "[INFO|modeling_utils.py:1243] 2026-01-20 18:36:05,069 >> Will use dtype=torch.bfloat16 as defined in model's config object\n",
            "[INFO|modeling_utils.py:2341] 2026-01-20 18:36:05,069 >> Instantiating Qwen2ForCausalLM model under default dtype torch.bfloat16.\n",
            "[INFO|configuration_utils.py:986] 2026-01-20 18:36:05,071 >> Generate config GenerationConfig {\n",
            "  \"bos_token_id\": 151643,\n",
            "  \"eos_token_id\": 151645,\n",
            "  \"use_cache\": false\n",
            "}\n",
            "\n",
            "[INFO|configuration_utils.py:941] 2026-01-20 18:36:16,859 >> loading configuration file generation_config.json from cache at /root/.cache/huggingface/hub/models--Qwen--Qwen2.5-1.5B-Instruct/snapshots/989aa7980e4cf806f80c7fef2b1adb7bc71aa306/generation_config.json\n",
            "[INFO|configuration_utils.py:986] 2026-01-20 18:36:16,859 >> Generate config GenerationConfig {\n",
            "  \"bos_token_id\": 151643,\n",
            "  \"do_sample\": true,\n",
            "  \"eos_token_id\": [\n",
            "    151645,\n",
            "    151643\n",
            "  ],\n",
            "  \"pad_token_id\": 151643,\n",
            "  \"repetition_penalty\": 1.1,\n",
            "  \"temperature\": 0.7,\n",
            "  \"top_k\": 20,\n",
            "  \"top_p\": 0.8\n",
            "}\n",
            "\n",
            "[INFO|dynamic_module_utils.py:423] 2026-01-20 18:36:16,996 >> Could not locate the custom_generate/generate.py inside Qwen/Qwen2.5-1.5B-Instruct.\n",
            "[INFO|2026-01-20 18:36:17] llamafactory.model.model_utils.checkpointing:143 >> Gradient checkpointing enabled.\n",
            "[INFO|2026-01-20 18:36:17] llamafactory.model.model_utils.attention:143 >> Using torch SDPA for faster training and inference.\n",
            "[INFO|2026-01-20 18:36:17] llamafactory.model.adapter:143 >> Upcasting trainable params to float32.\n",
            "[INFO|2026-01-20 18:36:17] llamafactory.model.adapter:143 >> Fine-tuning method: LoRA\n",
            "[INFO|2026-01-20 18:36:17] llamafactory.model.model_utils.misc:143 >> Found linear modules: q_proj,v_proj,up_proj,down_proj,gate_proj,o_proj,k_proj\n",
            "[INFO|2026-01-20 18:36:18] llamafactory.model.loader:143 >> trainable params: 36,929,536 || all params: 1,580,643,840 || trainable%: 2.3364\n",
            "[WARNING|trainer.py:906] 2026-01-20 18:36:18,108 >> The model is already on multiple devices. Skipping the move to device specified in `args`.\n",
            "[INFO|trainer.py:749] 2026-01-20 18:36:18,169 >> Using auto half precision backend\n",
            "[WARNING|trainer.py:982] 2026-01-20 18:36:18,172 >> The tokenizer has new PAD/BOS/EOS tokens that differ from the model config and generation config. The model config and generation config were aligned accordingly, being updated with the tokenizer's values. Updated tokens: {'bos_token_id': None, 'pad_token_id': 151643}.\n",
            "[INFO|trainer.py:2519] 2026-01-20 18:36:18,673 >> ***** Running training *****\n",
            "[INFO|trainer.py:2520] 2026-01-20 18:36:18,674 >>   Num examples = 300\n",
            "[INFO|trainer.py:2521] 2026-01-20 18:36:18,674 >>   Num Epochs = 4\n",
            "[INFO|trainer.py:2522] 2026-01-20 18:36:18,674 >>   Instantaneous batch size per device = 2\n",
            "[INFO|trainer.py:2525] 2026-01-20 18:36:18,674 >>   Total train batch size (w. parallel, distributed & accumulation) = 40\n",
            "[INFO|trainer.py:2526] 2026-01-20 18:36:18,674 >>   Gradient Accumulation steps = 20\n",
            "[INFO|trainer.py:2527] 2026-01-20 18:36:18,675 >>   Total optimization steps = 32\n",
            "[INFO|trainer.py:2528] 2026-01-20 18:36:18,682 >>   Number of trainable parameters = 36,929,536\n",
            "[INFO|integration_utils.py:867] 2026-01-20 18:36:18,714 >> Automatic Weights & Biases logging enabled, to disable set os.environ[\"WANDB_DISABLED\"] = \"true\"\n",
            "\u001b[34m\u001b[1mwandb\u001b[0m: [wandb.login()] Loaded credentials for https://api.wandb.ai from /root/.netrc.\n",
            "\u001b[34m\u001b[1mwandb\u001b[0m: Currently logged in as: \u001b[33mmariam9\u001b[0m (\u001b[33mmariam9-bfcai\u001b[0m) to \u001b[32mhttps://api.wandb.ai\u001b[0m. Use \u001b[1m`wandb login --relogin`\u001b[0m to force relogin\n",
            "\u001b[34m\u001b[1mwandb\u001b[0m: \u001b[38;5;178m⢿\u001b[0m setting up run rhseelv4 (0.0s)\n",
            "\u001b[34m\u001b[1mwandb\u001b[0m: \u001b[38;5;178m⣻\u001b[0m setting up run rhseelv4 (0.0s)\n",
            "\u001b[34m\u001b[1mwandb\u001b[0m: \u001b[38;5;178m⣽\u001b[0m setting up run rhseelv4 (0.0s)\n",
            "\u001b[34m\u001b[1mwandb\u001b[0m: Tracking run with wandb version 0.24.0\n",
            "\u001b[34m\u001b[1mwandb\u001b[0m: Run data is saved locally in \u001b[35m\u001b[1m/content/drive/.shortcut-targets-by-id/1_GzXpxDDuF7W4kQw4wsC-4QCgbmBihNW/COVID-19 Vaccine Side Effects and Safety/LLaMA-Factory/wandb/run-20260120_183620-rhseelv4\u001b[0m\n",
            "\u001b[34m\u001b[1mwandb\u001b[0m: Run \u001b[1m`wandb offline`\u001b[0m to turn off syncing.\n",
            "\u001b[34m\u001b[1mwandb\u001b[0m: Syncing run \u001b[33mmajor-deluge-1\u001b[0m\n",
            "\u001b[34m\u001b[1mwandb\u001b[0m: ⭐️ View project at \u001b[34m\u001b[4mhttps://wandb.ai/mariam9-bfcai/llamafactory\u001b[0m\n",
            "\u001b[34m\u001b[1mwandb\u001b[0m: 🚀 View run at \u001b[34m\u001b[4mhttps://wandb.ai/mariam9-bfcai/llamafactory/runs/rhseelv4\u001b[0m\n",
            "{'loss': 0.9536, 'grad_norm': 0.38928407430648804, 'learning_rate': 9.233620996141421e-05, 'epoch': 1.27}\n",
            "{'loss': 0.6092, 'grad_norm': 0.32682764530181885, 'learning_rate': 4.4401776194834613e-05, 'epoch': 2.53}\n",
            " 62% 20/32 [20:54<12:45, 63.75s/it][INFO|trainer.py:4643] 2026-01-20 18:57:22,468 >> \n",
            "***** Running Evaluation *****\n",
            "[INFO|trainer.py:4645] 2026-01-20 18:57:22,469 >>   Num examples = 40\n",
            "[INFO|trainer.py:4648] 2026-01-20 18:57:22,469 >>   Batch size = 2\n",
            "\n",
            "  0% 0/20 [00:00<?, ?it/s]\u001b[A\n",
            " 10% 2/20 [00:00<00:08,  2.05it/s]\u001b[A\n",
            " 15% 3/20 [00:02<00:13,  1.28it/s]\u001b[A\n",
            " 20% 4/20 [00:03<00:14,  1.12it/s]\u001b[A\n",
            " 25% 5/20 [00:04<00:15,  1.02s/it]\u001b[A\n",
            " 30% 6/20 [00:05<00:14,  1.01s/it]\u001b[A\n",
            " 35% 7/20 [00:06<00:13,  1.03s/it]\u001b[A\n",
            " 40% 8/20 [00:07<00:12,  1.05s/it]\u001b[A\n",
            " 45% 9/20 [00:08<00:11,  1.09s/it]\u001b[A\n",
            " 50% 10/20 [00:09<00:10,  1.06s/it]\u001b[A\n",
            " 55% 11/20 [00:10<00:09,  1.04s/it]\u001b[A\n",
            " 60% 12/20 [00:11<00:08,  1.08s/it]\u001b[A\n",
            " 65% 13/20 [00:12<00:07,  1.05s/it]\u001b[A\n",
            " 70% 14/20 [00:13<00:06,  1.03s/it]\u001b[A\n",
            " 75% 15/20 [00:15<00:05,  1.05s/it]\u001b[A\n",
            " 80% 16/20 [00:16<00:04,  1.03s/it]\u001b[A\n",
            " 85% 17/20 [00:17<00:03,  1.02s/it]\u001b[A\n",
            " 90% 18/20 [00:18<00:02,  1.10s/it]\u001b[A\n",
            " 95% 19/20 [00:19<00:01,  1.06s/it]\u001b[A\n",
            "                                   \n",
            "\u001b[A{'eval_loss': 0.5625579953193665, 'eval_runtime': 21.3815, 'eval_samples_per_second': 1.871, 'eval_steps_per_second': 0.935, 'epoch': 2.53}\n",
            " 62% 20/32 [21:16<12:45, 63.75s/it]\n",
            "100% 20/20 [00:20<00:00,  1.04s/it]\u001b[A\n",
            "{'loss': 0.534, 'grad_norm': 0.3919864594936371, 'learning_rate': 2.8058334845816213e-06, 'epoch': 3.8}\n",
            "100% 32/32 [33:26<00:00, 55.78s/it][INFO|trainer.py:4309] 2026-01-20 19:09:54,074 >> Saving model checkpoint to /content/drive/MyDrive/COVID-19 Vaccine Side Effects and Safety/models/checkpoint-32\n",
            "[INFO|configuration_utils.py:765] 2026-01-20 19:09:54,332 >> loading configuration file config.json from cache at /root/.cache/huggingface/hub/models--Qwen--Qwen2.5-1.5B-Instruct/snapshots/989aa7980e4cf806f80c7fef2b1adb7bc71aa306/config.json\n",
            "[INFO|configuration_utils.py:839] 2026-01-20 19:09:54,333 >> Model config Qwen2Config {\n",
            "  \"architectures\": [\n",
            "    \"Qwen2ForCausalLM\"\n",
            "  ],\n",
            "  \"attention_dropout\": 0.0,\n",
            "  \"bos_token_id\": 151643,\n",
            "  \"dtype\": \"bfloat16\",\n",
            "  \"eos_token_id\": 151645,\n",
            "  \"hidden_act\": \"silu\",\n",
            "  \"hidden_size\": 1536,\n",
            "  \"initializer_range\": 0.02,\n",
            "  \"intermediate_size\": 8960,\n",
            "  \"layer_types\": [\n",
            "    \"full_attention\",\n",
            "    \"full_attention\",\n",
            "    \"full_attention\",\n",
            "    \"full_attention\",\n",
            "    \"full_attention\",\n",
            "    \"full_attention\",\n",
            "    \"full_attention\",\n",
            "    \"full_attention\",\n",
            "    \"full_attention\",\n",
            "    \"full_attention\",\n",
            "    \"full_attention\",\n",
            "    \"full_attention\",\n",
            "    \"full_attention\",\n",
            "    \"full_attention\",\n",
            "    \"full_attention\",\n",
            "    \"full_attention\",\n",
            "    \"full_attention\",\n",
            "    \"full_attention\",\n",
            "    \"full_attention\",\n",
            "    \"full_attention\",\n",
            "    \"full_attention\",\n",
            "    \"full_attention\",\n",
            "    \"full_attention\",\n",
            "    \"full_attention\",\n",
            "    \"full_attention\",\n",
            "    \"full_attention\",\n",
            "    \"full_attention\",\n",
            "    \"full_attention\"\n",
            "  ],\n",
            "  \"max_position_embeddings\": 32768,\n",
            "  \"max_window_layers\": 21,\n",
            "  \"model_type\": \"qwen2\",\n",
            "  \"num_attention_heads\": 12,\n",
            "  \"num_hidden_layers\": 28,\n",
            "  \"num_key_value_heads\": 2,\n",
            "  \"rms_norm_eps\": 1e-06,\n",
            "  \"rope_scaling\": null,\n",
            "  \"rope_theta\": 1000000.0,\n",
            "  \"sliding_window\": null,\n",
            "  \"tie_word_embeddings\": true,\n",
            "  \"transformers_version\": \"4.57.1\",\n",
            "  \"use_cache\": true,\n",
            "  \"use_sliding_window\": false,\n",
            "  \"vocab_size\": 151936\n",
            "}\n",
            "\n",
            "[INFO|tokenization_utils_base.py:2421] 2026-01-20 19:09:54,896 >> chat template saved in /content/drive/MyDrive/COVID-19 Vaccine Side Effects and Safety/models/checkpoint-32/chat_template.jinja\n",
            "[INFO|tokenization_utils_base.py:2590] 2026-01-20 19:09:54,909 >> tokenizer config file saved in /content/drive/MyDrive/COVID-19 Vaccine Side Effects and Safety/models/checkpoint-32/tokenizer_config.json\n",
            "[INFO|tokenization_utils_base.py:2599] 2026-01-20 19:09:54,916 >> Special tokens file saved in /content/drive/MyDrive/COVID-19 Vaccine Side Effects and Safety/models/checkpoint-32/special_tokens_map.json\n",
            "[INFO|trainer.py:2810] 2026-01-20 19:09:56,976 >> \n",
            "\n",
            "Training completed. Do not forget to share your model on huggingface.co/models =)\n",
            "\n",
            "\n",
            "{'train_runtime': 2018.2942, 'train_samples_per_second': 0.595, 'train_steps_per_second': 0.016, 'train_loss': 0.6858983468264341, 'epoch': 4.0}\n",
            "100% 32/32 [33:29<00:00, 62.79s/it]\n",
            "[INFO|trainer.py:4309] 2026-01-20 19:09:57,006 >> Saving model checkpoint to /content/drive/MyDrive/COVID-19 Vaccine Side Effects and Safety/models/\n",
            "[INFO|configuration_utils.py:765] 2026-01-20 19:09:57,244 >> loading configuration file config.json from cache at /root/.cache/huggingface/hub/models--Qwen--Qwen2.5-1.5B-Instruct/snapshots/989aa7980e4cf806f80c7fef2b1adb7bc71aa306/config.json\n",
            "[INFO|configuration_utils.py:839] 2026-01-20 19:09:57,245 >> Model config Qwen2Config {\n",
            "  \"architectures\": [\n",
            "    \"Qwen2ForCausalLM\"\n",
            "  ],\n",
            "  \"attention_dropout\": 0.0,\n",
            "  \"bos_token_id\": 151643,\n",
            "  \"dtype\": \"bfloat16\",\n",
            "  \"eos_token_id\": 151645,\n",
            "  \"hidden_act\": \"silu\",\n",
            "  \"hidden_size\": 1536,\n",
            "  \"initializer_range\": 0.02,\n",
            "  \"intermediate_size\": 8960,\n",
            "  \"layer_types\": [\n",
            "    \"full_attention\",\n",
            "    \"full_attention\",\n",
            "    \"full_attention\",\n",
            "    \"full_attention\",\n",
            "    \"full_attention\",\n",
            "    \"full_attention\",\n",
            "    \"full_attention\",\n",
            "    \"full_attention\",\n",
            "    \"full_attention\",\n",
            "    \"full_attention\",\n",
            "    \"full_attention\",\n",
            "    \"full_attention\",\n",
            "    \"full_attention\",\n",
            "    \"full_attention\",\n",
            "    \"full_attention\",\n",
            "    \"full_attention\",\n",
            "    \"full_attention\",\n",
            "    \"full_attention\",\n",
            "    \"full_attention\",\n",
            "    \"full_attention\",\n",
            "    \"full_attention\",\n",
            "    \"full_attention\",\n",
            "    \"full_attention\",\n",
            "    \"full_attention\",\n",
            "    \"full_attention\",\n",
            "    \"full_attention\",\n",
            "    \"full_attention\",\n",
            "    \"full_attention\"\n",
            "  ],\n",
            "  \"max_position_embeddings\": 32768,\n",
            "  \"max_window_layers\": 21,\n",
            "  \"model_type\": \"qwen2\",\n",
            "  \"num_attention_heads\": 12,\n",
            "  \"num_hidden_layers\": 28,\n",
            "  \"num_key_value_heads\": 2,\n",
            "  \"rms_norm_eps\": 1e-06,\n",
            "  \"rope_scaling\": null,\n",
            "  \"rope_theta\": 1000000.0,\n",
            "  \"sliding_window\": null,\n",
            "  \"tie_word_embeddings\": true,\n",
            "  \"transformers_version\": \"4.57.1\",\n",
            "  \"use_cache\": true,\n",
            "  \"use_sliding_window\": false,\n",
            "  \"vocab_size\": 151936\n",
            "}\n",
            "\n",
            "[INFO|tokenization_utils_base.py:2421] 2026-01-20 19:09:57,890 >> chat template saved in /content/drive/MyDrive/COVID-19 Vaccine Side Effects and Safety/models/chat_template.jinja\n",
            "[INFO|tokenization_utils_base.py:2590] 2026-01-20 19:09:57,897 >> tokenizer config file saved in /content/drive/MyDrive/COVID-19 Vaccine Side Effects and Safety/models/tokenizer_config.json\n",
            "[INFO|tokenization_utils_base.py:2599] 2026-01-20 19:09:57,909 >> Special tokens file saved in /content/drive/MyDrive/COVID-19 Vaccine Side Effects and Safety/models/special_tokens_map.json\n",
            "***** train metrics *****\n",
            "  epoch                    =        4.0\n",
            "  total_flos               =  3141475GF\n",
            "  train_loss               =     0.6859\n",
            "  train_runtime            = 0:33:38.29\n",
            "  train_samples_per_second =      0.595\n",
            "  train_steps_per_second   =      0.016\n",
            "Figure saved at: /content/drive/MyDrive/COVID-19 Vaccine Side Effects and Safety/models/training_loss.png\n",
            "Figure saved at: /content/drive/MyDrive/COVID-19 Vaccine Side Effects and Safety/models/training_eval_loss.png\n",
            "[WARNING|2026-01-20 19:09:58] llamafactory.extras.ploting:148 >> No metric eval_accuracy to plot.\n",
            "[INFO|trainer.py:4643] 2026-01-20 19:09:58,918 >> \n",
            "***** Running Evaluation *****\n",
            "[INFO|trainer.py:4645] 2026-01-20 19:09:58,919 >>   Num examples = 40\n",
            "[INFO|trainer.py:4648] 2026-01-20 19:09:58,919 >>   Batch size = 2\n",
            "100% 20/20 [00:20<00:00,  1.01s/it]\n",
            "***** eval metrics *****\n",
            "  epoch                   =        4.0\n",
            "  eval_loss               =     0.5405\n",
            "  eval_runtime            = 0:00:21.31\n",
            "  eval_samples_per_second =      1.876\n",
            "  eval_steps_per_second   =      0.938\n",
            "[INFO|modelcard.py:456] 2026-01-20 19:10:20,266 >> Dropping the following result as it does not have all the necessary fields:\n",
            "{'task': {'name': 'Causal Language Modeling', 'type': 'text-generation'}}\n",
            "\u001b[1;34mwandb\u001b[0m: \n",
            "\u001b[1;34mwandb\u001b[0m: 🚀 View run \u001b[33mmajor-deluge-1\u001b[0m at: \u001b[34mhttps://wandb.ai/mariam9-bfcai/llamafactory/runs/rhseelv4\u001b[0m\n",
            "\u001b[1;34mwandb\u001b[0m: Find logs at: \u001b[1;35mwandb/run-20260120_183620-rhseelv4/logs\u001b[0m\n"
          ]
        }
      ]
    },
    {
      "cell_type": "markdown",
      "source": [
        "# **8. Evaluation**\n",
        "## 8.1 Load Fine-tuned Model\n"
      ],
      "metadata": {
        "id": "IM1XyB-V1tTH"
      }
    },
    {
      "cell_type": "code",
      "source": [
        "import torch\n",
        "from transformers import AutoModelForCausalLM, AutoTokenizer\n",
        "\n",
        "## Configure API Keys\n",
        "# Load WandB and HuggingFace tokens from Colab userdata for experiment logging and model authentication.\n",
        "\n",
        "from google.colab import userdata\n",
        "import wandb\n",
        "\n",
        "wandb.login(key=userdata.get('wandb'))\n",
        "hf_token = userdata.get('huggingface')\n",
        "!huggingface-cli login --token {hf_token}\n",
        "\n",
        "BASE_MODEL_ID = \"Qwen/Qwen2.5-1.5B-Instruct\"\n",
        "FINETUNED_MODEL_PATH = \"/content/drive/MyDrive/COVID-19 Vaccine Side Effects and Safety/models/\"\n",
        "\n",
        "# Load base model\n",
        "model = AutoModelForCausalLM.from_pretrained(\n",
        "    BASE_MODEL_ID,\n",
        "    device_map=\"auto\",\n",
        "    torch_dtype=torch.bfloat16\n",
        ")\n",
        "\n",
        "# Load tokenizer\n",
        "tokenizer = AutoTokenizer.from_pretrained(BASE_MODEL_ID)\n",
        "\n",
        "# Load LoRA-adapter\n",
        "model.load_adapter(FINETUNED_MODEL_PATH)\n",
        "\n",
        "device = \"cuda\" if torch.cuda.is_available() else \"cpu\"\n"
      ],
      "metadata": {
        "id": "DcT7t7cgIZsF"
      },
      "execution_count": null,
      "outputs": []
    },
    {
      "cell_type": "markdown",
      "source": [
        "## 8.2 Define Response Generation Function\n",
        "\n",
        "Prepare a helper to convert LLaMA-Factory style messages into model prediction"
      ],
      "metadata": {
        "id": "NT7JGJoOBwVV"
      }
    },
    {
      "cell_type": "code",
      "source": [
        "def generate_resp(messages):\n",
        "    text = tokenizer.apply_chat_template(\n",
        "        messages,\n",
        "        tokenize=False,\n",
        "        add_generation_prompt=True\n",
        "    )\n",
        "\n",
        "    model_inputs = tokenizer([text], return_tensors=\"pt\").to(device)\n",
        "\n",
        "    generated_ids = model.generate(\n",
        "        **model_inputs,\n",
        "        max_new_tokens=512,\n",
        "        do_sample=False\n",
        "    )\n",
        "\n",
        "    generated_ids = [\n",
        "        output_ids[len(input_ids):]\n",
        "        for input_ids, output_ids in zip(model_inputs.input_ids, generated_ids)\n",
        "    ]\n",
        "\n",
        "    response = tokenizer.batch_decode(generated_ids, skip_special_tokens=True)[0]\n",
        "    return response\n"
      ],
      "metadata": {
        "id": "ax3e1c1z3WO8"
      },
      "execution_count": null,
      "outputs": []
    },
    {
      "cell_type": "markdown",
      "source": [
        "## 8.3 Excute Benchmark\n",
        "Prepare a helper to convert LLaMA-Factory style messages into model prediction"
      ],
      "metadata": {
        "id": "smCdUWpRB2Aq"
      }
    },
    {
      "cell_type": "code",
      "source": [
        "!pip install evaluate\n",
        "!pip install rouge_score absl-py"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "l0jtd1Up-kmq",
        "outputId": "d83d6dab-53bd-4f0c-e9fd-e7d84da3dd1b"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "Requirement already satisfied: evaluate in /usr/local/lib/python3.12/dist-packages (0.4.6)\n",
            "Requirement already satisfied: datasets>=2.0.0 in /usr/local/lib/python3.12/dist-packages (from evaluate) (4.5.0)\n",
            "Requirement already satisfied: numpy>=1.17 in /usr/local/lib/python3.12/dist-packages (from evaluate) (2.0.2)\n",
            "Requirement already satisfied: dill in /usr/local/lib/python3.12/dist-packages (from evaluate) (0.3.8)\n",
            "Requirement already satisfied: pandas in /usr/local/lib/python3.12/dist-packages (from evaluate) (2.2.2)\n",
            "Requirement already satisfied: requests>=2.19.0 in /usr/local/lib/python3.12/dist-packages (from evaluate) (2.32.4)\n",
            "Requirement already satisfied: tqdm>=4.62.1 in /usr/local/lib/python3.12/dist-packages (from evaluate) (4.67.1)\n",
            "Requirement already satisfied: xxhash in /usr/local/lib/python3.12/dist-packages (from evaluate) (3.6.0)\n",
            "Requirement already satisfied: multiprocess in /usr/local/lib/python3.12/dist-packages (from evaluate) (0.70.16)\n",
            "Requirement already satisfied: fsspec>=2021.05.0 in /usr/local/lib/python3.12/dist-packages (from fsspec[http]>=2021.05.0->evaluate) (2024.9.0)\n",
            "Requirement already satisfied: huggingface-hub>=0.7.0 in /usr/local/lib/python3.12/dist-packages (from evaluate) (0.36.0)\n",
            "Requirement already satisfied: packaging in /usr/local/lib/python3.12/dist-packages (from evaluate) (25.0)\n",
            "Requirement already satisfied: filelock in /usr/local/lib/python3.12/dist-packages (from datasets>=2.0.0->evaluate) (3.20.2)\n",
            "Requirement already satisfied: pyarrow>=21.0.0 in /usr/local/lib/python3.12/dist-packages (from datasets>=2.0.0->evaluate) (23.0.0)\n",
            "Requirement already satisfied: httpx<1.0.0 in /usr/local/lib/python3.12/dist-packages (from datasets>=2.0.0->evaluate) (0.28.1)\n",
            "Requirement already satisfied: pyyaml>=5.1 in /usr/local/lib/python3.12/dist-packages (from datasets>=2.0.0->evaluate) (6.0.3)\n",
            "Requirement already satisfied: aiohttp!=4.0.0a0,!=4.0.0a1 in /usr/local/lib/python3.12/dist-packages (from fsspec[http]>=2021.05.0->evaluate) (3.13.3)\n",
            "Requirement already satisfied: typing-extensions>=3.7.4.3 in /usr/local/lib/python3.12/dist-packages (from huggingface-hub>=0.7.0->evaluate) (4.15.0)\n",
            "Requirement already satisfied: hf-xet<2.0.0,>=1.1.3 in /usr/local/lib/python3.12/dist-packages (from huggingface-hub>=0.7.0->evaluate) (1.2.0)\n",
            "Requirement already satisfied: charset_normalizer<4,>=2 in /usr/local/lib/python3.12/dist-packages (from requests>=2.19.0->evaluate) (3.4.4)\n",
            "Requirement already satisfied: idna<4,>=2.5 in /usr/local/lib/python3.12/dist-packages (from requests>=2.19.0->evaluate) (3.11)\n",
            "Requirement already satisfied: urllib3<3,>=1.21.1 in /usr/local/lib/python3.12/dist-packages (from requests>=2.19.0->evaluate) (2.5.0)\n",
            "Requirement already satisfied: certifi>=2017.4.17 in /usr/local/lib/python3.12/dist-packages (from requests>=2.19.0->evaluate) (2026.1.4)\n",
            "Requirement already satisfied: python-dateutil>=2.8.2 in /usr/local/lib/python3.12/dist-packages (from pandas->evaluate) (2.9.0.post0)\n",
            "Requirement already satisfied: pytz>=2020.1 in /usr/local/lib/python3.12/dist-packages (from pandas->evaluate) (2025.2)\n",
            "Requirement already satisfied: tzdata>=2022.7 in /usr/local/lib/python3.12/dist-packages (from pandas->evaluate) (2025.3)\n",
            "Requirement already satisfied: aiohappyeyeballs>=2.5.0 in /usr/local/lib/python3.12/dist-packages (from aiohttp!=4.0.0a0,!=4.0.0a1->fsspec[http]>=2021.05.0->evaluate) (2.6.1)\n",
            "Requirement already satisfied: aiosignal>=1.4.0 in /usr/local/lib/python3.12/dist-packages (from aiohttp!=4.0.0a0,!=4.0.0a1->fsspec[http]>=2021.05.0->evaluate) (1.4.0)\n",
            "Requirement already satisfied: attrs>=17.3.0 in /usr/local/lib/python3.12/dist-packages (from aiohttp!=4.0.0a0,!=4.0.0a1->fsspec[http]>=2021.05.0->evaluate) (25.4.0)\n",
            "Requirement already satisfied: frozenlist>=1.1.1 in /usr/local/lib/python3.12/dist-packages (from aiohttp!=4.0.0a0,!=4.0.0a1->fsspec[http]>=2021.05.0->evaluate) (1.8.0)\n",
            "Requirement already satisfied: multidict<7.0,>=4.5 in /usr/local/lib/python3.12/dist-packages (from aiohttp!=4.0.0a0,!=4.0.0a1->fsspec[http]>=2021.05.0->evaluate) (6.7.0)\n",
            "Requirement already satisfied: propcache>=0.2.0 in /usr/local/lib/python3.12/dist-packages (from aiohttp!=4.0.0a0,!=4.0.0a1->fsspec[http]>=2021.05.0->evaluate) (0.4.1)\n",
            "Requirement already satisfied: yarl<2.0,>=1.17.0 in /usr/local/lib/python3.12/dist-packages (from aiohttp!=4.0.0a0,!=4.0.0a1->fsspec[http]>=2021.05.0->evaluate) (1.22.0)\n",
            "Requirement already satisfied: anyio in /usr/local/lib/python3.12/dist-packages (from httpx<1.0.0->datasets>=2.0.0->evaluate) (4.12.1)\n",
            "Requirement already satisfied: httpcore==1.* in /usr/local/lib/python3.12/dist-packages (from httpx<1.0.0->datasets>=2.0.0->evaluate) (1.0.9)\n",
            "Requirement already satisfied: h11>=0.16 in /usr/local/lib/python3.12/dist-packages (from httpcore==1.*->httpx<1.0.0->datasets>=2.0.0->evaluate) (0.16.0)\n",
            "Requirement already satisfied: six>=1.5 in /usr/local/lib/python3.12/dist-packages (from python-dateutil>=2.8.2->pandas->evaluate) (1.17.0)\n",
            "Collecting rouge_score\n",
            "  Using cached rouge_score-0.1.2.tar.gz (17 kB)\n",
            "  Preparing metadata (setup.py) ... \u001b[?25l\u001b[?25hdone\n",
            "Requirement already satisfied: absl-py in /usr/local/lib/python3.12/dist-packages (1.4.0)\n",
            "Requirement already satisfied: nltk in /usr/local/lib/python3.12/dist-packages (from rouge_score) (3.9.1)\n",
            "Requirement already satisfied: numpy in /usr/local/lib/python3.12/dist-packages (from rouge_score) (2.0.2)\n",
            "Requirement already satisfied: six>=1.14.0 in /usr/local/lib/python3.12/dist-packages (from rouge_score) (1.17.0)\n",
            "Requirement already satisfied: click in /usr/local/lib/python3.12/dist-packages (from nltk->rouge_score) (8.3.1)\n",
            "Requirement already satisfied: joblib in /usr/local/lib/python3.12/dist-packages (from nltk->rouge_score) (1.5.3)\n",
            "Requirement already satisfied: regex>=2021.8.3 in /usr/local/lib/python3.12/dist-packages (from nltk->rouge_score) (2025.11.3)\n",
            "Requirement already satisfied: tqdm in /usr/local/lib/python3.12/dist-packages (from nltk->rouge_score) (4.67.1)\n",
            "Building wheels for collected packages: rouge_score\n",
            "  Building wheel for rouge_score (setup.py) ... \u001b[?25l\u001b[?25hdone\n",
            "  Created wheel for rouge_score: filename=rouge_score-0.1.2-py3-none-any.whl size=24934 sha256=a4830232f145e3e5de8cc7a6e77a537183377f4288ba98ba79b1be89f1538487\n",
            "  Stored in directory: /root/.cache/pip/wheels/85/9d/af/01feefbe7d55ef5468796f0c68225b6788e85d9d0a281e7a70\n",
            "Successfully built rouge_score\n",
            "Installing collected packages: rouge_score\n",
            "Successfully installed rouge_score-0.1.2\n"
          ]
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "import json\n",
        "import time\n",
        "import pandas as pd\n",
        "import torch\n",
        "import evaluate\n",
        "from tqdm import tqdm\n",
        "\n",
        "# Initialize automated evaluation metrics\n",
        "rouge = evaluate.load(\"rouge\")\n",
        "bleu = evaluate.load(\"bleu\")\n",
        "\n",
        "def run_benchmark(eval_path, output_excel=\"/content/drive/MyDrive/COVID-19 Vaccine Side Effects and Safety/evaluation_results.xlsx\"):\n",
        "\n",
        "    # Load your validation dataset\n",
        "    with open(eval_path, \"r\", encoding=\"utf-8\") as f:\n",
        "        eval_data = json.load(f)\n",
        "\n",
        "    results = []\n",
        "    all_predictions = []\n",
        "    all_references = []\n",
        "\n",
        "    print(f Starting Evaluation on {len(eval_data)} samples...\")\n",
        "\n",
        "    for item in tqdm(eval_data):\n",
        "        # Prepare the input prompt following your trained template\n",
        "        # 'instruction' usually contains the User Question in LLaMA-Factory format\n",
        "        user_query = item.get('instruction', \"\")\n",
        "        ground_truth = item.get('output', \"\")\n",
        "\n",
        "        messages = [\n",
        "            {\"role\": \"system\", \"content\": system_message},\n",
        "            {\"role\": \"user\", \"content\": f\"## User Question:\\n{user_query}\\n\\n## Structured Answer:\\n```json\"}\n",
        "        ]\n",
        "\n",
        "        # Measure Inference Latency (Time taken for a single request)\n",
        "        start_time = time.time()\n",
        "        try:\n",
        "            prediction = generate_resp(messages)\n",
        "        except Exception as e:\n",
        "            prediction = f\"Error: {str(e)}\"\n",
        "        end_time = time.time()\n",
        "\n",
        "        latency = end_time - start_time\n",
        "\n",
        "        # Store individual sample results\n",
        "        results.append({\n",
        "            \"Question\": user_query,\n",
        "            \"Ground_Truth\": ground_truth,\n",
        "            \"Model_Prediction\": prediction,\n",
        "            \"Latency_Seconds\": latency\n",
        "        })\n",
        "\n",
        "        all_predictions.append(prediction)\n",
        "        all_references.append(ground_truth)\n",
        "\n",
        "\n",
        "    rouge_results = rouge.compute(predictions=all_predictions, references=all_references)\n",
        "    bleu_results = bleu.compute(predictions=all_predictions, references=all_references)\n",
        "\n",
        "    # Convert results to a DataFrame for analysis and reporting\n",
        "    df = pd.DataFrame(results)\n",
        "\n",
        "    # Calculate Latency and Throughput (Inference speed metrics)\n",
        "    avg_latency = df[\"Latency_Seconds\"].mean()\n",
        "    total_time = df[\"Latency_Seconds\"].sum()\n",
        "    throughput = len(eval_data) / total_time # Samples processed per second\n",
        "\n",
        "    print(\"\\n\" + \"=\"*30)\n",
        "    print(\"BENCHMARK REPORT\")\n",
        "    print(\"=\"*30)\n",
        "    print(f\"Average Latency:  {avg_latency:.2f} sec/sample\")\n",
        "    print(f\"Throughput:       {throughput:.2f} samples/sec\")\n",
        "    print(f\"ROUGE-L Score:    {rouge_results['rougeL']:.4f}\")\n",
        "    print(f\"BLEU Score:       {bleu_results['bleu']:.4f}\")\n",
        "    print(\"=\"*30)\n",
        "\n",
        "    # Save to Excel for project documentation/presentation\n",
        "    df.to_excel(output_excel, index=False)\n",
        "    print(f\"Results saved to {output_excel}\")\n",
        "\n",
        "# Execute the benchmark\n",
        "VAL_DATA_PATH = \"/content/drive/MyDrive/COVID-19 Vaccine Side Effects and Safety/data/llamafactory-finetune-data/val.json\"\n",
        "run_benchmark(VAL_DATA_PATH)"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 353,
          "referenced_widgets": [
            "53dc0e65be0b47af93ff04908c3c1f69",
            "f1354b54455f46b39b956231ec38a639",
            "0df1d57039d641849cc85352b2dcf962",
            "e027623ed29c4f2396385f5ca7514e7b",
            "1fc0ebf03d704c21aa7f0773ac43c606",
            "359cd67521234752bd27b0166a329522",
            "8a46f755a0934603a766dc3e61b34626",
            "3d82a7da6b1346a5a72e515825c7fbf6",
            "7128fd6e541b4708aab7d937255a1948",
            "3e94fc8c1f844f5f92b5908fab8917be",
            "42b523d9112f4e00b7ef003e1f448b3c",
            "4fb99c701cae442bad9c6ef83bfdc270",
            "af6dc6ef700249f988d5a2a831c9c476",
            "1cf1402270ff4285a14694d704be3484",
            "c5fee0c6fff4457cbed716b0f595dcfd",
            "25ac0b56376a45fd9f9e4f1c05b91240",
            "ba142f8814dc40ac898a9e6a0d9a92d4",
            "7bdf5838c4ce44f68958fe7329892793",
            "6ee273f9f5bb4fda82d0d07b2b461bd8",
            "98acfbcf257d41afa18468cd2b6f7346",
            "122a97c8f18f43b9aea83f140988aadc",
            "7dcfd470ecf24a279d6e29e5903ffde7",
            "e3ccc246046a4da083ba2ca9bf0d5eea",
            "d6a0eb40b964473b8319cc2ff55da527",
            "30b89adb718c4f8c8a6a09e9a1f33f1e",
            "28071be0ea9e4bf382ff970e75a0a203",
            "19f40f7d184a4c7e8096fe7431cfdb3f",
            "07fda43f79d14c2f9aa219e70b3adb7c",
            "4af5743537c64b4598b4fed149c10c9a",
            "856eb9842163499097b35c670972d3fc",
            "c4531ace52094d518ae6185c25008715",
            "43dc7946b0294937afe1fc6fe9e7cfa7",
            "c5719fa413a94be2a742c21c5c0b2061",
            "6cab491972c14b399b4eae9ee2bd3639",
            "1959634c96364955af45cea54a958c33",
            "d5ceef6748014b2ca5cfd0811c8a4f70",
            "13943c4345db4075bbc608d7ccafa0af",
            "79629c8356754c7283a33a73dfbc453d",
            "9bca380c558d436c8b329a3615e4af65",
            "3acf3ffba1d642c598c0ba4d60e5b31b",
            "d297a4a9bd3d4b58bc3a18343ce95934",
            "90059f8edb8a4595addc637ae6e4d3c8",
            "bf895907ac7549969d752b8f59ac95a6",
            "98d67b71d9f44958b142ba1f668b8d4c"
          ]
        },
        "id": "Rfo8xDKP3Zjp",
        "outputId": "8e203439-69c4-43b9-edd2-85262cccd6a9"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "display_data",
          "data": {
            "text/plain": [
              "Downloading builder script: 0.00B [00:00, ?B/s]"
            ],
            "application/vnd.jupyter.widget-view+json": {
              "version_major": 2,
              "version_minor": 0,
              "model_id": "53dc0e65be0b47af93ff04908c3c1f69"
            }
          },
          "metadata": {}
        },
        {
          "output_type": "display_data",
          "data": {
            "text/plain": [
              "Downloading builder script: 0.00B [00:00, ?B/s]"
            ],
            "application/vnd.jupyter.widget-view+json": {
              "version_major": 2,
              "version_minor": 0,
              "model_id": "4fb99c701cae442bad9c6ef83bfdc270"
            }
          },
          "metadata": {}
        },
        {
          "output_type": "display_data",
          "data": {
            "text/plain": [
              "Downloading extra modules:   0%|          | 0.00/1.55k [00:00<?, ?B/s]"
            ],
            "application/vnd.jupyter.widget-view+json": {
              "version_major": 2,
              "version_minor": 0,
              "model_id": "e3ccc246046a4da083ba2ca9bf0d5eea"
            }
          },
          "metadata": {}
        },
        {
          "output_type": "display_data",
          "data": {
            "text/plain": [
              "Downloading extra modules: 0.00B [00:00, ?B/s]"
            ],
            "application/vnd.jupyter.widget-view+json": {
              "version_major": 2,
              "version_minor": 0,
              "model_id": "6cab491972c14b399b4eae9ee2bd3639"
            }
          },
          "metadata": {}
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "🚀 Starting Evaluation on 40 samples...\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "100%|██████████| 40/40 [05:05<00:00,  7.65s/it]\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "\n",
            "==============================\n",
            "📊 BENCHMARK REPORT\n",
            "==============================\n",
            "Average Latency:  7.65 sec/sample\n",
            "Throughput:       0.13 samples/sec\n",
            "ROUGE-L Score:    0.6489\n",
            "BLEU Score:       0.6121\n",
            "==============================\n",
            "✅ Results saved to evaluation_results.xlsx\n"
          ]
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [],
      "metadata": {
        "id": "to1i3oQA6O9n"
      },
      "execution_count": 1,
      "outputs": []
    }
  ]
}